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ABSTRACT OF THE DISSERTATION
THE ROLE OF THE TRANSCRIPTION FACTOR ETS1 IN MELANOCYTE
DEVELOPMENT
by
Amy Saldana Tavares
Florida International University, 2014
Miami, Florida
Professor Lidia Kos, Major Professor
Melanocytes, pigment-producing cells, derive from the neural crest (NC), a
population of pluripotent cells that arise from the dorsal aspect of the neural tube during
embryogenesis. Many genes required for melanocyte development were identified using
mouse pigmentation mutants. The deletion of the transcription factor Ets1 in mice results in
hypopigmentation; nevertheless, the function of Ets1 in melanocyte development is
unknown. The goal of the present study was to establish the temporal requirement and role
of Ets1 in murine melanocyte development. In the mouse, Ets1 is widely expressed in
developing organs and tissues, including the NC. In the chick cranial NC, Ets1 is required
for the expression of Sox10, a transcription factor critical for the development of
melanocytes, enteric ganglia, and other NC derivatives.
Using a combination of immunofluorescence and cell survival assays Ets1 was
found to be required between embryonic days 10 and 11, when it regulates NC cell and
melanocyte precursor (melanoblast) survival. Given the requirement of Ets1 for Sox10
expression in the chick cranial NC, a potential interaction between these genes was
investigated. Using genetic crosses, a synergistic genetic interaction between Ets1 and
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Sox10 in melanocyte development was found. Since Sox10 is essential for enteric ganglia
formation, the importance of Ets1 on gut innervation was also examined. In mice, Ets1
deletion led to decreased gut innervation, which was exacerbated by Sox10 heterozygosity.
At the molecular level, Ets1 was found to activate a Sox10 enhancer critical for
Sox10 expression in melanoblasts. Furthermore, mutating Ets1 at a site I characterized in
the spontaneous variable spotting mouse pigmentation mutant, led to a 2-fold decrease in
enhancer activation. Overexpression and knockdown of Ets1 did not affect Sox10
expression; nonetheless, Ets1 knockdown led to a 6-fold upregulation of the transcription
factor Sox9, a gene required for melanocyte and chondrocyte development, but which
impairs melanocyte development when its expression is prolonged. Together, these results
suggest that Ets1 is required early during melanocyte development for NC cell and
melanoblast survival, possibly acting upstream of Sox10. The transcription factor Ets1 may
also act indirectly in melanocyte fate specification by repressing Sox9 expression, and
consequently cartilage fate.
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I. INTRODUCTION
Melanocytes, the pigment producing cells, are derived from neural crest (NC)
cells, a population of pluripotent cells that arise from the dorsal aspect of the neural tube
during vertebrate embryogenesis (Le Douarin and Kalcheim, 1999). Neural crest cells
undergo an epithelial to mesenchymal transition (EMT) and migrate out of the neural
tube along distinct pathways to contribute to different tissues and organs (Le Douarin et
al., 2004). In addition to melanocytes, other NC-derived lineages include endocrine cells,
glial cells, neurons, craniofacial bone and cartilage, and cardiac cells (Le Douarin and
Kalcheim, 1999). Defects in NC cell development result in a range of human disorders
known as Neurocristopathies (Bolande, 1997). These include craniofacial malformations,
cardio- and neurocutaneous syndromes, Waardenburg Syndrome (WS), Hirschsprung’s
disease, Tietz Syndrome, and piebaldism, among others (reviewed in Hou and Pavan,
2008; Pingault et al., 2010).
Neurocristopathies are caused by mutations in genes required for proper NC cell
development. Mutations in the transcription factors sex determining region Y (SRY)-box
10 (SOX10), paired box 3 (PAX3), Microphthalmia-associated transcription factor
(MITF) and snail homolog 2 (SNAI2) and in the signaling molecules Endothelin 3
(EDN3) and Endothelin receptor b (EDNRB) are responsible for the four different known
types of WS. Waardenburg Syndrome is characterized by pigmentation defects,
congenital deafness, and heterochromia irides; however, other anomalies, such as
craniofacial and limb abnormalities, aganglionosis of the distal colon (Hirschsprung’s
disease), and neurological defects are found in a group of WS patients and serve for the
classification of the different types of WS. The study of mouse pigmentation mutants
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was instrumental in the identification of the genes involved in WS (reviewed in
Tachibana et al., 2003) (Figure 1.1). The first indication that PAX3 mutations were
responsible for WS type I was the identification of loss of function mutations in the
murine ortholog Pax3 gene in the Splotch mouse, an embryonic lethal pigmentation
mutant that exhibits neural tube and NC defects (Tassabehji et al., 1992). In the same
manner, the piebald lethal and lethal spotting mouse mutants, which harbor spontaneous
mutations in Ednrb and Edn3 respectively, were instrumental for the identification of
mutations in these genes in WS type IV and in Hirschsprung’s disease (Hosoda et al.,
1994; Puffenberger et al., 1994). The study of mouse pigmentation mutants has also been
important for the elucidation of signaling pathways required for proper melanocyte and
NC cell development and for understanding other pathological conditions of NC-derived
cell lineages (Barsh, 1996; Baxter et al., 2004)
1.1 The neural crest
1.1.1

Neural crest induction

The neural crest (NC) is a transient population of cells that originates during
embryonic development, between the neural ectoderm and the non-neural ectoderm,
which give rise to the central nervous system and the epidermis, respectively (Le Douarin
and Kalcheim, 1999). Neural crest cells delaminate from the dorsal aspect of the neural
tube and travel through the embryo giving rise to various cell lineages, which include
neurons and glia of the sympathetic, parasympathetic, and sensory nervous systems,
smooth muscle cells, facial cartilage and bone cells, medullary secretory cells, and
pigment cells or melanocytes (reviewed in Dupin et al., 2006). Much of what is known
about the NC has been elucidated using avian and amphibian embryos, since these
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develop externally, and are easier to manipulate than mouse embryos. Additionally, NC
cells arise very early in development, at a time when mouse embryos are difficult to
experiment on as a result of their small size (Gammill and Bronner-Fraser, 2003).
Transplantation and in vitro culture experiments using quail and chick neural
plate and prospective epidermis have demonstrated that both the neural and the nonneural ectoderm contribute to the formation of the NC. Nonetheless, older neural plates,
in the absence of prospective epidermis, are able to give rise to certain NC derivatives,
particularly melanocytes, under permissive culture conditions (Selleck and Broner-Fraser,
1995). The paraxial mesoderm, which gives rise to paired somites from which the axial
skeleton and skeletal muscles are derived, was also found to contribute to NC cell
formation (Selleck and Broner-Fraser, 1995; Bonstein et al., 1999).
Several secreted signaling molecules are required for the induction of the NC
(Figure 1.2). Intermediate levels of Bone Morphogenetic Proteins (BMPs) at the neural
plate border were initially thought to be required for NC induction (Marchant et al., 1998;
Tribulo et al., 2003). Bone Morphogenetic Protein levels are controlled by the BMP
antagonists, Noggin, Chordin and Follistatin, all of which are expressed in the paraxial
mesoderm and are important for embryonic patterning (reviewed in Sauka-Spengler and
Bronner-Fraser, 2008). Experiments in the avian system using the BMP inhibitor Noggin
later showed that BMPs are not required for NC induction, but rather appear to be
required after neural tube closure for the maintenance of the induced NC cell population
(Selleck et al., 1998). Similar experiments in Xenopus, using the BMP inhibitor Chordin,
showed that intermediate levels of BMP signaling are not essential for NC induction
(LaBonne and Broner-Fraser, 1998). In frogs and birds, BMP appears to be regulated via
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Notch-Delta signaling. In the avian system, Notch activation via Delta1 was found to be
required for BMP4 expression in the epidermis and for inhibiting NC formation in this
region (Endo et al., 2002). The requirement of Notch for both BMP4 expression and
inhibition of NC cell formation in the epidermis suggests that Notch signaling is not only
important for NC formation or maintenance via BMP4, but also for restricting the NC to
the neural plate border (Sauka-Spengler and Bronner-Fraser, 2008). In addition to BMPs
and Notch, in Xenopus, fibroblast growth factor (FGF) signaling proteins from the
paraxial mesoderm, particularly FGF2 and FGF8, have been found to be important for
NC induction (reviewed in Gammill and Bronner-Fraser, 2003; Sauka-Spengler and
Bronner-Fraser, 2008).
Experiments in Xenopus, zebrafish, and the chick have placed the canonical Wnt
signaling pathway at the center of NC induction. In Xenopus, β-catenin overexpression
can cell autonomously induce the expression of the NC marker Slug in cells that normally
give rise to the epidermis (LaBonne and Broner-Fraser, 1998). Furthermore,
overexpression of Wnt3a in the neuroectoderm can expand the number of cells expressing
the NC markers Slug and Krox20, even in the presence of proliferation inhibitors.
Conversely, overexpression of the β-catenin inhibitor, glycogen synthase kinase 3 beta
(GSK3β), was found to inhibit NC cell formation (Saint-Jeannet et al., 1997). Similarly,
in zebrafish, early blockage of Wnt signaling results in a significant loss of expression of
NC cell markers. Moreover, transplantation experiments confirmed that Wnt acts cellautonomously to direct the formation of NC cells (Lewis et al., 2004). In the chick,
blocking Wnt signaling inhibits the expression of the NC cell marker Slug. On the other
hand, incubating naïve neural plate cells in medium containing the Drosophila Wnt
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homolog wingless, can induce NC cell formation, in the absence of other factors. These
experiments showed that Wnt signaling is both required and sufficient for NC induction
in the chick embryo (Garcia-Castro et al., 2002).
In the mouse, the role of the canonical Wnt signaling pathway in NC induction
has not been well established (Sauka-Spengler and Bronner-Fraser, 2008). Double
knockout mouse embryos of Wnt1 and Wnt3a have severely reduced numbers of cells
expressing NC markers and decreased numbers of NC derivatives. Similarly, conditional
β-catenin knockout mice have severe abnormalities in cranial NC cell derivatives, but the
expression of NC cell markers is unaffected in these embryos. Given the normal levels of
NC cell marker expression in β-catenin knockout mice, it is unclear whether the decrease
in NC cells seen in these mutant embryos is the result of improper NC formation or of
decreased survival or proliferation (reviewed in Wu et al., 2003).
1.1.2

Specification of the neural plate border and neural crest specifier genes.
The induction signals at the border between the neural and non-neural ectoderm,

lead to the expression of transcription factors that serve to specify the neural plate border,
which is the region from which NC cells will be derived (Figure 1.2). The transcription
factors expressed in this region are known as neural plate border specifiers (SaukaSpengler and Bronner-Fraser, 2008). The neural plate border is not a well demarcated
area (Sargent, 2006). Fate mapping experiments in the chick embryo have shown that NC
cells are interspersed with otic placode precursor cells, epidermal, and neural progenitor
cells in this region (Streit, 2002). The neural plate border specifier genes include the zincfinger transcription factor Zic1, the activating enhancer binding protein 2 alpha (TFAP2
or AP2) transcription factor, members of the paired box family of transcription factors
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Pax3 and Pax7, the homeobox transcriptional repressors Msx1 and Msx2, and the
homeodomain transcription factors Dlx3 and Dlx5 (Figure 1.2) (reviewed in Gammill and
Bronner-Fraser, 2003; Sargent, 2006; Sauka-Spengler and Bronner-Fraser, 2008). The
expression of these genes at the neural plate border is required for the subsequent
specification of NC cells. In addition to being expressed in prospective NC cells, some of
the neural plate border specifiers are expressed in the neural plate while others are
expressed in the non-neural ectoderm (reviewed in Gammill and Bronner-Fraser, 2003).
In the mouse, most neural plate border specifiers begin to be expressed at embryonic day
(E) 7.5, around the time the neural folds form (reviewed in Stuhlmiller and GarciaCastro, 2012).
Following neural plate border specification, a group of transcription factors
required for the specification of NC cells is upregulated. Neural crest specifier
transcription factors include Snail2, Sex determining region Y (SRY)-box 9 (Sox9),
Sox10 and Forkhead box D3 (FoxD3) (Figure 1.2). In the mouse, Sox9, Sox10 and FoxD3
are expressed in the neural folds soon after the neural plate border is specified and right
before the initiation of cranial NC cell migration around E8 (reviewed in Stuhlmiller and
Garcia-Castro, 2012). The expression of NC specifiers is essential for the maintenance of
the NC population and for the epithelial-to-mesenchymal transition (EMT), delamination
and migration that these cells must undergo in order to reach their final destinations
(Sauka-Spengler and Bronner-Fraser, 2008). Members of the Snail family of transcription
factors seem to play an essential role in NC specification and EMT in chick (Nieto et al.,
1994; Del Barrio and Nieto, 2002; Taneyhill et al., 2007), and frog (Carl et al., 1999;
LaBonne and Bronner-Fraser, 2000) embryos, however; in the mouse embryo, migrating
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NC cells can be detected in double knockouts of the Snail and Slug mouse homologs
Snai1 and Snai2, respectively, which suggests that other transcription factors are able to
compensate for the deficiency of these two (Murray and Gridley, 2006). The transcription
factor FoxD3 is also involved in NC specification. It is expressed in almost all premigratory and migratory NC cells, except for cells fated to become melanocyte
precursors (melanoblasts) (Kos et al., 2001). In NC cells, FoxD3 cooperates with Snail2,
Sox9 and Sox10 to promote the changes required for EMT (reviewed in Theveneau and
Mayor, 2012).
The transcription factors Sox9 and Sox10 are expressed in the pre-migratory NC
in the frog and zebrafish. In the frog, Sox9 expression is maintained in migrating NC cells
(Spokony et al., 2002). In the mouse, Sox9 is expressed in pre-migratory and migratory
NC cells, while Sox10 expression is initiated at the onset of NC cell migration. The
transcription factor Sox9 is required for the formation of NC precursor cells by driving
the expression of other NC cell markers, including Sox10 (Cheung and Briscoe, 2003;
Cheung et al., 2005; Betancur et al., 2010). In addition to its importance for NC cell
formation, Sox9 is also required for NC cell survival (Yan et al., 2005; Cheung et al.,
2005) and delamination (Cheung et al., 2003). Like Sox9, Sox10 is also essential for NC
cell survival; however, it does not appear to be required for the initial specification of the
NC cells (Southard-Smith et al., 1998; Kapur, 1999). Sox10 also appears to be required
for maintaining the pluripotency of NC cells (Kim et al., 2003; McKeown et al., 2005),
and in cooperation with Sox9, FoxD3 and Snail, it is also involved in NC cell
delamination (McKeown et al., 2005; reviewed in Theveneau and Mayor, 2012).
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1.1.3

Neural crest delamination and neural crest derivatives
Neural crest delamination refers to the segregation of the NC into separate

populations. The process of NC delamination varies according to the region along the
anterior-posterior axis from which the cells delaminate. Cranial NC cell delamination
occurs all at once, while trunk NC cells delaminate gradually in a cranial to caudal order.
In the mouse, cranial NC cells delaminate prior to the closure of the neural tube, while
trunk NC cells migrate after neural tube closure (reviewed in Theveneau and Mayor,
2012). Nevertheless, neural tube closure and NC cell delamination do not appear to be
related, as NC cell delamination and NC derivatives are unaffected in Pax3 null mouse
embryos, in which failure of neural tube closure results in severe spina bifida (Estiberio
et al., 1993; Franz, 1993).
Neural crest cell delamination has been mostly studied in the chick embryo;
however, the general events and signaling cascades at work are common to other
vertebrate species (Sauka-Spengler and Bronner-Fraser, 2008). As a result of somite
maturation, BMP and Wnt signaling promote EMT via activation of the transcription
factors FoxD3, Snail2, Sox8 and Sox9. The combined effect of these transcription factors
is a shift in the expression of calcium-dependent adhesion proteins, or Cadherins, from
type I Cadherins, like E-Cadherin and N-Cadherin, which are associated with stable
epithelial and neuronal cell assemblies, respectively, to type II cadherins, like Cadherin
6B, Cadherins 7 and 11, which are expressed in mesenchymal cells (Figure 1.2)
(reviewed in Sauka-Spengler and Bronner-Fraser, 2008; Theveneau and Mayor, 2012).
The transcription factors FoxD3, Snail2, Sox8 and Sox9 also activate the expression of

	
  

9

	
  

extracellular signaling molecules and cytoskeletal proteins and promote laminin synthesis
and the degradation of the basal lamina (Theveneau and Mayor, 2012).
Neural crest cells are divided into four overlapping domains, along the anteriorposterior axis, which give rise to different cell lineages. Nonetheless, NC cells from
different levels or domains contribute to both distinct and overlapping derivatives
(Bronner and Le Douarin, 2012). The four NC domains are the cranial and cephalic, the
vagal and sacral, the trunk, and the cardiac NC (Le Douarin, 1982). The cranial and
cephalic NC includes the cells derived from the prosencephalic, mesencephalic and
anterior rhomencephalic regions (Bronner and Le Douarin, 2012). Cranial NC cells
migrate dorsolaterally and give rise to mesenchymal cells that contribute to cartilage,
bone, cranial neurons, glia and Schwann cells, ciliary and cranial sensory ganglia, and
melanocytes of the skin and inner ear (Gilbert, 2003; Dupin and Sommer, 2012; Bronner
and Le Douarin, 2012). The vagal crest is composed of the posterior rhombencephalic
crest at the level of somites 1 through 7, while the sacral crest refers to the NC cells
caudal to somite 28. Vagal NC cells give rise to the sympathetic ganglia of the gut. Some
cells from the vagal and sacral levels also give rise to melanocytes (Bronner and Le
Dourain, 2012). Cardiac NC cells overlap with the anterior portion of the vagal NC. They
are located in the region from the first to the third somite between the cranial and trunk
NC (Gilbert, 2003). Cardiac NC cells contribute to the septum and outflow tract of the
heart (Bronner and Le Douarin, 2012). They can also give rise to melanocytes, neurons,
connective tissue and cartilage (Gilbert, 2003).
Trunk NC cells comprise the cells at the cervical and thoracic levels adjacent to
somites 8-28 (Bronner and Le Douarin, 2012). In the mouse, trunk NC cells migrate via
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two mayor pathways, the ventral and dorsolateral pathways. Cells of the ventral pathway
migrate through the rostral side of the somite between the neural tube and the
dermamyotome. Trunk NC cells of the ventromedial pathway migrate in two overlapping
phases. The first wave of cells migrate ventrolaterally from E9 through E9.5 (Serbedzija
et al., 1990); these cells migrate more ventrally than those from the second wave, and
give rise to the sympathetic ganglia, the adrenal medulla, and nerves around the aorta
(Gilbert, 2003). The second wave of cells migrates ventromedially, along the lateral
surface of the neural tube, in the ventromedial portion of the sclerotome, from E9.5
through E10.5. The second wave of ventrally migrating trunk NC cells gives rise to the
dorsal root ganglia (DRG), Schwann cells (Serbedzija et al., 1990), and a portion of the
skin melanocytes that derive from Schwann cell precursor cells (Adameyko et al., 2009).
Trunk NC cells of the dorsolateral pathway migrate between the dermamyotome and the
epidermis (Serbedzija et al., 1990). Dorsolaterally migrating NC cells move through the
epidermis to the ventral midline and give rise to skin melanocytes (Gilbert, 2003).
The NC has been referred to as the fourth germ layer because it makes
contributions to almost every tissue of the body (Hall, 2000). The large diversity of cells
that are derived from the neural crest contributes to numerous features that are specific to
vertebrates, including craniofacial bone and sensory glia (Bronner and Le Douarin,
2012). The multipotent nature of NC cells also makes them a useful model for the field of
stem cell biology (Dupin and Sommer, 2012).
1.2 Melanocyte Development
The pigment producing cells, or melanocytes, are derived from all NC domains,
but most are derived from the cranial and trunk NC. In mice, the cells fated to become
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melanocyte precursors (melanoblasts) develop around E8.5, when they express Wnt1,
Pax3 and Sox10. Around E10-10.5, these cells begin to express the melanoblast markers
microphthalmia-associated transcription factor (Mitf) and Kit, which codes for a tyrosine
kinase receptor. After a few hours, melanoblasts localize to the migration staging area
(MSA), which is located in the dorsal aspect of the neural tube. At this point
melanoblasts begin to express Dopachrome tautomerase (Dct), which codes for one of the
key enzymes in the melanin synthesis pathway. Between E10 and E12.5, signaling via the
Endothelin receptor b (Ednrb) and the tyrosine kinase receptor Kit are required for
melanoblast survival, proliferation, and migration. At this point, melanoblasts continue to
divide as they migrate through the dermis. A large portion of melanoblasts enter the
epidermis between E13.5 and E14.5 and by E15.5, a subset of them populate the still
developing hair follicles. At E15.5, melanoblasts begin to express other melanogenic
enzymes, including Tyrosinase (Tyr) and Tyrosinase-related protein 1 (Tyrp1 or Trp1),
and sometime between E15.5 and birth, these cells differentiate into mature melanocytes
once they begin to produce pigment (reviewed in Silver et al., 2006) (Figure 1.3). The
final steps of differentiation also require the transcription factors Mitf and Sox10 as well
as Kit and Endothelin signaling for the expression of melanogenic enzymes and
subsequent pigment production (Hou et al., 2004; Hou et al., 2006; Levy et al., 2006).
For many years, all trunk melanoblasts where thought to derive solely from cells
traveling via the dorsolateral pathway. Recently, a second population of melanocytes was
found to derive from NC cells traveling along the ventral pathway, specifically from
Schwann cell precursors (SCPs) (Adameyko et al., 2009). Schwann cell precursors
express Sox10, and associate with neuronal projections that allow them to travel long
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distances along the nerves (Jessen and Mirsky, 2005). In the chick and mouse embryos, a
population of Mitf-positive cells was found within nerves of the peripheral nervous
system, particularly in the distal ventral ramus of the spinal nerve, which innervates the
skin. These cells were associated but not in direct contact with nerve bundles, and were
found, via lineage tracing experiments, to be derived from SCPs (Adameyko et al., 2009).
In the mouse, a subset of cranially derived melanocytes has also been shown to arise from
SCPs around cranial nerves IX-X. Similar to trunk melanoblasts of the dorsolateral
pathway, cranial SCP-derived melanoblast appear to depend on Ednrb signaling for their
expansion and dispersal (Adameyko et al., 2012).
1.3. Genetic network of melanocyte development: Lessons from pigmentation
mutants
The development of melanocytes from the NC is dependent upon the activation of
several transcription factors, including Sox10, Pax3, and Mitf, which are involved in the
specification, survival and final differentiation of melanocyte precursors. In addition to
these factors, environmental cues also guide the development of melanocytes. Signaling
molecules such as Wnt, Kitl and Edn3 are essential for the survival, proliferation,
migration and differentiation of melanocytes. Studies in various model organisms,
including the chick, zebrafish, Xenopus, and the mouse, have been essential for
understanding the various functions and interactions of these transcription factors and
signaling molecules in melanocyte development (Silver et al., 2006).
1.3.1 Cell intrinsic factors
The

basic-helix-loop-helix-leucine-zipper

Microphthalmia-associated

transcription factor (Mitf) has been described as the master regulator of melanocyte
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development (McGill et al., 2002). The expression of this transcription factor is
considered the key event in the specification of melanoblasts from the neural crest. In
humans, MITF is mutated in Waardenburg syndrome type 2a (WS2a), which is
characterized by a decrease in the number of melanocytes of the eye, inner ear and
forelock (Levy et al., 2006). In mice, at least 25 spontaneous Mitf allelic mutants have
been identified. The effect of these mutations range from minor pigmentation defects in
some, to complete absence of mature melanocytes in others (reviewed in Hou and Pavan,
2008). In mice homozygous for a severe Mitf mutation in which Mitf function is
completely abrogated, NC-derived cells fail to express Dct. In addition, a small number
of Mitf-expressing cells arise in NC cell cultures derived from wild type and Mitf
mutants; however, Mitf mutant cells fail to express Dct and are quickly lost (Opdecamp et
al., 1997). These results suggest that Mitf is necessary for either the survival,
proliferation, or to prevent the trans-differentiation of melanocytes into other cell
lineages. Of these functions, support for the role of Mitf in survival has come from the
hypomorphic Mitfvit mouse mutants, which initially exhibit normal coat pigmentation, but
gradually lose it as a result of the depletion of melanocyte stem cells caused by reduced
Mitf levels within the bulge of the hair follicles (Lerner et al., 1986; Nishimura et al.,
2005).
Additional evidence supporting a role for Mitf in melanocyte survival stems from
its role as a transcriptional regulator of the Bcl2 anti-apoptotic protein (McGill et al.,
2002).

This protein has also been shown to be required for melanocyte viability,

specifically for the maintenance of melanocyte stem cells (Nishimura et al., 2005) and
melanoblasts (Mak et al., 2006). Mitf also interacts with cyclin-dependent kinase 2
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(Cdk2), a cell cycle regulator essential for the maintenance of melanoma cell viability
and cell cycle. Phenotypes associated with deletion Bcl2 and Cdk2 are less severe than
those that result from Mitf null mutations, suggesting that Mitf may be important for
melanocyte survival during development through additional pathways as of yet
characterized (Lin and Fisher, 2007). Another transcriptional target of Mitf, is the
hepatocyte growth factor (HGF) receptor, c-Met which has been shown to be involved in
melanocyte survival in vitro, where HGF treatment of NC cells results in increased
melanoblast numbers, and in vivo, where restricted HGF expression in the epidermis
leads to an increase in the number of melanoblasts and mature dermal melanocytes
(McGill et al., 2006).
A role for Mitf in melanocyte proliferation has been suggested because many of
its transcriptional targets are important regulators of cell cycle progression and
proliferation. One such target is the T-Box transcription factor 2 (TBX2), which indirectly
regulates cell cycle progression and apoptosis by repressing the p19 Alternate Reading
Frame (p19Arf) promoter and thus inducing the degradation of the pro-apoptotic p53
protein. Mitf regulation of Cdk2 may also be important for melanocyte proliferation, as
Cdk2 promotes cell cycle progression (reviewed in Hou and Pavan, 2008). Interestingly,
Mitf targets also include the cell cycle inhibitors p21 and Ink4a (Inhibitor of CKD4). The
inhibition of cell cycle progression is essential for differentiation, an additional role of
Mitf in melanocyte development. Mitf promotes early melanocyte fate specification and
melanocyte differentiation through direct transcriptional regulation of Tyrosinase (Tyr),
Tyrosinase related protein-1 (Trp1) and Tyrosinase-related protein-2 (Trp2 or Dct), all of
which code for pigment enzymes. Other genes that have been implicated in melanocyte
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differentiation and are transcriptionally regulated by Mitf include absent in melanoma-1
(AIM-1), melanoma antigen recognized by T-cells 1 (MART1), and silver homolog (SILV
or PMEL17). The latter two genes encode melanosomal structural proteins (reviewed in
Levy et al., 2006).
Other transcription factors interact with Mitf to promote melanocyte development.
The transcription factors Pax3 and Sox10 have been shown to activate the Mitf promoter
both individually (Watanabe et al., 1998; Bondurand et al., 2000; Lee et al., 2000; Potterf
et al., 2000; Verastegui et al., 2000) and synergistically (Bondurand et al., 2000; Potterf
et al., 2000). The specific roles of Pax3 in melanocyte development are not fully
understood. In humans, PAX3 mutations are associated with Waardenburg Syndrome
(WS) types 1 and 3, which are characterized, by hipopigmentation, heterochromia irides,
deafness, and in type 3, skeletal abnormalities. Spontaneous Pax3 mutations have also
been described in the mouse. The spontaneous Splotch mouse mutant harbors a loss of
function mutation in Pax3. Homozygous Splotch mutants exhibit spina bifida and are
embryonic lethal as a result. Splotch heterozygotes present a belly spot, suggesting a role
for this transcription factor in melanocyte development (reviewed in Hou and Pavan,
2008). In homozygous Splotch mutants, Dct-positive melanoblasts can be observed
traveling along the dorsolateral pathway. In these mutants melanoblast numbers are
reduced but not completely absent, which suggests that Pax3 may not be essential for the
initial specification of melanoblasts, but appears to be required for their expansion
(Hornyak et al., 2001).
The transcription factor Pax3 has been suggested to both promote and inhibit
melanocyte fate specification (Kubic et al., 2008). By activating Mitf, Pax3 may influence
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melanoblasts towards the melanocytic fate. At the same time Pax3 has also been shown
to inhibit Dct activation, which is dependent on Sox10 and Mitf, by forming a repressor
complex with the transcription factor Lymphoid enhancer binding factor 1 (Lef1) and the
Groucho co-repressor Grg4, and by competing with Mitf for binding to Dct regulatory
elements (Lang et al., 2005). The dual role of Pax3 in promoting Mitf expression while
inhibiting Dct expression, suggests that Pax3 may be involved in the initial fate decision
of melanoblasts as well as in preventing the terminal differentiation of precursors.
Maintenance of melanoblasts in an undifferentiated state may be necessary to allow the
sufficient expansion of melanocyte precursors before they become terminally
differentiated (Lang et al., 2005). Interestingly, Pax3 may also act to promote melanocyte
differentiation as it has been shown to transactivate the Trp1 promoter (Galibert et al.,
1999).
The transcription factor Sox10 appears to be important in the specification of
melanoblasts from the NC. Sox10 is a member of the SoxE family of transcription
factors, which contain a high mobility group (HMG) box DNA-dependent dimerization
domain (reviewed in Harris et al., 2010). Zebrafish harboring a mutant allele of the
zebrafish Sox10 homologue display an almost complete absence of NC cells on migratory
pathways associated with pigment cells. In these mutants, the differentiation of certain
tissues arising from NC derivatives, including craniofacial skeleton and fin mesenchyme,
is unaffected, while differentiation of other NC derivatives, including melanocytes, is
severely impaired and is accompanied by the lack of Mitf or Kit expression. The
pigmentation phenotype of these mutants can be rescued by Mitf overexpression, pointing
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to a role for Sox10 in the specification of melanocytes from the NC that appears to be
mediated via transcriptional activation of Mitf (Dutton et al., 2001).
In the mouse, the role of Sox10 in melanocyte development appears to be slightly
different than in zebrafish. The spontaneous Dominant megacolon (Dom) mouse mutant
harbors a mutation in Sox10 which results in premature truncation of the Sox10 protein.
Heterozygous Dom (Sox10Dom/+) mutants exhibit white spotting and aganglionosis of the
distal colon. Similar developmental abnormalities are observed in human cases of WS2
and WS4, a subset of which are associated with SOX10 mutations (Bondurand et al.,
2007). Homozygous Dom (Sox10Dom/Dom) mutants die by E13.5 for reasons that are not
fully understood. Homozygous Dom mutant embryos have defects in dorsal root ganglia,
sympathetic ganglia, and terminal oligodendrocyte differentiation, reduced dorsal
trigeminal and facial ganglia, and absence of melanoblasts and enteric neurons (Herbarth
et al., 1998; Southard-Smith et al., 1998). Similar developmental defects are also
observed in Sox10LacZ mice, in which the Sox10 open reading frame is replaced by the
LacZ gene (Britsch et al., 2001). The pigmentation phenotype observed in both Sox10
mutants results from decreased melanoblast numbers. In Sox10Dom/Dom embryos, complete
lack of Dct expression (Southard-Smith et al., 1998), and increased apoptosis in NC
migratory pathways (Southard-Smith et al., 1998; Kapur, 1999) are observed and suggest
a role for Sox10 in NC cell survival. Overexpression of Mitf in NC cultures from
Sox10LacZ/LacZ mice can partially rescue cell survival, which implies that the regulation of
melanoblast survival by Sox10 may be linked to its role in driving Mitf expression (Hou
et al., 2006).
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The role of Sox10 in melanoblast specification appears to be both Mitf-dependent
and Mitf-independent. In Sox10Dom/+ mice, melanoblasts lack Dct expression between
E10.5 and E12.5; nevertheless, this transient lack of Dct expression does not appear to
affect melanocyte differentiation because adult mice are almost completely pigmented,
and Dct-expressing melanoblasts, although in reduced numbers, can be detected after
E13.5. Neural tube cultures from Sox10Dom/Dom mice completely lack Mitf and Kit
positive cells, while those from Sox10Dom/+ mice have Mitf and Kit positive cells, but lack
Dct expression. The lack of Dct expression in Mitf positive cells from Sox10Dom/+ mice
suggests that Sox10 is required for Dct expression and that endogenous Mitf may not be
sufficient to drive Dct expression when Sox10 levels are reduced. Furthermore, Sox10
was found to transactivate the Dct promoter in melanocyte cell lines as well as in nonmelanocyte cell lines, which do not express Mitf (Potterf et al., 2001). The requirement of
Sox10 for Mitf and Dct expression suggests a role for Sox10 in the initial specification of
melanoblasts. Sox10 also appears to be required for the final differentiation of
melanocytes via Mitf-independent transcriptional regulation of Tyr, the rate-limiting
enzyme in melanin-synthesis (Hou et al., 2006).
Another member of the SoxE family of transcription factors that has recently been
implicated in melanocyte development is Sox9. Although Sox9 appears to be involved in
early melanocyte development its specific role in this process is not well characterized. In
the mouse, Sox9 is first expressed in pre-migratory NC cells around E8.5, prior to the
expression of migratory NC markers, in the hindbrain region at the dorsal tip of the
closing neural tube and in the dorsal folds of the neural tube in the trunk. Sox9 remains
expressed in migrating cranial NC cells (reviewed in Lee and Saint-Jeannet, 2011) but it
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is downregulated in trunk NC cells soon after they become migratory (Cheung et al.,
2005). The expression of Sox9 appears to be required for the initial specification and
survival of NC cells, but it is unclear whether it acts to promote melanocyte development.
Loss of function experiments in the frog and zebrafish suggest that Sox9 does not appear
to be important for melanocyte development. In Xenopus embryos, morpholino-induced
Sox9 depletion results in decreased expression of the NC marker Slug (Snail homolog)
and loss of cranial NC cell progenitors; however, melanoblasts in the trunk appear to
develop normally (Spokony et al., 2002). Likewise zebrafish mutants of the Sox9
ortholog, Sox9b, which is expressed in cranial and trunk NC cells, have severe
craniofacial defects but only mild defects in pigment cells. These defects, which include a
reduction in the number of iridophores, one of the types of pigment cells present in
zebrafish, and dispersed melanosomes within melanocytes, do not seem to be associated
with impaired melanocyte development because Dct expression is normal in Sox9b
mutants (Yan et al., 2006).
Although loss of function experiments do not implicate Sox9 in melanocyte
development, gain of function experiments support a role for Sox9 in the development of
melanocytes from the NC. In the chick embryo, forced expression of Sox9 in the neural
tube induces neural crest-like properties at the expense of neuronal progenitors.
Furthermore, Sox9 overexpression in migrating NC cells in the trunk region seems to bias
these cells to melanocyte and glial fates, at the expense of neuronal NC-derivatives
(Cheung and Briscoe, 2003). In zebrafish, both Sox9 and Sox10 overexpression were
shown to strongly favor melanocytic fate specification, as confirmed by the presence of
ectopic melanoblasts, labeled via Mitf, Sox10 and Dct, in embryos, and the presence of
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greater than normal melanocyte numbers in the tadpole stage (Taylor and LaBonne,
2005). The inconsistencies observed in Sox9 loss of function and gain of function studies
suggests that other factors may be able to compensate for the absence of Sox9 expression
in melanoblast; consequently, the effects of Sox9 in melanocyte development may be
more apparent when Sox9 is overexpressed rather than when it is knocked down.
In the mouse, Sox9 appears to be important for the survival of trunk NC cells and
for the formation of trunk NC cell derivatives. Homozygous embryos carrying a
conditional Sox9 null allele, exhibit reduced numbers of neurons and glia in the trunk
region as a result of increased apoptosis of pre-migratory and early migrating NC cells at
E9.5 and E10.5. In these embryos, Sox10 expression is maintained in pre-migratory NC
cells but is reduced along the NC cell migration route. In pre-migratory NC cells, Sox9
was also found to be required for the expression of Snail (Cheung et al., 2005), a
transcription factor that has been implicated in early pigment cell development and
differentiation (Silver et al., 2006). Although Sox9 seems to be required for melanocyte
development early on, its prolonged expression in cells fated to become melanoblast has
been shown to negatively affect melanocyte development (Qin et al., 2004). The adverse
effect of prolonged Sox9 expression on melanocyte development may be an indirect
result of the role of Sox9 in the development of chondrocyte precursor cells, in which
Sox9 is required for the regulation of alpha-1 type-II Collagen (Col2A1) expression (Bell
et al., 1997). Studies in the mouse, chick and Xenopus suggest that Sox9 acts upstream of
Sox10 (reviewed in Silver et al., 2006). In the chick, Sox9 was recently shown to directly
bind to and activate Sox10 regulatory regions, and to be required, for Sox10 expression in
cranial NC cells (Betancur et al., 2010). The decrease in Sox10 expression observed in
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migratory trunk NC cells in Sox9 null mutant mouse embryos also implicates Sox9 in the
regulation of Sox10 expression in the mouse. It has been suggested that the importance of
Sox9 in melanocyte development may be related to its role in regulating embryonic
Sox10 expression (Harris et al., 2010).
Although in the mouse embryo, members of the Snail family of zinc-finger
transcription factors do not seem to be required for NC formation or delamination
(Murray and Gridley, 2006), the mouse Slug homolog gene Snai2 appears to be involved
in melanocyte development. Early in development, the expression domains of the mouse
homologs of the Snail and Slug genes are reversed relative to the expression domains of
these genes in the chick. Later in development the expression domains of these two
transcription factors are conserved in the chicken and the mouse. In the chick, Snail is not
expressed in pre-migratory or migratory NC cells; however, the mouse Snail homolog
Snai1 is expressed in both pre-migratory and migratory NC cells. In contrast, Slug is
expressed in pre-migratory and migratory NC cells, while in the mouse the Slug homolog
Snai2 is expressed in migratory NC cells but not in pre-migratory NC cells (Sefton et al.,
1998). Snai2 null mutant mice exhibit pigmentation defects and display similar
developmental defects as those observed in Kit and Kit ligand (Kitl) null mutant mice.
The phenotypic similarities observed in Snai2 and Kit/Kitl mutants suggests that Snai2
may be involved in melanocyte development and that its function in this process may be
associated to Kit expression. Kit-positive cells from wild type mice express Snai2, while
Kit-positive cells derived from the Kit and Kitl null mutants W/Wv and Sl/Sld respectively,
do not express Snai2. Furthermore, Kitl is unable to drive melanoblast migration in Kitpositive cells purified from Snai2 null mutant mice. These results suggest that Snai2 may
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be a transcriptional target of Kit signaling, thus it is possible that at least some of the
roles of Kit signaling in melanocyte development are mediated by Snai2 (Perez-Losada et
al., 2002). Mutations in the human SNAI2 gene have been described in WS2, which is
characterized by pigmentation defects and sensorineural deafness (Tachibana et al.,
2003), further implicating this transcription factor in melanocyte development.
While Mitf, Pax3, Sox10, Sox9 and Slug seem to promote melanocyte
development, the transcription factor FoxD3 has been found to inhibit melanocyte
development. Although FoxD3 has been shown to be required for the maintenance and
specification of NC cells in the chick (Kos et al., 2001), the frog (Sasai et al., 2001) and
the mouse (Teng et al., 2008), it appears to negatively regulate melanoblast specification.
In the chick embryo, FoxD3 is expressed in all NC cell lineages, except for lateemigrating melanoblasts. In vitro and in vivo knockdown of FoxD3 results in an
expansion of the melanoblast lineage at the expense of neurons and glia. On the other
hand, ectopic FoxD3 expression in late-migrating NC cells prevents the entrance of these
cells into the dorsolateral migration pathway. The inability of FoxD3-expressing NC cells
to enter the dorsolateral migration pathway is assumed to be the result of FoxD3mediated inhibition of melanoblast specification (Kos et al., 2001), because melanoblast
specification has been shown to be required for dorsolateral migration (Erickson and
Goins, 1995; Erickson et al., 1998; Reedy et al., 1998). In quail NC cell cultures, FoxD3
overexpression inhibits Mitf expression and melanoblast specification, driving instead the
expression of glial cell markers (reviewed in Thomas and Erickson, 2008). In zebrafish,
FoxD3 prevents NC precursors from being specified as melanophores by inhibiting Mitfa
expression (Curran et al., 2009). At the same time, FoxD3 works to promote the
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specification of another type of pigment cell, the iridophore, by inhibiting Mitfa
expression in a bi-potent precursor of iridophores and melanophores (Curran et al., 2010).
1.3.2. Signaling molecules and receptors
Melanocyte development begins with the induction of NC cells by cues received
from the surrounding environment. In addition to its importance in NC induction, the
canonical Wnt signaling pathway, which acts via the Frizzled receptor and activates the
signaling molecule and transcription factor β-catenin as well as the transcription factor
Lef1, is also essential for melanoblast specification. In mice, individual knockouts of
Wnt1 and Wnt3a do not present with defects in NC derivatives; however Wnt1 and Wnt3a
double knockouts have decreased numbers of melanoblasts, which appear to be result of
defective melanoblast specification, rather than decreased survival or proliferation (Ikeya
et al., 1997). In mice, NC-specific deletion of β-catenin prevents the proper formation of
melanoblasts and sensory neurons (Hari et al., 2002). On the other hand, overexpression
of β-catenin in migratory NC cells promotes the formation of pigment cells at the
expense of neurons and glia in zebrafish (Dorsky et al., 1998). The transcription factor
Lef1, which functions downstream of the canonical Wnt/β-catenin pathway, is also
important in melanocyte development. Loss of function of Lef1 in Xenopus results in the
depletion of NC-derived cell lineages, including melanocytes (Roel et al., 2009).
Molecular targets of the canonical Wnt signaling pathway, as it pertains to melanocyte
development, include Mitf, Dct, and Sox10, which further supports a role for this
signaling pathway in the early stages of melanoblast specification (reviewed in Larue and
Delmas, 2006).
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Signaling via the Endothelin receptor b is also essential for melanoblast
development. In humans, mutations in EDNRB and its ligand Endothelin 3 (EDN3) are
associated

with

WS4,

which

is

characterized

by

sensorineural

deafness,

hypopigmentation, and aganglionosis of the distal colon (Puffenberg et al., 1994; Attie et
al., 1995). Mutations or deletions of the mouse Ednrb and Edn3 result in the piebald
lethal and lethal spotting phenotypes, respectively, which display similar characteristics
to those seen in humans. Ednrb and Edn3 null homozygotes have a mostly white coat
except for the head and rump, while heterozygotes usually have a belly spot. Piebald
lethal mice also display megacolon as a result of the absence of enteric ganglia in the
distal colon (Baynash et al., 1994; Hosoda et al., 1994).
Endothelin signaling plays multiple roles in melanocyte development, regulating
the survival, proliferation, migration, and final differentiation of melanoblasts (reviewed
in Saldana-Caboverde and Kos, 2010). In the mouse, signaling via Ednrb is required
between E10 and E12.5, which corresponds to the time point when melanoblasts reach
the migration stage area (MSA). Through the use of inducible mouse models, Ednrb was
shown to rescue hypopigmentation in Ednrb mutants as late as E10 (Shin et al., 1999).
Additionally, the hypopigmentation phenotype of piebald lethal mice was shown to be
rescued by driving Ednrb expression via the Dct promoter, which does not become active
until E10 (Ittah, 2005). The results of these studies suggest that Ednrb is not required for
the initial specification of melanocytic fate. The presence of small numbers of
melanoblasts at E10-11.5 in Ednrb null mutants is consistent with Ednrb not being
required for melanoblast specification. Given that Ednrb is required during the time
melanoblasts reach the MSA, it has been suggested that Endothelin signaling may be
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required for melanoblast migration. In transgenic Ednrb null mice, Dct-positive cells are
present and can be found at the right locations from E10.5-E11.5; however, these
melanoblasts are gradually lost without apparent defects in survival, and the few
melanoblasts that remain appear to accumulate in the MSA. The apparent defect in
melanoblast migration observed in Ednrb null mice implies that Endothelin signaling
may be required for these cells to enter the dorsolateral migration pathway (Lee et al.,
2003).
Several in vitro studies have implicated the Ednrb signaling pathway in the
survival and proliferation of melanoblasts. Endothelin 3 has been shown to promote the
survival and proliferation of glia and melanocyte precursors in NC cultures (Reid et al.,
1996; Lahav et al., 1998; Opdecamp et al., 1998; Dupin et al., 2000). Endothelin
signaling was also shown to promote the maintenance of an undifferentiated state in vitro.
Treatment of pigmented melanocytes with Edn3 can induce the expression of the NC
markers Slug, Sox10, FoxD3, and Pax3 in these cells and can lead to the transdifferentiation of pigmented melanocytes into cells expressing glial markers (reviewed in
Saldana-Caboverde and Kos, 2010)
Although Ednrb does not appear to be required for the initial specification of
melanoblasts and appears to favor the maintenance of undifferentiated state, in vitro and
in vivo studies have implicated Endothelin signaling in melanocyte differentiation. Even
though Edn3 treatment of avian NC cultures initially promotes the maintenance of
undifferentiated precursors, prolonged treatment leads to the development of pigmentproducing melanocytes (Lahav et al., 1996; Lahav et al., 1998). In mouse NC cultures,
Dct-positive cells are found in the absence of Edn3; however, Edn3 treatment, or
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activation of protein kinase C (PKC), a downstream target of Endothelin signaling, is
necessary for the generation of pigmented melanocytes (Ono et al., 1998; Opdecamp et
al., 1998). Similarly, Dct-positive cells from Ednrb null mutant embryos can express
Sox10, Mitf and Kit but fail to express Tyr and do not differentiate into mature pigmentproducing melanocytes (Hou et al., 2004). Together these results suggest that although
Endothelin signaling does not appear to be required for the initial specification of
melanoblasts, it is essential for the final differentiation of melanocytes (reviewed in
Saldana-Caboverde and Kos, 2010).
Signaling via the tyrosine kinase receptor Kit has also been shown to be involved
in normal melanocyte development. In the mouse, mutations in Kit and Kit ligand (Kitl)
(formerly known as Stem Cell Factor) result in a phenotype characterized by a belly spot
in heterozygous animals, and by anemia, lack of coat pigmentaion, and sterility in
homozygotes that survive to adulthood. In humans, KIT and KITL mutations are
responsible for piebaldism, which is characterized by hair and skin hypopigmentation
(reviewed in Hou and Pavan, 2008). Similar to Endothelin signaling, Kit signaling does
not appear to be required for the initial specification of melanoblasts, as Dct and Mitf
positive cells are present in Kit null mutants and in mice carrying a dominant negative
form of the Kit receptor (reviewed in Sommer, 2011).
Kit ligand is produced in soluble and membrane bound forms, which are
differentially required in melanocyte development, with the former being required for
melanoblast migration on the lateral pathway and/or their survival in the MSA, and the
latter being required for melanoblast survival in the dermis (Wherler-Haller and Weston,
1995). During development, melanocyte precursors are sensitive to Kit signaling at
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particular stages, specifically during migration in the dermis and after entering the
epidermal layer before entering the hair follicle. Inhibition of Kit signaling with the
ACK2 anti-Kit antibody during these stages results in the loss of melanocytes hinting at
the importance of Kit signaling for melanocyte survival and proliferation (Yoshida et al.,
1996). Additional evidence for these roles comes from the K14-SCF transgenic mouse, in
which transgenic Kitl (formerly known as SCF) expression in the epidermis promotes the
survival of melanocytes in the epidermis, where they are not normally found in the adult
mouse, and leads to a large increase in melanocyte numbers (Kunisada et al., 1998).
Endothelin and Kit signaling have been found to interact in melanocyte
development. In mouse NC cultures, treatment with Edn3 and Kitl significantly increases
melanoblasts numbers, compared to treatment with either factor on its own. Nevertheless,
Edn3 treatment of Kitl null NC cells cannot induce Kit expression or the generation of
fully pigmented melanocytes in vitro. Similarly, Kitl treatment in the absence of Edn3
cannot induce the differentiation of pigment-producing melanocytes, which can only be
found in culture in the presence of both factors (Ono et al., 1998). The apparent
interaction between Endothelin and Kit signaling may underlie the non-cell autonomous
and cell-autonomous roles of Ednrb signaling in melanocyte differentiation. Neural crest
cells from Ednrb null mice can give rise to melanoblasts; however, these melanoblasts
fail to express Tyr. Treatment of Ednrb null melanoblasts with Kitl can induce Tyr
expression; nevertheless, pigmented melanocytes do not develop in the absence of
functional Ednrb signaling. These results suggest that Ednrb functions non-cell
autonomously to induce Tyr expression in the presence of Kitl, and cell-autonomously in
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the final differentiation of melanocytes (Hou et al., 2004). These results also help explain
why both factors are needed for the generation of fully pigmented melanocytes
1.4 Research Questions
Melanocytes provide pigmentation to skin and hair via the production of melanin,
and confer protection against the damaging effects of ultraviolet radiation. Mutations or
deletions in genes required for the development of melanocytes from the NC can result in
hypopigmentation owing to the reduction or complete loss of melanocyte precursors
(melanoblasts) or to the impaired migration of these precursors (reviewed in Lin and
Fisher, 2007). For this reason, the study of mouse pigmentation mutants has been
instrumental for the elucidation of genes and signaling pathways involved in NC and
melanocyte development (Baxter et al., 2004). Nevertheless, fundamental questions
regarding the transcriptional regulation of these genes as well as their interactions in NC
and melanocyte development remain to be answered. In recent studies, mice having a
targeted disruption of the transcription factor Ets1 were shown to develop cardiac
malformations, as a result of NC defects, and to exhibit ventral hypopigmentation (Gao et
al., 2010). A specific role for Ets1 in melanocyte development has not been established;
however, the hypopigmentation phenotype observed in Ets1 mutants suggests that this
transcription factor is involved in this process. Recent studies in the chick embryo have
established a requirement for Ets1 in the endogenous expression of the transcription
factor Sox10 in cranial NC cells (Betancur et al., 2010); therefore, it is possible that the
role of Ets1 in melanocyte development could be mediated via transcriptional activation
of Sox10. Establishing the function(s) of this transcription factor in melanocyte
development has important implications for understanding pathological NC and
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melanocytic conditions. It can also serve to provide a more complete picture of the
transcriptional network that controls melanocyte development. My central hypothesis is
that Ets1 plays a role in early melanocyte development and regulates the activity of other
critical melanoblast-specific genes. To test this hypothesis I addressed the following
questions:
Question 1: What is the temporal requirement of Ets1 in murine melanocyte
development?
I hypothesized that Ets1 is required early in melanocyte development. I used DctLacZ transgenic mice in which LacZ expression is driven to melanoblasts under the
control of the Dopachrome tautomerase (Dct) promoter (Zhao and Overbeek, 1999), to
label melanoblasts via β-galactosidase activity in Ets1 null, heterozygous, and wild type
embryos in order to determine the earliest time at which differences in melanoblast
numbers and/or position can be observed.
Question 2: Is Ets1 required for melanoblast survival or proliferation in the mouse
embryo?
Given the hypopigmentation phenotype observed in Ets1 mutant mice, I
hypothesized that Ets1 regulates melanocyte survival or proliferation during embryonic
development. Using a combination of in vivo and in vitro proliferation and cell survival
assays I compared the extent of melanoblast survival and proliferation in Ets1 null,
heterozygous, and wild type mouse embryos.
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Question 3: Does Ets1 genetically interact with the transcription factor Sox10 in
melanocyte development?
Findings in the avian system, which implicate Ets1 in the regulation of the
transcription factor Sox10 (Betancur et al., 2010), pointed to a potential interaction
between Ets1 and Sox10 in melanocyte development. To establish whether Ets1
genetically interacts with Sox10, Ets1 heteroxygous (Ets1+/-) mice were crossed to Sox10
heterozygous (Sox10LacZ/+) mice, in which LacZ is inserted into the Sox10 locus (Britsch
et al., 2001). The hypopigmentation phenotypes of the double heterozygous progeny were
compared to that of single heterozygotes in 3 generations of mice, to establish whether an
additive, epistatic, suppressed, or synergistic genetic interaction exists between Ets1 and
Sox10 in melanocyte development.
Question 4: Does Ets1 affect the development of enteric ganglia and does it interact
with the transcription factor Sox10 in enteric innervation?
In addition to being required for melanocyte development, Sox10 is also required
for the development of NC-derived enteric ganglia (Kapur, 1999) and mutations in this
transcription factor have been described in both syndromic and non-syndromic
aganglionosis of the distal colon or Hirschsprung’s disease (Sanchez-Mejias et al., 2010).
Given the importance of Sox10 for proper gut innervation, I also analyzed the guts of
Ets1 heterozygous and null mutant mice that were either wild type or heterozygous for
Sox10, to establish whether Ets1 plays a role in the development of enteric ganglia, and if
so, whether it genetically interacts with Sox10 to promote proper gut innervation.
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Question 5: Can Ets1 transcriptionally regulate Sox10?
In light of the importance of Ets1 for Sox10 expression in cranial NC cells in the
chick embryo, I hypothesized that Ets1 can activate the expression of Sox10 by binding to
cis-binding sites on Sox10 enhancers. To address this question I tested the ability of wild
type and mutated Ets1 protein to activate the Sox10-MCS4 enhancer, which is known to
drive Sox10 expression to melanocytes and melanoblasts in the mouse (Antonellis et al.,
2008).
Question 6: Does Ets1 regulate the expression of genes required for melanoblast
development?
In order to characterize the molecular basis for the hypopigmentation phenotype
observed in Ets1 mutant mice, I analyzed the effect of Ets1 overexpression and
knockdown on the expression of various genes required for melanocyte development.
Using semi-quantitative real-time Polymerase Chain Reaction (PCR), I compared the
expression levels of the transcription factors Pax3, Mitf, Sox9, and Sox10, and of the
Ednrb and Kit receptors, in mouse melanocyte and melanoma cell lines transfected with
Ets1 and control siRNAs or with Ets1 overexpression and control vectors.
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Figure 1.1. Mouse pigmentation mutants. Mutations in Endothelin 3 (Edn3) (A) and the
Endothelin receptor b (Ednrb) (C) are responsible for the hypopigmentation phenotypes
of the lethal spotting (Edn3ls/ls) and piebald lethal (Ednrbsl/sl) spontaneous mouse
mutants. Mutations or deletions in the transcription factors Mitf (B), Sox10 (D) and Pax3
(E) also result in hypopigmentation in mice.
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Figure 1.2. Neural crest development. Neural crest induction is mediated by Wnt, BMP,
Delta and FGF signaling molecules which are released from the surrounding
neuroectoderm, paraxial mesoderm and non-neural ectoderm. The induction signals at the
border between the neural and non-neural ectoderm, lead to the expression of
transcription factors that serve to specify the neural plate border, which is the region from
which NC cells will be derived. The neural plate border specifiers include the
transcription factors Pax3, Pax7, Zic, Msx1, Msx2, Dlx3, and Dlx5. Following neural
plate border specification, a group of transcription factors required for the specification of
NC cells is upregulated. These transcription factors include Snail2, Sox9, Sox10 and
FoxD3. In the mouse, Sox9, Sox10 and FoxD3 are expressed in the neural folds soon after
the neural plate border is specified. The expression of NC specifiers is essential for the
maintenance of the NC population and for the epithelial-to-mesenchymal transition
(EMT), delamination and migration that these cells must undergo in order to reach their
final destinations. Neural crest EMT, delamination and migration are mediated by the
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transcription factors, FoxD3, Snail2, Sox8 and Sox9. These transcription factors work
together to induce a switch in the expression of calcium-dependent adhesion proteins
(Cadherins), from type I Cadherins to type II Cadherins. They also activate the
expression of extracellular signaling molecules and cytoskeletal proteins and promote
laminin synthesis and the degradation of the basal lamina.
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Figure 1.3. Melanocyte development from the neural crest. Cells fated to give rise to
melanocyte precursors are specified by Wnt signaling and the transcription factors Pax3
and Sox10, among others. Around E10-10.5, these cells begin to express the melanoblast
markers Kit and Mitf and localize to the migration staging area (MSA), which is located
in the dorsal aspect of the neural tube. At this point melanoblasts begin to express Dct,
which codes for one of the key enzymes in the melanin synthesis pathway. Between E10
and E12.5, signaling via the Endothelin receptor b (Ednrb) and the tyrosine kinase
receptor Kit are required for melanoblast survival, proliferation, and migration, and
differentiation. Melanoblasts continue to divide as they migrate through the dermis. A
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large portion of melanoblasts enter the epidermis between E13.5 and E14.5 and by E15.5,
a subset of them populate the still developing hair follicles. At E15.5, melanoblasts begin
to express other melanogenic enzymes, including Tyrosinase (Tyr) and Tyrosinaserelated protein 1 (Tyrp1 or Trp1), which are transcriptionally regulated by Mitf and
Sox10. Sometime between E15.5 and birth, these cells differentiate into mature
melanocytes once they begin to produce pigment.
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II. TEMPORAL REQUIREMENT OF THE TRANSCRIPTION FACTOR Ets1 IN
MURINE MELANOCYTE DEVELOPMENT
2.1 Abstract
Melanocytes are derived from neural crest (NC) cells, which arise from the dorsal
aspect of the neural tube. Several genes required for the specification of melanocytes
were identified via the study of mouse pigmentation mutants. Recently, the deletion of
the transcription factor Ets1 was shown to cause hypopigmentation in mice; however, the
role of Ets1 in melanocyte development is unknown. The Ets1 gene codes for a helixturn-helix transcription factor that is expressed in various developing organs and tissues,
including the NC, in the mouse embryo. It is required for the expression of the
melanocyte-specific transcription factor Sox10 in the chick cranial NC. The goal of the
present study is to determine the temporal requirement and mechanism of action of Ets1
in melanocyte development. Embryos from crosses between Ets1 heterozygous (Ets1+/-)
and Dct-LacZ transgenic mice, in which LacZ expression is driven to melanocyte
precursors (melanoblasts) under the control of the Dopachrome tautomerase (Dct)
promoter, were harvested between embryonic days (E) 10.75-15.5 and LacZ staining was
performed. Ets1-/- embryos have fewer melanoblasts compared to Ets1+/- and wild type
littermates. Cell survival assays showed increased melanoblast cell death in E10.75 Ets1-/embryos. Similarly, double-label immunofluorescence staining against Sox10 and
cleaved Caspase-3 showed increased NC cell death in E10.25 Ets1-/- embryos. The
increased numbers of dying NC cells and melanoblasts in Ets1 null mutants suggest that
Ets1 acts early during melanocyte development and regulates melanoblasts and NC cell
survival.
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2.2 Introduction
The transcription factor Ets1 is a member of a large family of helix-turn-helix
transcription factors that are characterized by the presence of the E26 transforming
specific sequence (Ets) domain, which was first identified in the avian erythroblastosis
virus, E26. The Ets domain recognizes the core nucleotide sequence GGAA/T (Dittmer,
2003). Human homologs of the viral Ets were later discovered on chromosomes 11 and
21, and designated Ets1 and Ets2 respectively (Watson et al., 1985). Homologs of Ets1
from a wide variety of species, which include birds, amphibians, fish and mammals,
share high sequence similarity. In fact, the mouse and human Ets1 protein sequences are
highly homologous, sharing 97% amino acid identity (Garrett-Sinha, 2013).
The transcription factor Ets1 is widely expressed during embryonic development.
In the chick embryo, Ets1 is expressed in the mesoderm, the blood-forming system
endothelial cells (Vandenbunder et al., 1989), in mesenchymal cells, lymphocytes,
erithrocytes (Queva et al., 1993), and NC cells (Fafeur et al., 1997; Theveneau et al.,
2007). In the mouse embryo, Ets1 is expressed early in the developing hindbrain, the
neural tube, the second and third brachial arches (Maroulakou et al., 1994), and the NC
(Kola et al., 1993; Maroulakou et al., 1994; Dittmer et al., 2003; Gao et al., 2010; Ye et
al., 2010). It is later expressed in the blood-forming system, lymphoid organs, lung, gut,
and skin (Maroulakou et al., 1994) and becomes expressed in all organs by embryonic day
(E) 15 (Kola et al., 1993). In later stages of fetal development and after birth, Ets1
expression becomes primarily restricted to lymphoid organs and the brain (Kola et al.,
1993). Expression of Ets1 has also been correlated with pathological invasive processes.
It has been found to be upregulated in various tumor types, including melanoma (Keehn
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et al., 2003; Rothhammer et al., 2004; Rothhammer et al., 2005; reviewed in GarrettSinha, 2013), and its expression in certain tumors has been correlated with the expression
of matrix metalloproteases (MMPs), particularly MMP1, MMP2 and MMP9 (reviewed in
Dittmer, 2003; Rothhammer et al., 2004; Okuducu et al., 2006). The Ets1-induced
upregulation of MMPs has also been reported in several in vitro and in vivo Ets1
overexpression studies (Oda et al., 1999; Park et al., 2008; Nagarajan et al., 2009).
Several studies implicate Ets1 in the proper development of NC cell derivatives. In
the mouse, Ets1 is expressed by cardiac NC cells and Ets1 deletion was found to produce
cardiac malformations (Gao et al., 2010; Ye et al., 2010). Some of these cardiac
malformations were found to arise as a result of the lack of NC-derived cells in the proximal
aspects of the outflow tract endocardial cushions and the presence of an abnormal nodule of
NC-derived cartilage within the heart. The cardiac defects seen in Ets1 null mice have been
attributed to a role of Ets1 in proper NC cell migration and differentiation (Gao et al., 2010).
During chick embryonic development, Ets1 expression is correlated with epithelial-tomesenchymal transition (EMT). It is expressed in migrating NC cells and in dispersing
somites but is not detected in tissues where EMT does not occur (Fafeur et al., 1997).
Additionally, Ets1 is required for the initiation of cranial NC cell delamination by promoting
cell mobilization, and can induce cranial-like delamination when misexpressed in trunk NC
cells. Although Ets1 is not required for cranial NC cell EMT per se, it cooperates with the
transcription factor Snail homolog 2 (Snail2) to promote EMT in NC cells (Theveneau et al.,
2007).
In addition to being involved in NC cell migration, Ets1 is also required for the
survival of various cell lineages. Murine thymocytes and T cells derived from Ets1 null
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mutant mice display higher apoptotic rates compared to those derived from wild type mice
(Muthusamy et al., 1995). In cooperation with Ets2, Ets1 is also required for the survival of
endothelial cells in the developing mouse embryo. Although, Ets1-/- mice and mice carrying a
mutation in an important threonine target of ERK (extracellular signal regulated kinase)
phosphorylation in Ets2 (Ets2A72/A72) are viable, Ets1-/-;Ets2A72/A72 double homozygous
mutants are embryonic lethal. The embryonic lethality observed in these double mutant mice
is caused by impaired angiogenesis as a result of decreased endothelial cell survival (Wei et
al., 2009).
Recently, the deletion of the transcription factor Ets1 in particular murine genetic
backgrounds (i.e., C57BL/6J), was shown to produce ventral hypopigmentation (Gao et
al., 2010) (Figure 2.1), hinting to the involvement of this transcription factor in
melanocyte development from the NC. The exact mechanism by which Ets1 deficiency
during embryonic development results in hypopigmentation is currently unknown. In the
chick embryo, Ets1 is required for the activation of the transcription factor sex determining
region Y (SRY)-box 10 (Sox10) (Betancur et al., 2010), a gene required for the
development of various NC cell derivatives, including melanocytes (Herbarth et al., 1998;
Southard-Smith et al., 1998; Kapur, 1999; Potterf et al., 2001). The importance of Sox10 for
melanocyte survival is evidenced by the hypopigmentation phenotype that results when it
is mutated or deleted. The targeted deletion of Sox10 in the mouse results in almost a
complete absence of trunk melanoblasts (Hou et al., 2006). Although Ets1 has not been
linked to Sox10 expression in the mouse embryo, its requirement for proper Sox10 expression
in the chick embryo and the hypopigmentation phenotype of Ets1 null mutants, suggests that
Ets1 could also play an important role in the regulation of this and other melanocyte-specific
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genes in the mouse. Furthermore, the involvement of Ets1 in normal and pathological
invasive processes (Fafeur et al., 1997; Theveneau et al., 2007; Garrett-Sinha, 2013), and its
requirement for the survival of certain cell lineages (Muthusamy et al., 1995; Wei et al.,
2009) suggest that this transcription factor may be an important regulator of NC cell and/or
melanoblast survival, proliferation, migration, and/or differentiation.
2.3 Materials and methods
2.3.1 Animals
Mice heterozygous for Ets1 were obtained from Dr. Eric Svensson (Universtiy of
Chicago, Chicago, IL) and generated as previously described to harbor a targeted deletion
of exons 3 and 4 of the Ets1 gene (Barton et., al. 1998). Mice heterozygous for Ets1 were
re-derived by outcrossing to C57BL/6J mice for eight generations (Gao et., al. 2010).
They have been maintained on C57BL/6J genetic background by intercrossing and by
outcrossing to C57BL/6J mice (Jackson Laboratories). Mice carrying the Dct-LacZ
transgene were obtained from Dr. Paul Overbeek (Baylor College of Medicine, Houston,
TX). The Dct-LacZ transgenic mice were generated on an FVB/N genetic background as
previously described (Zhao and Overbeek, 1999) by embryonic microinjection of a
transgene composed of the mouse Dopachrome tautomerase (Dct) promoter upstream of
the LacZ gene. Sox10tmlWegLacZ mice (hereafter referred to as Sox10LacZ/+) were obtained
from Dr. Michael Wegner (Institut für Biochemie, Universität Erlangen-Nürnberg,
Germany). Sox10LacZ/+ mice were generated as previously described (Britsch et al., 2001)
via insertion of the LacZ gene into the Sox10 coding sequence. Sox10LacZ/+ mice have
been maintained on their original C3H mixed background by backcrossing.
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Timed matings were set for the generation of embryos. Animals were mated
overnight, and females were examined for vaginal plugs after approximately 16 hours.
Noon of the day a vaginal plug was observed, was considered embryonic day (E) 0.5.
Pregnant females were euthanized by exposure to Isoflurane (Vedco, Inc.) followed by
cervical dislocation, and an abdominal incision was made to expose the uterus. As soon
as embryos were recovered from the euthanized mother, they were dissected out of the
uterine sacs and placed in Phosphate Buffered Saline (PBS) (pH7.2 or 7.4, depending on
the procedure for which the embryos were used). For all embryos, yolk sacs were isolated
for genotyping. Embryos that were used for Lysotracker Red staining were stained
immediately after dissection and fixed in 2% paraformaldehyde prior to β-galactosidase
staining. Embryos that were used for immunofluorescence staining of tissue sections
were fixed with 4% paraformaldehyde immediately after dissection. Embryos that were
used for in situ hybridization were dehydrated via incubation in methanol solutions of
increasing concentrations (25%, 50%, 75% methanol in PBT (PBS containing 0.1%
Tween 20 (Fisher Scientific)), and 100% methanol, 5 minutes each at room temperature)
and stored at - f BB7D?C7BMEHAM7IF;H<EHC;:799EH:?D=JE?DIJ?JKJ?ED7B=K?:;B?D;I
established by the National Institutes of Health (NIH) (Guide for the Care and Use of
Laboratory Animals, 2011; Institutional Animal Care and Use Committee (IACUC)
Protocol No. 13-064).
2.3.2 Genotyping
Genomic DNA was isolated from tail biopsies for adult mice or yolk sacs for
embryos, and used for PCR genotyping. Genotyping for Ets1was performed using the
primers

	
  

5’-GTCTTCTTCTCTAGTTTCTGAGTGCTC,

55

5’-

	
  

GTCCTGCTTACAACACTCTGAATCCTG

and

5’-

GCCTGCTCTTTACTGAAGGCTCTTT (Gao et al., 2010), under standard PCR
9ED:?J?EDI9O9B;IE<f<EH I  f<EH I 7D:f<EH I Products were
visualized in a 2% agarose gel containing 0.5µg/ml Ethidium Bromide (Fisher Scientific).
The wild type Ets1 allele produced a 438bp product while the mutant allele produced a
350bp product (Gao et al., 2010). Heterozygous animals were identified by the presence
of both PCR products. For Sox10, genotyping of adult mice and embryos was performed
using the primers 5’-CAGGTGGGCGTTGGGCTC, 5’-CAGAGCTTGCCTAGTGTCT,
and 5’-TAAAAATGCGCTCAGGTCAA, under standard PCR conditions (35 cycles of
f <EH   I  f <EH   I  7D: f <EH   I  Products were visualized in a 2%
agarose gel containing 0.5µg/ml Ethidium Bromide (Fisher Scientific). The wild type
Sox10 allele produced a 500bp product while the mutant allele produced a 600bp product
(Britsch et al., 2001). Heterozygous animals were identified by the presence of both PCR
products.
The Dct-LacZ mice were genotype via β-galactosidase staining. Briefly, ear tip
biopsies were fixed with 2% paraformaldehyde for 50 minutes at room temperature.
Samples were briefly washed in PBS (pH 7.2) and incubated oL;HD?=>J7J f?D3-gal
solution consisting of 2mM MgCl2, 0.01% Sodium Deoxycholate, 5mM Potassium
Ferricyanide, 5mM Postassium Ferrocyanide (Fisher Scientific), 0.02% Nonidet P40
(Roche Diagnostics), and 1mg/ml X-gal (Life Technologies) (Nagy, 2003). The staining
was visualized under a dissecting scope (Leica Model MZ6). Mice carrying the Dct-LacZ
transgene were identified by positive X-gal staining.
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2.3.3 β-galactosidase and Lysotracker Red staining of whole mount embryos
Embryos from intercrosses between Ets1+/-::Dct-LacZ+ mice were harvested
between E11.5 and E15.5, while those from intercrosses between Ets1+/-::Sox10LacZ/+
mice were harvested at E9.5. β-galactosidase (LacZ) staining was performed using
standard protocols (Nagy, 2003). Whole embryos were dissected in cold 0.05M PBS
(pH7.2) and fixed with 2% paraformaldehyde for 50 minutes at room temperature.
Embryos were briefly washed in PBS (pH 7.2) and incubated 3 to12 hours (the
incubation time was directly proportional to the embryonic age), protected from light, at
 f?D3-gal solution consisting of 2mM MgCl2, 0.01% Sodium Deoxycholate, 5mM
Potassium Ferricyanide, 5mM Postassium Ferrocyanide (Fisher Scientific), 0.02%
Nonidet P40 (Roche Diagnostics), and 1mg/ml X-gal (Life Technologies). Embryos were
washed twice in PBS to stop the reaction. The staining was visualized under a dissecting
scope (Leica, Model MZ6). Whole embryos were photographed using a Leica DC500
camera. For each stage, at least 3 embryos of each genotype (Ets1+/+, Ets1+/-, and Ets1-/-)
were stained and photographed.
Embryos from crosses between Ets1+/-::Dct-LacZ+ mice were harvested at
E10.75. Lysotracker Red (Zucker et al., 1998) and LacZ staining (Nagy, 2003) were
performed after dissection to identify melanoblasts (LacZ positive cells), dying cells
(Lysotracker Red positive cells), and dying melanoblasts (double-labeled cells). To
perform Lysotracker Red staining, embryos were incubated in 5µM Lysotracker Red
DND-99 (Life Technologies) in PBS FHEJ;9J;:<HECB?=>J 7Jf<EH C?Dutes. Still
protected from light, embryos were washed twice with PBS (pH7.2) and β-galactosidase
staining was performed, visualized, and photographed as described above. Still protected
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from light, embryos were then post-fixed in 4% paraformaldehyde, 20 minutes at room
temperature, incubated in 10% sucrose 4->EKHI7JfM?J>B?=>JHE9A?D= 7D:?D 
IK9HEI;  EL;HD?=>J 7J f M?J> B?=>J HE9A?D=  Embryos were embedded in Tissue-Tek
Tissue Freezing Medium (Sakura), frozen at - f 7D:I;9J?ED;:7J µm. Sections were
then stained against phospho-Histone H3 (Millipore) via immunofluorescence (as
described in 2.3.4).
2.3.4 Immunofluorescence
Cryosections of 10µm thickness from E10.75 embryos previously stained with
'795 7D: 'OIEJH79A;H -;: M;H; :H?;: <EH  >EKHI 7J f  .;9J?EDI M;H; M7I>;: M?J>
PBS and blocked with 1% Bovine Serum Albumin (BSA) (Amresco), 0.1% Triton X-100
(Sigma) in PBS 45 minutes at room temperature. Sections were incubated in rabbit antiphospho-Histone H3 antibody (Ser10) (06-570, Millipore), (1:100 in 1% BSA, 0.1% Triton
X-100 in PBS), 1 hour at room temperature, to label proliferating cells. After washing,
sections were incubated in a secondary antibody against rabbit, tagged with Alexa Fluor
488 (A11008, Invitrogen) (1:200 in 1% BSA, 0.1% Triton X-100 in PBS), 1 hour at room
temperature, to label proliferating cells with green fluorescence. Cell nuclei were
counterstained using 1µg/ml Hoechst Dye (BioRad). Using a compound fluorescence
microscope (Leica, Model DMRB), melanoblasts (LacZ positive cells), dying
melanoblasts (LacZ and Lysotracker Red positive cells), and proliferating melanoblasts
(LacZ and p-Histone H3 positive cells) were counted over 80 sections spanning the trunk
region for E10.75 Ets1-/-::Dct-LacZ+ (n=3) and Ets1+/-::Dct-LacZ+ (n=3) embryos.
In order to label dying NC cells parallel cryosections from E10.25 embryos were
stained with antibodies against Sox10, to label NC cells, and Cleaved caspase-3, to label
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dying cells. Specifically, embryos were harvested in PBS and fixed in 4% paraformaldehyde,
>EKHI7JfM?J>B?=>JHE9A?D= <J;HM7I>?D=M?J>+. ;C8HOEIM;H;?D9K87J;:?D10%
sucrose 4-6 hours 7JfM?J>B?=>JHE9A?D= 7D:?D IK9HEI; EL;HD?=>J7JfM?J>
light rocking. Embryos were embedded in Tissue-Tek Tissue Freezing Medium (Sakura)
and frozen at - f HOEI;9J?EDIE< µm thickness were prepared and dried, 2 hours at
f 7I FH;L?EKIly described. Sections were incubated with goat polyclonal anti-Sox10
(N20) (sc-17342, Santa Cruz Biotechnology) (1:100) antibody and rabbit anti Cleaved
Caspase-3 (9664S, Cell Signaling) (1:100) antibody. After washing extensively with PBS,
sections were incubated in donkey anti-goat Alexa Fluor 594 (A11058, Invitrogen) (1:200).
Sections were once again washed extensively with PBS and subsequently incubated in goat
anti-rabbit Alexa Fluor 488 (A11008, Invitrogen), followed by extensive PBS washes. All
antibodies were diluted in 1% BSA, 0.1% Triton X-100 in PBS. All antibody incubations
were carried out for 1 hour at room temperature. Cell nuclei were counterstained using
1µg/ml Hoechst Dye (BioRad). Neural crest cells (Sox10 positive cells) and dying neural
crest cells (double-labeled cells) were counted over 35 sections spanning the anterior half
of the trunk region for E10.25 Ets1-/- (n=3) and Ets1+/- (n=3) embryos.
2.3.5 Probe preparation for in situ hybridization
In situ hybridization probes were prepared from plasmids containing the full
length Pmel17 cDNA (Baxter and Pavan, 2003) or a 1.5kb cDNA fragment of the Sox10
cDNA (Southard-Smith et al., 1998). The plasmids used for cloning the Pmel17 and
Sox10 constructs contained the promoters for T3 and T7 RNA Polymerase, respectively.
In these plasmids, the cDNAs are oriented such that an antisense probe can be generated
from in vitro transcription. In order to have a sufficient amount of plasmid for probe

	
  

59

	
  

synthesis, plasmids were transformed into Escherichia coli Dh5α competent cells (Life
Technologies) and glycerol stocks were prepared (Appendix I). Plasmids were purified
from overnight cultures using the Promega Wizard Plus SV Minipreps DNA Purification
System (Promega). Plasmids were linearized via restriction enzyme digestion, using KpnI
(Promega) for Pmel17 and PvuII (New England Biolabs) for Sox10. Digestions were
97HH?;: EKJ <EBBEM?D= C7DK<79JKH;HbI ?DIJHK9J?EDI   >EKHI 7J f  ?=;IJ?ED FHE:K9JI
were visualized in a 1% agarose gel containing 0.5µg/ml Ethidium Bromide (Fisher
Scientific). Linearized templates were purified via phenol-chloroform extraction,
followed by ethanol precipitation. Template DNA was resuspended in Diethyl
Pyrocarbonate (DEPC) (Sigma-Aldrich) treated water at an approximate concentration of
1µg/ml.
Riboprobe synthesis was carried out by incubating 5µl of linearized template with
4µl of 5x transcription buffer (Promega), 2µl of nucleotide tri-phosphate (NTP) labeling
mix (Roche Diagnostics), 2µl of T3 or T7 RNA Polymerase (Promega), 1µl of RNasin
RNase inhibitor (Promega) and 6µl of DEPC-JH;7J;: M7J;H   >EKHI 7J f 
Transcription efficiency was assayed by visualizing the resulting probes in a 1% agarose
gel containing 0.5µg/ml Ethidium Bromide (Fisher Scientific). Probes were purified via
Ethanol precipitation with 0.02M EDTA and 0.5M LiCl, and resuspended in 20µl of
DEPC-treated water.
2.3.6 In situ hybridization
In situ hybridization using Pmel17 and Sox10 probes were performed on E10.5
and E9.5 embryos, respectively, according to standard protocols (Wilkinson and Nieto,
1993; Wilkinson, 1998). Embryos that had been previously dehydrated with methanol,
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were re-hydrated by incubation in methanol solutions of decreasing concentration (75%,
50% and 25% methanol in PBT (PBS containing 0.1% Tween 20 (Fisher Scientific)), 5
minutes each at room temperature), and washed with PBT. Embryos were then bleached
with 6% Hydrogen Peroxide (Fisher) in PBT, 1 hour at room temperature with light
rocking. Permeabilization of the tissue was achieved by incubation in 10µg/ml Proteinase
K (Fisher Scientific) in PBT (8 minutes for E9.5 and 12 minutes for E10.5).
Permeabilization was stopped by incubation in 2mg/ml Glycine (Fisher Scientific) in
PBT,

10

minutes

at

room

temperature.

Embryos

were

post-fixed

in

4%

paraformaldehyde, 20 minutes at room temperature and pre-hybridized by incubation in
Hybridization Solution (50% Formamide (Fisher Scientific), 5XSSC, pH4.5 (0.75M
NaCl, 0.075M Sodium Citrate), 50µg/ml yeast tRNA (Sigma Aldrich), 1% SDS (Fisher
Scientific), 50µg/ml Heparin (Sigma-Aldrich   >EKH 7J  f  C8HOEI M;H; J>;D
incubated in fresh, pre-M7HC;:  f #O8H?:?P7J?ED .EBKJ?ED 9EDJ7?D?D= >O8H?:?P7J?ED
probe (2µl per ml of Hybridization Solution), oveHD?=>J7J f 
The second day of in situ hybridization consisted of washes and antibody
incubation. Embryos were first washed with Solution 1 (50% Formamide, 5XSSC, 1%
..   J?C;I 7J  f  <EH   C?DKJ;I ;79> J?C;  C8HOEI M;H; J>;D M7I>;: M?J>
SolutiED    !EHC7C?:;  3..  J?C;I 7J f  <EH   C?DKJ;I ;79> J?C; 
Embryos were washed in TBST (Tris Buffered Saline (TBS): 137mM NaCl, 2.7mM KCl,
25mM Tris-Base (Fisher Scientific), pH8.0 + 0.1% Tween 20 (Fisher Scientific)) 3 times,
5 minutes each time at room temperature. Blocking was achieved by incubating the
embryos in 10% goat serum (Gibco) in TBST, 2 hours at room temperature with rocking.
During this time, the anti-Digoxigenin antibody (Roche Diagnostics) was pre-absorbed as
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follows. For each embryo, a pinch of embryo powder (Appendix II) was added to 0.5ml
of TBST in a 1.5ml sterile microcentrifuge tube. The embryo powder in TBST was
>;7J;: 7J  f  <EH   C?DKJ;I  8H?;<BO LEHJ;N;: 7D: ?D9K87J;: ?D ?9; <EH   C?DKJ;I 
Subsequently, 5µl of heat inactivated 100% goat serum and 1µl of anti-Digoxigenin
7DJ?8E:OM;H;7::;:JE;79>JK8; /K8;IM;H;HE9A;:<EH>EKH7Jf7D:9;DJH?<K=;:
<EH C?DKJ;I7J

-+( 7Jf />;supernatant was then collected and placed in a

sterile 2ml microcentrifuge tube containing 1.5ml of 1% goat serum in TBST. Embryos
were incubated in pre-absorbed anti-?=EN?=;D?D7DJ?8E:OIEBKJ?ED EL;HD?=>J7JfM?J>
light rocking.
On the third day of in situ hybridization, embryos were washed with TBST, 3
times, 5 minutes each time at room temperature, followed by 5 washes of at least 1 hour
each, at room temperature. Embryos were incubated overnight in 2mM Levamisole
(Sigma-Aldrich) in TBST. The purpose of the prolonged washes was the removal of
excess antibody to prevent background staining. On the fourth and final day, embryos
were washed with NTMT (100mM NaCl, 100mM Tris pH9.5, 50mM MgCl2, 0.1%
Tween 20 (Fisher Scientific) 2mM Levamisole (Sigma-Aldrich)), 3 times, 10 minutes
each time at room temperature. Each embryo was then protected from light and incubated
in a color substrate solution consisting of 4.5µl of 4-Nitro blue tetrazolium chloride
(NBT) (Roche Diagnostics) and 3.5µl of 5-Bromo-4-chloro-3-indolyl-phosphate (BCIP)
(Roche Diagnostics) in 1ml of NTMT for a period of 45 minutes to 2 hours, depending
on the amount of time it took for the staining to develop. Embryos were monitored
periodically (approximately every 20 minutes) under a dissecting scope, for color
development. The staining was stopped by washing the embryos 2 times with PBT, 5
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minutes each time at room temperature. Embryos were photographed in 50% Glycerol in
PBT under a dissecting scope (Leica, Model MZ6) using a Leica DC500 camera. Pictures
were taken at a total magnification of 40X. For each stage, at least 3 embryos of each
genotype (Ets1+/- and Ets1-/-) were stained and photographed.
2.3.7 Statistical analysis
The Student’s t-test was used to compare the mean number of melanoblasts, as well
as the mean numbers of dying and proliferating melanoblasts in E10.75 Ets1-/- and Ets1+/embryos. The same statistical test was used to compare the mean number of NC cells and the
mean number of dying NC cells in E10.25 Ets1-/- and Ets1+/- embryos. Data were considered
statistically significant at p<0.05. All analyses were carried out using PASW Statistics 18
(IBM). Graphical representations of the data were generated using GraphPad Prism 6
(GraphPad Software, Inc).
2.4 Results
2.4.1 Ets1 null embryos show reduced numbers of melanoblasts
In order to establish the earliest time point at which Ets1 deficiency results in
impaired melanocyte development, embryos from intercrosses between Ets1+/-::DctLacZ+ mice were harvested between embryonic days (E) 10.75 and E15.5 and subjected
to LacZ staining. A gross decrease in the number of trunk melanoblasts is visibly
apparent in E11.5-E15.5 Ets1-/- embryos compared to Ets1+/- littermates (Figure 2.2).
Melanoblasts were counted in 80 sections spanning the trunk region in E10.75 embryos
(Figure 2.3). These counts revealed a significant decrease in the number of trunk
melanoblasts in Ets1-/- embryos compared to Ets1+/- littermates (p=0.018, Figure 2.3 E).
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2.4.2

Ets1 deletion results in decreased melanoblast survival
To establish the mechanism of action of Ets1 in murine melanocyte development,

the total numbers of trunk melanoblasts, as well as the numbers of dying and proliferating
melanoblasts, were quantified at E10.75. The earliest time point at which Dct is
expressed in melanoblasts is E10.5; however, at this stage most melanoblasts are
restricted to the head and cervical region and the number of trunk melanoblasts is very
small (Baxter et al., 2004). For this reason, trunk melanoblasts, labeled via LacZ staining,
were quantified at E10.75. Embryos from crosses between Ets1+/-::Dct-LacZ+ mice were
harvested at E10.75 and subjected to Lysotracker Red staining, LacZ staining, and
phospho-Histone H3 immunofluorescence staining.

LacZ positive cells, as well as

double-labeled cells (LacZ and Lysotracker Red positive, and LacZ and phospho-Histone
H3 positive) were counted in 80 sections spanning the trunk region of each embryo. As
previously stated, a significant decrease in the number of trunk melanoblasts was
observed in Ets1-/- embryos compared to Ets1+/- littermates (p=0.018, Figure 2.3 E). At
this stage, the percent of proliferating melanoblasts, which are identified by LacZ and
phospho-Histone H3 double-labeling, did not differ significantly between Ets1+/- and
Ets1-/- littermates (p=0.852, Figure 2.3 G). These results indicate that Ets1 deficiency
does not result in impaired melanoblast proliferation at E10.75. A significant increase in
the percent of dying melanoblasts, labeled by Lysotracker Red and LacZ staining, was
observed in Ets1-/- embryos compared to Ets1+/- littermates (p=0.023, Figure 2.3 F). The
increase in melanoblast cell death observed in E10.75 Ets1-/- embryos indicates that Ets1
is required for melanoblast survival at this stage.
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Melanoblasts were also labeled via Pmel17 in situ hybridization in E10.5 embryos
(Figure 2.4). The Pmel17 gene encodes a melanocyte-specific transmembrane protein,
which has been shown to label melanoblast and cells of the retinal pigmented epithelium
(RPE) beginning at E9.5. At E9.5, Pmel17 expression is restricted to the otic vesicle and
presumptive RPE. At E10.5, Pmel17 has been shown to be expressed in the RPE as well
as in melanoblasts mostly in the head and neck, although a few melanoblasts are also
labeled along the trunk (Baxter and Pavan, 2003). Although no gross differences in the
number of melanoblasts between Ets1-/- and Ets1+/- littermates were observed at E10.5,
only a few melanoblasts located in the cervical region were labeled by Pmel17 in situ
hybridization at this stage (Figure 2.4). The absence of Pmel17-positive cells along the
trunk region did not allow for the quantification of trunk melanoblasts at this stage.
2.4.3

Ets1 deletion results in decreased neural crest cell survival
Given the increase in cell death observed in Ets1-/- mutant embryos at E10.75, a

potential role for Ets1 prior to melanocyte cell specification was investigated. Embryos
from intercrosses between Ets1+/- mice were harvested at E10.25. Embryos were fixed,
embedded in tissue freezing media and sectioned at 10µm. Neural crest cells were labeled
via Sox10 antibody staining, while dying cells were labeled via cleaved Caspase-3
antibody staining (Figure 2.5). The transcription factor Sox10 was chosen as a NC cell
marker because it is expressed in various migrating NC cell derivatives, including the
dorsal root, cranial, enteric and sympathetic ganglia (Southard-Smith et al., 1998). Sox10
is initially expressed in NC cells as they begin to delaminate from the neural tube and
persists in cells that will give rise to peripheral nervous system components (Kuhlbrodt et
al., 1997) and melanocytes (Southard-Smith et al., 1998). Neural crest cells as well as
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dying NC cells were counted in 35 sections spanning the anterior portion of the trunk
region for 3 embryos of each genotype (Ets1-/- and Ets1+/-). The total number of NC cells
(Sox10 positive cells) did not differ significantly between Ets1-/- and Ets1+/- embryos
(p=0.848, Figure 2.5 C). Nonetheless, the percent of dying NC cells (Sox10 and cleaved
Caspase-3 positive cells) was significantly higher in Ets1-/- embryos compared to Ets1+/littermates (p=0.033, Figure 2.5 D).
Embryos at E9.5 were also assessed for Sox10 expression via in situ hybridization
(Figure 2.6) and LacZ staining (Figure 2.7) of whole embryos from crosses between
Ets1+/-::Sox10LacZ/+ mice. At this stage, the pattern and levels of Sox10 expression as well
as the numbers of Sox10 positive cells do not appear to differ much between Ets1 null
embryos and Ets1 wild type or heterozygous littermates. Nevertheless, Sox10 in situ
hybridization revealed ectopic Sox10 expression in the frontal aspect of the head in Ets1
null embryos.
2.5 Discussion
While coat color variations in mice are the result of changes in melanin
production and distribution, white spotting is caused by impaired melanoblast
development, or from defects in melanocyte stem cell survival. Specifically, defects in
melanoblast survival, proliferation, migration, hair follicle and integument invasion, and
stem cell renewal in the hair follicles will result in various spotting phenotypes, which
include head and belly spots, white belts that extend to the caudal trunk region, piebald
spotting and peppering (Baxter et al., 2004). The hypopigmentation phenotype observed
in Ets1 mutant mice pointed to a potential role for Ets1 in melanocyte development,
particularly in survival, proliferation or migration.
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In vivo analysis of Ets1 mutant embryos via labeling of melanoblasts using DctLacZ transgenic mice, revealed an apparent gross decrease in melanoblast numbers in
embryos ranging from E15.5 through E10.75 (Figure 2.2). Quantification of trunk
melanoblasts at E10.75 revealed a large and significant reduction in melanoblast
numbers, as a result of increased apoptosis, in Ets1 null mutants compared to
heterozygous littermates (Figure 2.3). The increased melanoblast cell death observed in
Ets1 null mutants indicates that Ets1 acts early during melanocyte development and
appears to be required for the survival of melanocyte precursors. The presence of viable
melanocytes in Ets1 null mutant mice implies that Ets1 may not be required for
melanocyte differentiation. We also failed to detect significant differences in the numbers
of proliferating melanoblasts between Ets1 null and heterozygous embryos at this stage.
The early defect observed in the melanoblast population in Ets1 null mutant mice
suggests that Ets1 may be involved in the regulation of one or more early melanocytespecific genes. Although the presence of viable melanocytes in Ets1 null mutants
suggests that Ets1 is not required for proper melanocyte differentiation, it is possible that
the large decrease in melanoblast cell numbers observed in these mice could in part arise
as a consequence of altered NC cell fate decisions. The presence of ectopic NC cellderived cartilage nodules in the hearts of Ets1 null mutant mice suggests that Ets1 may
act as a negative regulator of cartilage fate in NC cells (Gao et al., 2010). Consequently,
in spite of the melanoblast survival defect observed in Ets1 null mutants, we cannot
discard the possibility that, in addition to being required for melanoblast survival, Ets1
may also be involved in NC cell lineage specification.
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Given the increase in melanoblast cell death observed in Ets1 null mutant mice at
E10.75, it was plausible that Ets1 may regulate the survival of NC cells prior to their
specification into the melanocyte lineage. Labeling of NC cells via Sox10 antibody
staining revealed similar numbers of trunk NC cells in Ets1-/- and Ets1+/- littermates. In
spite of this, double-labeling with cleaved Caspase-3 antibody revealed a significant
increase in the percent of dying NC cells from 4.2% in Ets1 heterozygotes to 6.5% in
Ets1 null littermates (Figure 2.5). These results point to a role for Ets1 as a survival factor
for NC cells prior to their differentiation into the melanocytic lineage. The lack of a
significant difference in the numbers of Sox10-positive NC cells at this stage, implies that
Ets1 appears to act precisely at this time point so that the effects of Ets1 deficiency would
become apparent soon after. The sharp and significant decrease observed in melanoblast
numbers at E10.75 supports this possibility. Furthermore, Sox10 expression did not
appear to be affected in Ets1 null mutant mice at E9.5, suggesting that the critical time
point at which Ets1 regulates NC cell and melanoblast survival is somewhere between
E10 and E11.
Other pigmentation mutants in which melanoblast survival defects are observed as
early as E10.5-E11.5 include mutants of the transcription factors Sox10, paired box 3
(Pax3), and Microphthalmia-associated transcription factor (Mitf) as well as mutants of
the G-coupled Endothelin receptor b (Ednrb) and

the tyrosine kinase receptor Kit.

Mutations in these genes not only affect melanoblast survival, but also proliferation,
migration and final differentiation (Baxter et al., 2004; Silver et al., 2006). The
transcription factors Pax3 and Sox10 are initially expressed in NC cells at E8.5 prior to
their commitment into the melanocytic fate. Mitf, Kit, and Ednrb, on the other hand are
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first expressed at E10-E10.5, around the time of melanoblast specification from the NC
(reviewed in Silver et al., 2006). All of these genes are required for melanoblast survival
and it is possible that the Ets1-induced effect on melanoblast survival is mediated via one
or more of these essential melanocytic genes. In the chick embryo, Ets1 drives Sox10
expression in cranial NC cells via the Sox10E2 enhancer, which is critical for the
initiation of Sox10 expression in cranial NC cells. Ets1 was found to directly bind to and
activate this enhancer (Betancur et al., 2010). Although the hypopigmentation phenotype
observed in Ets1 null mutant mice is the result of improper development of NC cells
emerging from the trunk region, it is possible that in the mouse, Ets1 may be an important
regulator of Sox10 in the trunk NC. The early defects in melanoblast and NC cell survival
observed in Ets1 null mutants point to Sox10 as a probable target of Ets1, particularly in
light of the essential role of Sox10 in NC cell, melanocyte and glial cell survival (Britsch
et al., 2001). In an attempt to examine whether Ets1 acts upstream of Sox10, phenotypic
analysis of Ets1 and Sox10 double heterozygous mutants will be carried in order to
determine whether a synergistic genetic interaction exists between these genes in
melanocyte development.
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Figure 2.1. Ventral hypopigmentation in Ets1 mutant mice. Ets1 null (Ets1-/-) and
heterozygous (Ets1+/-) mice (A and B, respectively) exhibit ventral hypopigmentation
compared to Ets1 wild type (Ets1+/+) (C) littermates.
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Figure 2.2. Ets1 null mutant embryos have decreased melanoblast numbers. Dct-LacZ
transgenic mice, in which LacZ expression is driven by the Dopachrome tautomerase
(Dct) promoter that drives expression to melanoblasts, were crossed to Ets1+/- mice to
produce Ets1+/-::Dct-LacZ+ mice. Embryos from intercrosses between Ets1+/-::Dct-LacZ+
mice were harvested at embryonic days (E)10.75-15.5, subjected to LacZ staining and
analyzed for the amount and position of melanoblasts (blue dots) in the trunk region. At
all these ages, Ets1-/- embryos have reduced numbers of melanoblasts (D, H, L, P, T, X)
compared to Ets1+/- (B, F, J, N, R, V) and wild type (not shown) littermates (HL:
Hindlimb, FL: Forelimb).
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Figure 2.3. Decreased melanoblast survival in E10.75 Ets1 null mutants. LacZ staining,
Lysotracker Red staining, and phospho-Histone H3 (p-Histone H3) immunofluorescence
of E10.75 mouse embryos. (A & C) Melanoblasts traveling along the surface of the
embryo are marked via LacZ staining (black arrows). (B) Lysotracker Red marks
lysosomes in dying cells (red fluorescence). (D) Proliferating cells are positive for the pHistone H3 antibody (green fluorescence). (A & B) Dying melanoblasts (DM, arrows)
are LacZ and Lysotracker Red positive. (C & D) Proliferating melanoblasts (PM, arrows)
are LacZ and p-Histone H3 positive. (E) Melanoblasts (LacZ positive cells), (F) dying
melanoblasts (LacZ and Lysotracker Red positive cells) and (G) proliferating
melanoblasts (LacZ and p-Histone H3 positive cells) were counted in 80 sections for
E10.75 Ets1+/- (n=3) and Ets1-/- (n=3) embryos. (E) Ets1-/- embryos have significantly
reduced numbers of melanoblasts compared to Ets1+/- littermates (*p<0.05). (F) The
percent of dying melanoblasts was significantly higher (*p<0.05) in Ets1-/- embryos
compared to Ets1+/- littermates, (G) while the percent of proliferating melanoblasts did
not differ significantly between these.
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Figure 2.4. Melanoblasts in E10.5 Ets1 null vs. Ets1 heterozygous mouse embryos. In
situ hybridization using a Pmel17 probe was carried out to label developing melanoblasts
at E10.5. No gross differences in the position and numbers of melanoblasts are apparent
between Ets1+/- and Ets1-/- littermates (black arrows) (Magnification = 40x).
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Figure 2.5. Decreased neural crest cell survival in E10.25 Ets1 null mutants. Sox10 and
cleaved Caspase-3 double-label immunofluorescence of E10.25 mouse embryos. (A & B)
Neural crest (NC) cells traveling along the surface of the embryo were labeled with
Sox10 antibody (red fluorescence). Dying cells were labeled using a cleaved Caspase-3
antibody (green fluorescence). Dying NC cells are positive for Sox10 and cleaved
Caspase-3 (white arrows). (C) NC cells and (D) dying NC cells were counted in 35
sections spanning the anterior half of the trunk region for E10.25 Ets1+/- (n=3) and Ets1-/(n=3) embryos. (C) The number of NC cells in Ets1-/- embryos is not significantly
different from that of Ets1+/- littermates (p=0.848). (D) The percent of dying NC cells is
significantly higher (*p<0.05) in Ets1-/- embryos compared to Ets1+/- littermates.
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Figure 2.6. Sox10 expression in E9.5 Ets1 mutant embryos examined via in situ
hybridization. Whole mount in situ hybridization of E9.5 embryos using a Sox10
riboprobe. Sox10 expression can be seen in the cranial ganglia (cg), otocyst (ot) and
dorsal root ganglia (drg). Ectopic Sox10 expression was also detected on the frontal
aspect of the head in Ets1-/- embryos (red arrowhead) (Magnification = 40x).
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Figure 2.7. Sox10 expression in Ets1 mutant embryos visualized via LacZ staining.
Sox10 expression was visualized via LacZ staining in E9.5 embryos from intercrosses
between Ets1+/-::Sox10LacZ/+ mice. Sox10 expression can be seen in the cranial ganglia
(cg), the otocyst (ot), the dorsal root ganglia (drg) and the first and second branchial
arches (ba1 and ba2, respectively). Overall, no gross differences were observed in Sox10
expression between Ets1-/- and Ets1+/+ or Ets1+/- (not shown) littermates (Magnification:
40x).
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CHAPTER III
GENETIC INTERACTION BETWEEN THE TRANSCRIPTION FACTORS Ets1 AND
Sox10 IN THE DEVELOPMENT OF MELANOCYTES AND ENTERIC GANGLIA
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III. GENETIC INTERACTION BETWEEN THE TRANSCRIPTION FACTORS Ets1
AND Sox10 IN THE DEVELOPMENT OF MELANOCYTES AND ENTERIC
GANGLIA
3.1 Abstract
The study of synergistic genetic interactions through the use of double
heterozygous pigmentation mutants has been instrumental to the elucidation of the
transcriptional networks at play in the development of melanocytes from the neural crest
(NC). We previously established a role for Ets1 in the survival of early melanocyte
precursors (melanoblasts). This observation, along with findings in the avian system,
which implicate Ets1 in the regulation of the transcription factor Sox10, a factor critical
for melanoblast survival, pointed to a potential genetic interaction between Ets1 and
Sox10 in melanocyte development. To establish whether Ets1 interacts with Sox10,
Ets1+/- mice were crossed to Sox10LacZ/+ mice, in which LacZ is inserted into the Sox10
locus, and the hypopigmentation phenotypes of the progeny were compared. The
incidence of hypopigmentation in Ets1+/-::Sox10LacZ/+ mice was significantly higher than
that of Ets1+/- and Sox10LacZ/+ mice. Additionally, the areas of hypopigmentation of
Ets1+/-::Sox10LacZ/+ mice were significantly greater than the sum of the areas of
hypopigmentation of Ets1+/- and Sox10LacZ/+ mice, suggesting that a synergistic genetic
interaction exists between Ets1 and Sox10 in melanocyte development. The transcription
factor Sox10 is also required for the development of NC-derived enteric ganglia, and
mutations in this transcription factor have been described in both syndromic and nonsyndromic aganglionosis of the distal colon or Hirschsprung’s disease. Given the
importance of Sox10 for proper gut innervation, the enteric innervation in the distal
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portion of the colon from Ets1 heterozygous and null mutant mice, that were either wild
type or heterozygous for Sox10, were also analyzed. Colons from Ets1-/-::Sox10+/+ mice
had significantly larger nerve-free areas compared to Ets1+/-::Sox10+/+ and Ets1+/::Sox10LacZ/+ mice. Sox10 heterozygosity was found to exacerbate the decrease in gut
innervation observed in Ets1 null mutants. Finally, analysis of Sox10 expression, via
LacZ staining in E11.5 and E12.5 Ets1-/-::Sox10LacZ/+ and Ets1+/-::Sox10LacZ/+ littermates
revealed an apparent decrease in Sox10 expression in approximately 50% of the embryos
analyzed. Together, these results suggest that Ets1 interacts synergistically with Sox10 in
melanocyte and enteric ganglia development. Furthermore, the nature of this synergistic
interaction may underlie a functional interaction, with Ets1 acting in the regulation of
Sox10 expression during embryonic development.
3.2 Introduction
The study of genetic interactions has been widely used as a means of revealing
functional interactions among genes (Mani et al., 2008). A genetic interaction is the
interaction of two genetic alterations in the specification of a given phenotype (Drees et
al., 2005). Genetic interactions can be additive, epistatic, suppressed, or synergistic in
nature. A genetic interaction is considered additive when the phenotype of the double
mutant is a combination of the phenotypes observed in the single mutants. An epistatic
interaction refers to interactions in which the phenotype of the double mutant is similar to
that of one of the single mutants but not the other. Suppressed genetic interactions are
those in which the phenotype of the double mutant more closely resembles the wild type
phenotype than the phenotype of the single mutants. A synergistic genetic interaction, on
the other hand, exists when the presence of both mutations results in a more extreme or
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exacerbated phenotype than would be expected from the addition of the phenotypes of
the single mutants (Mani et al., 2008; Perez-Perez et al., 2009). Epistatic and suppressive
genetic interactions are considered as evidence of an underlying functional relationship,
while additive interactions indicate the absence of a functional relationship (Perez-Perez
et al., 2009).
Instances of suppressed genetic interactions have been described in mouse
pigmentation mutants. One such instance revealed a functional interaction between Nf1,
the gene encoding the Ras-GTPase activating protein Neurofibromin, with two critical
melanocytic genes, the tryrosine kinase receptor Kit and the Microphthalmia-associated
transcription factor (Mitf). When mice heterozygous for Nf1 were crossed to KitW/+ or
Mitfwh/+ mutant mice a reduction in the sizes of the belly spots normally present in these
mutants was observed in progeny that were also heterozygous for Nf1. In triple
heterozygotes for Kit, Mitf, and Nf1, Nf1 heterozygosity was also able to partially rescue
the exacerbated hypopigmentation phenotype that is normally observed in mice that are
double heterozygous for KitW/+ and MitfWh/+ (KitW/+;MitfWh/+). These results not only
suggested a functional interaction between Nf1 and Kit, and between Nf1 and Mitf, but
also suggested that this interaction occurs via a pathway that links Mitf and Kit rather
than through independent downstream and upstream regulators of Kit and Mitf,
respectively. At the cellular level, Nf1 heterozygosity was found to induce an increase in
the expression of melanogenic enzymes. Additionally, higher levels of phosphorylated
ERK (extracellular signal regulated kinase), a component of the mitogen activated protein
kinase (MAPK) pathway, which acts downstream of Kit to activate Mitf, were observed
in Nf1+/- melanocytes prior to and after stimulation with Kit ligand (Diwakar et al., 2008).
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Whether synergistic genetic interactions can serve as evidence of an underlying
functional relationship remains controversial (Perez-Perez et al., 2009). A synergistic
interaction may result if the genes in question are involved in the same genetic pathway,
but act at different nodes, so that the process is more severely impaired when both genes
are mutated compared to when either gene is mutated (Hekimi et al., 2001). An apparent
synergistic interaction can also result if a mutation increases the sensitivity of an
organism to the effects of another mutation (Perez-Perez et al., 2009).
Synergistic genetic interactions identified through the study of double
heterozygous mice were the first indication of an underlying functional interaction
between Kit and Mitf. Mice heterozygous for a semi-dominant Mitf mutation (Mitfmi-wh/+)
have a uniform ventral spot and a lighter coat color. Crossing Mitfmi-wh/+ mice to mice
heterozygous for a semi-dominant mutation in Kit (KitW-36H), which only have ventral
spots and occasionally white feet and tail, resulted in an exacerbated pigmentation
phenotype, which was more severe than expected if the hypopigmented areas of the
single heterozygotes were added (Beechey et al., 1994). Similar results were obtained
when Mitfmi-wh/+ mice were crossed to heterozygous mice in which the LacZ gene was
inserted into the Kit locus (KitW-LacZ/+). Additional experiments demonstrated that
signaling via the Kit receptor modulates Mitf and is required for Mitf-dependent induction
of Tyrosinase (Tyr), a rate limiting enzyme in melanin production (Hou et al., 2000).
Evaluation of other Mitf mutant alleles, demonstrated that not all Mitf alleles produce a
similar effect when present in a Kit-deficient background, even if the alleles have
equivalent mutations or produce similar alterations in mRNA levels (Hou et al., 2010).
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The study of double heterozygous pigmentation mutants also revealed a
synergistic interaction between Mitf and the anti-apoptotic factor Bcl2. Mice homozygous
for a recessive Bcl2 null allele or for the recessive Mitfvit allele, exhibit gradual pigment
loss over time, whereas heterozygous mice do not show pigmentation defects. Similar to
the homozygous mice for either allele, double heterozygotes display a gradual loss of
pigmentation as a result of melanocyte stem cell death. The synergistic genetic
interaction between Mitf and Bcl2 was found to be the result of a direct functional
interaction between these genes, with Mitf directly binding to and activating the Bcl2
promoter (McGill et al., 2002).
A synergistic genetic interaction has likewise been described between Kit and the
transcription factor paired box 3 (Pax3). Double heterozygous mice for semi-dominant
mutations in Pax3 (wbs+/-) and Kit (wps+/-) exhibit significantly more severe dorsal and
ventral hypopigmentation compared to single heterozygous littermates. At the cellular
level, luciferase assays revealed the ability of Pax3 to transactivate the Kit promoter.
Furthermore, a form of Pax3 carrying the same mutation present in the wps mice
abrogated Kit promoter activation, further validating a role for Pax3 in Kit regulation.
Nonetheless, Pax3 was not found to directly bind the Kit promoter, which suggests that
the functional interaction between these genes is most likely indirect (Guo et al., 2010).
Given the hypopigmentation phenotype observed in Ets1 mutant mice and the
increased melanocyte and NC cell death observed in Ets1 null mutant embryos, it is
likely that Ets1 plays a role in the regulation of melanocyte or NC-specific genes. In
order to dissect potential functional interactions between Ets1 and other melanocytespecific genes, a genetic interactions approach was chosen because the pigmentation
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phenotypes of single and double mutant progenies can be easily assessed and compared.
In light of the fact that, in the chick embryo, Ets1 is required for the activation of the
transcription factor sex determining region Y (SRY)-box 10 (Sox10) (Betancur et al.,
2010), a gene required for the development of various NC cell derivatives, including
melanocytes and enteric ganglia (Herbarth et al., 1998; Southard-Smith et al., 1998; Kapur,
1999; Potterf et al., 2001), Sox10 was the best candidate for this study. A potential
synergistic genetic interaction between Ets1 and Sox10 was studied by comparing the
areas of hypopigmentation in single and double heterozygous progenies. Additionally,
because Sox10 is also required for the development of enteric ganglia, the innervation of
colons from Ets1 heterozygous and null mutant mice, that were either wild type or
heterozygous for Sox10, was also examined.
3.3 Materials and methods
3.3.1 Animals
Mice heterozygous for Ets1 were obtained from Dr. Eric Svensson (Universtiy of
Chicago, Chicago, IL) and generated as previously described to harbor a targeted deletion
of exons 3 and 4 of the Ets1 gene (Barton et., al. 1998). Mice heterozygous for Ets1 were
re-derived by outcrossing to C57BL/6J mice for eight generations (Gao et., al. 2010).
They have been maintained on C57BL/6J genetic background by intercrossing and by
outcrossing to C57BL/6J mice (Jackson Laboratories). Sox10tmlWegLacZ mice (hereafter
referred to as Sox10LacZ/+) were obtained from Dr. Michael Wegner (Institut für
Biochemie, Universität Erlangen-Nürnberg, Germany). Sox10LacZ/+ mice were generated
as previously described (Britsch et al., 2001) via insertion of the LacZ gene into the
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Sox10 coding sequence. Sox10LacZ/+ mice have been maintained on their original C3H
mixed genetic background by backcrossing.
Timed matings were set for the generation of embryos. Animals were mated
overnight, and females were examined for vaginal plugs after approximately 16 hours.
Noon of the day a vaginal plug was observed, was considered embryonic day (E) 0.5.
Pregnant females were euthanized by exposure to Isoflurane (Vedco, Inc.) followed by
cervical dislocation, and an abdominal incision was made to expose the uterus. As soon
as embryos were recovered from the euthanized mother, they were placed in Phosphate
Buffered Saline (PBS) (pH7.2) and dissected out of the uterine sacs. For all embryos,
yolk sacs were isolated for genotyping. Embryos were fixed in 2% paraformaldehyde
immediately after dissection, just prior to β-galactosidase staining. All animal work was
performed according to institutional guidelines established by the National Institutes of
Health (NIH) (Guide for the Care and Use of Laboratory Animals, 2011; Institutional
Animal Care and Use Committee (IACUC) Protocol No. 13-064).
3.3.2 Genotyping
Genomic DNA was isolated from tail biopsies from adult mice, or yolk sacs from
embryos, and used for PCR genotyping. For Ets1, genotyping of adult mice and embryos
was performed using the primers 5’-GTCTTCTTCTCTAGTTTCTGAGTGCTC, 5’GTCCTGCTTACAACACTCTGAATCCTG

and

5’-

GCCTGCTCTTTACTGAAGGCTCTTT (Gao et al., 2010), under standard PCR
9ED:?J?EDI9O9B;IE<f<EH I  f<EH I 7D:f<EH I Products were
visualized in a 2% agarose gel containing 0.5µg/ml Ethidium Bromide (Fisher Scientific).
The wild type Ets1 allele produced a 438bp product while the mutant allele produced a
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350bp product (Gao et al., 2010). For Sox10, genotyping of adult mice and embryos was
performed

using

the

CAGAGCTTGCCTAGTGTCT,

primers
and

5’-CAGGTGGGCGTTGGGCTC,
5’-TAAAAATGCGCTCAGGTCAA

5’under

IJ7D:7H:+-9ED:?J?EDI9O9B;IE<f<EH I f<EH  I 7D:f<EH I 
Products were visualized in a 2% agarose gel containing 0.5µg/ml Ethidium Bromide
(Fisher Scientific). The wild type Sox10 allele produced a 500bp product while the
mutant allele produced a 600bp product (Britsch et al., 2001). Heterozygous animals
were identified by the presence of both PCR products.
3.3.3 Crosses and phenotypic analysis
Heterozygous Ets1 mutant (Ets1+/-) mice were crossed to Sox10 heterozygous
mutants (Sox10LacZ/+) to generate progeny that were either heterozygous for Ets1,
heterozygous for Sox10, or heterozygous for both genes (Ets1+/-::Sox10LacZ/+). The single
heterozygous progeny of the first generation (F1) were intercrossed to generate the second
generation (F2) animals of the genotypes noted above. Third generation animals (F3) were
generated by intercrossing single heterozygous as well as double heterozygous F2 mice.
For each generation, the ventral aspects of each mouse were photographed at 6 weeks of
age. The areas of hypopigmentation were measured using the Image J 1.44p program
(NIH).
3.3.4 β-galactosidase staining of whole mount embryos
Embryos from intercrosses between Ets1+/-::Sox10LacZ/+ mice were harvested at
E11.5 and E12.5. β-galactosidase (LacZ) staining was performed using standard
protocols (Nagy, 2003). Whole embryos were dissected in 0.05M PBS (pH7.2) and fixed
with 2% paraformaldehyde for 50 minutes at room temperature. Embryos were briefly
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washed in PBS (pH 7.2) and incubated 3-5 hours (the incubation time was directly
FHEFEHJ?ED7B JE J>; ;C8HOED?9 7=;  FHEJ;9J;: <HEC B?=>J  7J  f ?D 3-gal solution
consisting of 2mM MgCl2, 0.01% Sodium Deoxycholate, 5mM Potassium Ferricyanide,
5mM Postassium Ferrocyanide (Fisher Scientific), 0.02% Nonidet P40 (Roche
Diagnostics), and 1mg/ml X-gal (Life Technologies). Embryos were washed twice in
PBS to stop the reaction. The staining was visualized under a dissecting scope (Leica,
Model MZ6). Whole Embryos were photographed using a Leica DC500 camera. For each
stage, at least 3 embryos of each genotype (Ets1+/+, Ets1+/- and Ets1-/-) were stained and
photographed.
3.3.5 Colon dissection and Acetylcholinesterase staining
Mice heterozygous for Ets1 (Ets1+/-), Sox10 (Sox10LacZ/+) or both genes (Ets1+/::Sox10LacZ/+) were crossed to generate progeny of the following genotypes: Ets1+/::Sox10+/+, Ets1+/-::Sox10LacZ/+, Ets1-/-::Sox10+/+, and Ets1-/-::Sox10LacZ/+. Littermates of
the genotypes listed above, ranging from 4 to 7 months of age, were euthanized and their
colons dissected. Euthanasia was carried out by exposure to Isoflurane in a closed
chamber, and was followed by cervical dislocation. Once euthanized, approximately
30mm of the distal aspect of the colons of each animal were removed and pinned down to
4% agar plates, with the serosa aspect of each colon facing up. Colons were fixed in 4%
paraformaldehyde, containing 10mM CaCl2 EL;HD?=>J7Jf .K8I;GK;DJBO 9EBEDIM;H;
washed twice with PBS (pH7.4), 5 minutes each time, and incubated overnight in 5%
sucrose. On the third and last day, colons were washed twice with PBS (pH7.4), 5
minutes each time, and subjected to Acetylcholinesterase staining to visualize gut
innervation. Briefly, colons were transferred to 3ml glass vials, and incubated in a
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solution consisting of 15mM Sodium Citrate, 3mM Copper Sulfate, 64mM Sodium
Acetate (Fisher Scientific), 1% Triton X-100 (Sigma-Aldrich), 0.5mM Potassium
Ferricyanide (Fisher Scientific), 0.05% Acetylcholine Iodide, and 5mM Tetraisopropyl
Pyrophosphoramide (Sigma-B:H?9>   >EKHI 7J f  HE9A?D= 7J  H;LEBKJ?EDI F;H
minute (RPM). Colons were then washed twice with PBS (pH7.4), 5 minutes each time,
and incubated for 5 minutes at room temperature in a color substrate solution prepared
with the SIGMAFASTTM Diamonobenzidine Peroxidase tablet set (Sigma-Aldrich). The
solution consisted of 0.7mg/ml 3,3’-Diaminobenzidine (DAB), 2.0mg/ml Urea Hydrogen
Peroxide, and 60mM Tris Buffer (Sigma-Aldrich). Finally colons were rinsed with
10mM Tris Base (pH 8.0) and pinned in 4% agar plates, with the serosa aspect of each
colon facing up (Gariepy et al., 1998). The staining was visualized under a dissecting
scope (Leica, Model MZ6). Colons were photographed using a Leica DC500 camera.
Colons from at least 5 animals of each genotype were stained and photographed. The
extent of innervation of each colon was quantified using the images captured, by
measuring the white (nerve-free) area in 8 squares of 0.25mm2 each (for a total of 2mm2),
within a region located 15mm anterior to the anus (Appendix IV). The ImageJ 1.44p
program (NIH) was used for measuring the white areas in each segment of colon.
3.3.6 Statistical analysis
Statistical analyses were carried out using the PASW Statistics 18 Software
(IBM). The frequency of belly spot appearance was analyzed using the Chi-square test. In
order to compare the mean areas of hypopigmentation among the different genotypes, a
Box-Cox transformation was applied to the belly spot area data (measured in mm2). This
transformation was used to approximate a normal distribution and to achieve equal or
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near equal variances, in order to enable the use of parametric tests (Appendix III). The
lambda value used for the Box-Cox transformations was 0.35 for generations 1 and 3 (F1
and F3) and 0.3 for generation 2 (F2). For each generation, the transformed areas of
hypopigmentation of Ets1+/-::Sox10LacZ/+ mice were compared to the sum of the
transformed areas of hypopigmentation of Ets1+/- and Sox10LacZ/+ mice using a One-Way
ANOVA with a contrast, where Ets1+/- = 1, Sox10LacZ/+ = 1, and Ets1+/-::Sox10LacZ/+ = -2.
Scatter plots of the hypopigmentation areas showing the mean and standard deviations for
each group were created using GraphPad Prism 6 (GraphPad Software, Inc).
To compare the nerve-free areas in colons from Ets1+/-::Sox10+/+, Ets1+/::Sox10LacZ/+, and Ets1-/-::Sox10+/+ mice a One-Way ANOVA with Tukey’s and
Bonferroni’s Post-Hoc Multiple Comparisons was carried out. An independent samples
t-test was carried out to compare the nerve-free area of colons from Ets1-/-::Sox10+/+ and
Ets1-/-::Sox10LacZ/+ mice. All data were confirmed to follow a normal distribution and to
have variances that did not differ significantly within the genotypes being tested. Scatter
plots of the nerve-free areas in 2mm2 of colon for each genotype, showing the mean and
standard deviations were created using GraphPad Prism 6 (GraphPad Software, Inc).
3.4. Results
3.4.1 Ets1 and Sox10 double heterozygosity increases hypopigmentation frequency
In order to determine whether a genetic interaction exists between Ets1 and
Sox10, Ets1+/- mice were crossed to Sox10LacZ/+ mice and the hypopigmentation
phenotypes of the progeny were examined for three generations. For all generations, the
frequency of belly spot appearance in double heterozygotes (Ets1+/-::Sox10LacZ/+) was
significantly higher than in Ets1+/- and Sox10LacZ/+ mice (Figure 3.1, p<0.001 for all
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generations). In the three generations examined, almost all Ets1+/-::Sox10LacZ/+ mice had
belly spots (F1: 97%, F2: 96%, F3: 100%), compared to approximately 40% for Ets1+/mice and 48% of Sox10LacZ/+ mice. The increased frequency of belly spot appearance
observed in double heterozygotes suggests that a genetic interaction exists between Ets1
and Sox10.
3.4.2 Ets1 and Sox10 double heterozygosity exacerbates hypopigmentation
To further characterize the nature of the genetic interaction between Ets1 and
Sox10 the areas of the belly spots of the Ets1 heterozygous and Sox10 heterozygous mice
were compared to the areas of the belly spots of double heterozygous mice. Mice
heterozygous for Ets1 mice usually display a normal coat color. Small belly spots are
observed in approximately 40% of Ets1+/- mice. Sox10LacZ/+ mice have belly spots
approximately 50% of the time. The belly spots in Sox10LacZ/+ mice vary in size but also
tend to be small. If a synergistic interaction exists between Ets1 and Sox10, the areas of
the belly spots of Ets1+/-::Sox10LacZ/+ should be greater than the sum of the areas of the
belly spots of Ets1+/- and Sox10LacZ/+ mice. For all three generations examined, double
heterozygotes were found to have belly spots that were significantly larger than expected
from the addition of the areas of the belly spots in the single heterozygotes (p<0.001 for
all generations, Figures 3.2 and 3.3, Apprendix III), indicating that a synergistic genetic
interaction exists between Ets1 and Sox10 in melanocyte development.
3.4.3 Ets1 null mutants show decreased gut innervation.
Mutations in the transcription factor Sox10 are responsible for Waardenburg
syndrome type IV (WS4), which is characterized by pigmentation defects and
aganglionosis of the distal colon (Hirschsprung’s disease) (Pingault et al., 1998).
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Mutations in Sox10 have also been associated with non-syndromic Hirschsprung’s
disease (Sanchez-Mejias et al., 2010). Given the importance of Sox10 for proper gut
innervation, and the synergistic genetic interaction between Ets1 and Sox10 in
melanocyte development, it was possible that Ets1 deficiency would negatively affect gut
innervation. Megacolon was observed in two Ets1 null mice, both of which were
heterozygous for Sox10 (Ets1-/-::Sox10LacZ/+) (Figure 3.4). In both instances, the
megacolon manifested early (3.5 weeks of age and 12 weeks of age) and was found to be
the result of severe hypoganglionosis of the distal colon (Figure 3.4). Nevertheless, since
megacolon was only observed in 2 animals (of the 7 animals that were obtained for this
genotype), a more detailed analysis was required to determine whether or not Ets1
deficiency results in impaired gut innervation and, if a defect was observed, whether
Sox10 heterozygosity would exacerbate this phenotype.
To analyze the effect of Ets1 deficiency on gut innervation, colons from animals
from crosses between Ets1+/-, Sox10LacZ/+ and Ets1+/-::Sox10LacZ/+ mice were dissected
and the innervation of the gut labeled via Acetylcholinesterase staining. For each colon,
the nerve-free (white) area in 8 squares of 0.25mm2 each, within a region located 15mm
anterior to the anus, was measured using the ImageJ program (Appendix IV). The mean
nerve-free area in colons from Ets1+/-::Sox10+/+ mice (n=6, mean=1.260±0.048mm2) did
not differ significantly (p=1.000) from that of colons from Ets1+/-::Sox10LacZ/+ mice (n=5,
mean=1.291±0.075mm2) (Figures 3.5 and 3.6). The mean nerve-free area of colons from
Ets1-/-::Sox10+/+ mice (n=8, mean=1.402±0.048mm2) was significantly larger than the
mean nerve-free areas of colons from Ets1+/-::Sox10+/+ (p=0.001) and Ets1+/-::
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Sox10LacZ/+

(p=0.010) mice (Figures 3.5 and 3.6). These results suggest that Ets1

deficiency results in impaired gut innervation.
Since no significant difference in gut innervation was observed between Ets1+/::Sox10+/+ and Ets1+/-::Sox10LacZ/+ mice, in order to further explore whether a synergistic
genetic interaction exists between Ets1 and Sox10 in gut innervation, the nerve free areas
of Ets1-/-, Sox10LacZ/LacZ and Ets1-/-::Sox10LacZ/LacZ mice would have to be compared.
Unfortunately, this comparison could not be carried out because Sox10LacZ/LacZ mutants
are embryonic lethal. Nonetheless, a comparison of the mean nerve-free areas in colons
from Ets1-/-::Sox10LacZ/+ mice (n=5, mean=1.501±0.081mm2) and Ets1-/-::Sox10+/+ mice
revealed a significant difference between these two groups (p=0.017) (Figures 3.5 and
3.6, Appendix IV), with colons from Ets1-/-::Sox10LacZ/+ having a greater nerve-free area.
These results support a potential genetic interaction between Ets1 and Sox10 in the
development of enteric ganglia. The colons from the two Ets1-/-::Sox10LacZ/+ animals in
which megacolon was detected were not included in this analysis because these were
considered extreme cases.
3.4.4 Ets1 null mutants appear to display decreased Sox10 expression
The synergistic genetic interaction observed between Ets1 and Sox10 in double
heterozygous mutants pointed to a potential functional interaction between these
transcription factors in melanocyte development. Given that Ets1 is required for Sox10
expression in the chick cranial NC (Betancur et al., 2010), it is possible that it could also
be an important regulator of Sox10 expression in the mouse embryo. In order to visualize
gross changes in Sox10 expression in Ets1 null mutants, embryos from intercrosses
between Ets1+/-::Sox10LacZ/+ mice were harvested between E11.5 and E12.5 and Sox10
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expression was analyzed via LacZ staining. At E11.5, Sox10 expression appeared to be
reduced in 75% of the Ets1-/- (n=4) embryos examined compared to Ets1+/- (n=3) (Figure
3.7) and Ets1+/+ (n=3) (not shown) littermates. At E12.5, Sox10 expression appeared to
be reduced in 50% of Ets1-/- (n=6) embryos compared to heterozygous (n=9) (Figure 3.7)
and wild type (n=3) (not shown) littermates. The apparent decrease in Sox10 expression
observed in Ets1 null mutant embryos suggests that Ets1 may regulate Sox10 expression
during embryonic development.
3.5 Discussion
The study of the transcriptional networks underlying the development of NC cell
derivatives, and particularly of melanocytes, has been largely aided by the use of double
heterozygous mouse mutants (Beechey et al., 1994, Cantrell et al., 2004, Stanchina et al.,
2006, Diawakar et al., 2008, Guo et al., 2010, Hou et al., 2010). In the case of
melanocytes, the use of double heterozygous pigmentation mutants is well suited for the
study of genetic interactions because of the ease with which these interactions can be
analyzed by comparing the pigmentation phenotypes of double and single heterozygotes.
The presence of a pigmentation defect in Ets1 mutant mice points to the requirement of
this transcription factor for proper melanocyte development; however, the mechanism via
which Ets1 acts to promote melanocyte development is currently unknown. We
previously showed that the marked decrease in melanoblast numbers in Ets1 null mutant
embryos is caused, at least in part, by an increase in apoptosis, which suggests that Ets1
is required for early melanoblast survival. Other genes required for melanoblast survival,
include those that code for the transcription factors Mitf, Sox10, and Pax3, and for the
signaling molecules Edn3 and Kitl, and their receptors Ednrb and Kit (Silver et al., 2006).
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Evidence from studies in the chick embryo pointed to a potential interaction
between Ets1 and Sox10. In the chick embryo, Ets1, along with Sox9 and c-Myb, directly
binds to and activates a Sox10 enhancer element that drives Sox10 expression to cranial
but not trunk or vagal NC cells (Betancur et al., 2010). Melanocytes are mostly derived
from trunk NC cells, and currently there are no studies linking Ets1 to Sox10 expression
in trunk NC cells; Nonetheless, the pigmentation defect observed in Ets1 mutant mice,
the importance of Ets1 for melanoblast survival, and its role in the regulation of Sox10
expression in the chick embryo, hinted to a potential genetic interaction between these
two transcription factors in murine melanocyte development.
The study of genetic interactions can be influenced by the presence of genetic
background modifiers, which can affect the penetrance of the phenotype in question
(Cantrell et al., 2004). For this reason, genetic interactions should be studied across more
than a single generation, particularly if different genetic strains are being used. The
potential effect that background modifiers can exert upon a given phenotype is illustrated
by studies describing both the absence and presence of a genetic interaction between
Sox10 and the Endothelin receptor b (Ednrb) in melanocyte development. In one study,
mice heterozygous for both Ednrb and Sox10 (Ednrbs-l/+;Sox10Dom/+), were found to
exhibit belly spots that were not significantly larger than the belly spots of the single
heterozygotes. In this study, progeny from a single generation of mice were analyzed and
a lack of a synergistic interaction between Sox10 and Ednrb was reported (Hakami et al.,
2006). In a subsequent study, progeny from crosses between Ednrbs-l/+ and Sox10LacZ/+
mice were analyzed for three generations. In the first generation, a genetic interaction
was not observed between Sox10 and Ednrb; however, a synergistic genetic interaction
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became apparent in the second and third generations, in which double heterozygous mice
had belly spots that were significantly larger than would be expected from the sum of the
areas of the belly spots present in the single heterozygous mice (Lowenstein, 2009). It is
likely that in the first study, which reported a lack of a genetic interaction between Ednrb
and Sox10, strain-specific loci decreased the penetrance of the hypopigmentation
phenotype that results from combined Ednrb and Sox10 heterozygosity, masking the
existence of an interaction between these genes.
To begin dissecting a potential interaction between Ets1 and Sox10, the
pigmentation phenotypes of single heterozygotes were compared to those of double
heterozygotes. Three generations of mice were examined in order to take into account the
potential effect of background modifiers, since the Ets1+/- and Sox10LacZ/+ mice were
generated in different genetic backgrounds. A significant increase in the frequency of
belly spot appearance was observed in Ets1+/-::Sox10LacZ/+ mice compared to single
heterozygotes. These results were consistent throughout the 3 generations examined, with
almost all double heterozygous mice having belly spots, compared to 40-50% of single
heterozygotes. Analysis of the hypopigmentation areas of Ets1+/-, Sox10LacZ/+ and Ets1+/::Sox10LacZ/+ mice revealed that the mean areas of hypopigmentation in double
heterozygous mice were significantly larger than the sum of the areas of
hypopigmentation in the single heterozygous progeny. These results were consistent and
significant across all generations and indicate that a synergistic genetic interaction exists
between Ets1 and Sox10. The fact that the results were consistent across all generations
suggests that the presence of strain-specific alleles did not seem to significantly affect the
penetrance of the phenotype in these mice.
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In addition for being required for proper melanocyte development, Sox10 is also
required for the development of enteric ganglia (Southard-Smith et al., 1998). In the
spontaneous embryonic lethal Sox10Dom/Dom mutant mouse, NC cells fail to colonize the
gut as a result of increased apoptosis (Kapur, 1999). This may be the result, at least in
part, of decreased activation of the tyrosine kinase receptor c-Ret, which is also required
for the development of enteric ganglia, and has been shown to be activated by Pax3 and
Sox10 (Lang et al., 2000). The requirement of Sox10 for the survival of enteric ganglia
precursors prompted the examination of the guts of Ets1 null mutant mice to determine
whether Ets1 deficiency would negatively affect gut innervation. Close examination of
the guts of Ets1-/-::Sox10+/+ and Ets1+/-::Sox10+/+ mice revealed a significantly larger
nerve-free area in Ets1-/-::Sox10+/+ mutant mice compared to Ets1+/-::Sox10+/+, suggesting
that Ets1 may play a role in the development of enteric ganglia during development.
Given the role of Ets1 in NC cell survival (Figure 2.5), it is possible that the decreased
innervation observed in Ets1 null mutant mice may be the result of a reduction in the
number of NC cells available to colonize the distal colon.
Throughout the course of the present study, two instances of hypoganglionic
megacolon were observed in Ets1 null mutant mice, which were also heterozygous for
Sox10 (Ets1-/-::Sox10LacZ/+). Although no significant difference in the extent of gut
innervation was observed between Ets1+/-::Sox10+/+ and Ets1+/-::Sox10LacZ/+ mice, Ets1-/::Sox10LacZ/+ mice were found to have colons with greater nerve-free areas compared to
Ets1-/- mice carrying both copies of the wild type Sox10 allele. The significant decrease in
gut innervation observed in Ets1-/-::Sox10LacZ/+ mice compared to Ets1-/-::Sox10+/+ may
be the result of a synergistic interaction between Ets1 and Sox10. In light of the absence

	
  

99

	
  

of a significant difference in gut innervation between Ets1+/-::Sox10+/+ and Ets1+/::Sox10LacZ/+ mice and the embryonic lethality of Sox10LacZ/LacZ mutants, it was not
possible to directly test the presence of a synergistic interaction by using double null
mutant mice. Nevertheless, the decrease in gut innervation observed in Ets1-/::Sox10LacZ/+ mice compared to Ets1-/-::Sox10+/+ mice and the presence of
hypoganglionic megacolon in 2 of 7 Ets1-/-::Sox10LacZ/+ mice examined suggests that
Ets1 and Sox10 may interact in the development of enteric ganglia. Our previous finding
that Ets1 plays a role in promoting the survival of melanoblasts and NC cells is also
consistent with this hypothesis (Figure 2.3 and Figure 2.5).
A decrease in enteric progenitor cell survival has been described in Sox10
heterozygous mice that are also homozygous for the mutant Ednrbsl/sl (piebald) or
Edn3ls/ls (lethal spotting) alleles. Compared to single mutants, these animals show a
dramatic decrease in the number of enteric neuronal progenitor cells in the gut, which
results from increased apoptosis in vagal neural crest cells prior to the time when they
begin to invade the gut at E9.5-10 (Stanchina et al., 2006). In Sox10 homozygous mutants
increased apoptosis of enteric ganglia precursor cells, also results in the failure of these
cells to colonize the gut (Kapur, 1999). Additional cell survival assays to compare the
numbers of dying enteric ganglia precursor cells in Ets1-/-::Sox10+/+ and Ets1-/::Sox10LacZ/+embryos are needed to determine whether Ets1 and Sox10 work together to
promote the survival of these cells.
Synergistic genetic interactions may or may not indicate the presence of a
functional interaction between the genes in question. The apparent decrease in Sox10
expression observed in about half of all E11.5 and E12.5 Ets1-/- embryos compared to
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Ets1+/- and wild type littermates suggests that Ets1 may play a role in the regulation of
Sox10 expression. However, this apparent decrease in expression may also be the result
of a decrease in the number of NC cell derivatives, thus further studies are needed to
determine whether Ets1 regulates embryonic Sox10 expression. In order to gain a better
understanding of the underlying functional interaction that may exist between Ets1 and
Sox10, the ability of wild type and mutated Ets1 protein to activate the Sox10-MCS4
enhancer, an enhancer critical for Sox10 expression in mouse melanocytes (Antonellis et
al., 2008) will be analyzed via luciferase reporter assay in the next chapter.

Figure 3.1. Ets1 and Sox10 double heterozygosity increases hypopigmentation
frequency. The incidence of hypopigmentation in Ets1+/-::Sox10LacZ/+ mice was
significantly greater than the incidence of hypopigmentation in Ets1+/- and Sox10LacZ/+
mice (p<0.001) for all three generations analyzed.
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Figure 3.2. Ets1 and Sox10 double heterozygotes display increased ventral
hypopigmentation compared to single heterozygotes. Representative pictures of ventral
hypopigmentation for each genotype show that double heterozygous mice had larger
areas of hypopigmentation compared to Ets1 and Sox10 single heterozygotes (F1 = 1st
generation, F2 = 2nd generation, F3 = 3rd generation).
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Figure 3.3. Ets1 and Sox10 double heterozygosity results in an aggravated
hypopigmentation phenotype. The areas of hypopigmentation of Ets1+/-::Sox10LacZ/+ mice
were significantly greater than the sum of the areas of hypopigmentation of Ets1+/- and
Sox10LacZ/+ mice (p<0.001) in all three generations analyzed (Appendix III).
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Figure 3.4. Aganglionic megacolon in Ets1-/-::Sox10LacZ/+ mice. (A) 3.5-week-old and
(C) 3 month old Ets1-/-::Sox10LacZ/+ mice exhibiting megacolon as a result of impaired
innervation of the distal colon (B & D, respectively) (Magnifications B=35x, D=25x).
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Figure 3.5. Ets1 null mutants show decreased gut innervation. Representative images of
colon innervation labeled via Acetylcholinesterase staining in colons from (A) Ets1+/::Sox10+/+, (B) Ets1+/-::Sox10LacZ/+, (C) Ets1-/-::Sox10+/+, and (D) Ets1-/-::Sox10LacZ/+
mice. (Magnifications = 16x). Colons from Ets1 null mutants (C & D) appear less
innervated compared to colons from Ets1 heterozygotes (A & B). (D) Sox10
heterozygosity further exacerbates the hypoganglionic phenotype observed in Ets1 null
mutants.
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Figure 3.6. Ets1 deficiency results in decreased gut innervation. Scatterplots showing the
nerve-free areas (including means and standard deviations) in 2mm2 regions of colons
from Ets1+/-::Sox10+/+, Ets1+/-::Sox10LacZ/+, Ets1-/-::Sox10+/+, and Ets1-/-::Sox10LacZ/+
mice. The mean nerve-free area in colons from Ets1+/-::Sox10+/+ mice did not differ
significantly from that of Ets1+/-::Sox10LacZ/+ (p=1.000). The mean nerve-free area of
colons from Ets1-/-::Sox10+/+ mice was significantly larger than the mean nerve-free
areas of colons from Ets1+/-::Sox10+/+ (p=0.001) and Ets1+/-::Sox10LacZ/+ (p=0.010) mice.
The mean nerve-free area of the colons from Ets1-/-::Sox10LacZ/+mice was significantly
greater compared to that of Ets1-/-::Sox10+/+ mice (p=0.017).
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Figure 3.7. Sox10 expression in Ets1 mutant embryos. Sox10 expression was visualized
via LacZ staining in E11.5 (A-D) and E12.5 (E-H) embryos from intercrosses between
Ets1+/-::Sox10LacZ/+ mice. At E11.5, Sox10 expression appears to be reduced in 75% of
Ets1-/- embryos (n=4) (C & D), compared to Ets1+/- (n=3) (A & B) and Ets1+/+ (n=3) (not
shown) littermates. At E12.5, Sox10 expression appears to be reduced in 50% of Ets1-/embryos (n=6) (G & H) compared to Ets1+/- (n=9) (E & F), and Ets1+/+ (n=3) (not
shown) littermates. (Magnifications: A & C= 16x, B & D= 25x, E & G= 12.5x, F & H=
21x).
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CHAPTER IV
THE TRANSCRIPTION FACTOR Ets1 ACTIVATES THE MELANOCYTE
LINEAGE-SPECIFIC Sox10-MCS4 ENHANCER
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IV. THE TRANSCRIPTION FACTOR Ets1 ACTIVATES THE MELANOCYTE
LINEAGE-SPECIFIC Sox10-MCS4 ENHANCER
4.1. Abstract
Phenotypic analysis of double heterozygous mutants for the transcription factors
Ets1 and Sox10 revealed a synergistic genetic interaction between these genes in
melanocyte development. The presence of this synergistic genetic interaction hinted to a
potential functional interaction between Ets1 and Sox10. To characterize the nature of
this interaction, the ability of Ets1 to activate the Sox10-MCS4 enhancer, which was
previously shown to direct Sox10 expression in melanoblasts and melanocytes, was
analyzed via luciferase reporter assay. In the mouse melanoma cell line B16, Ets1 was
able to activate the Sox10-MCS4 enhancer, suggesting a possible role for Ets1 in the
regulation of Sox10 expression. Consistent with Ets1 function in melanocyte
development, whole exome sequence analysis of the spontaneous mouse mutant variable
spotting at the NIH Sequencing Center identified a G-to-A nucleotide transition in exon 3
of the Ets1 gene, which results in a missense Glycine to Glutamate mutation at amino
acid 102 (G102E) of the Ets1 protein. We determined that this results in a hypomorphic
mutation as in vitro luciferase reporter assay demonstrated a 2-fold decrease in the
activation of the Sox10-MCS4 enhancer compared to wild type Ets1 protein. The ability
of Ets1 to activate the Sox10-MCS4 enhancer and the effect of the variable spotting
mutation on Sox10-MCS4 activation suggest that Ets1 may act as a regulator of Sox10
expression during melanocyte development in the mouse embryo.
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4.2. Introduction
The transcription factor Sox10 is essential for the development of various neural
crest (NC) cell-derived structures during vertebrate embryogenesis. During development,
Sox10 is expressed in migrating NC cell derivatives, which include the cranial, dorsal
root, sympathetic, and enteric ganglia, as well as the melanocyte precursors, or
melanoblasts (Southard-Smith et al., 1998). The importance of Sox10 in the development
of NC-derived cell lineages was first recognized in the spontaneous Dominant megacolon
(Dom) mouse mutant. Sox10Dom mutants harbor a frameshift mutation in Sox10 that
results in a truncated protein (Herbarth et al., 1998, Southard-Smith et al., 1998).
Sox10Dom heterozygotes display ventral hypopigmentation and aganglionic megacolon
(Herbarth et al., 1998, Southard-Smith et al., 1998; Kapur, 1999). Similarly, in humans,
Sox10 mutations have been associated with Waardenburg Syndrome type IV (WS4),
which is characterized by pigmentation defects, congenital deafness, and aganglionosis of
the distal colon, or Hirschsprung’s disease (Tachibana et al., 2003).
Neural-crest derived structures can be found in Sox10Dom/Dom and in the genetically
engineered Sox10LacZ/LacZ mouse mutants, indicating that Sox10 is not required for the
initial specification of NC cells (Southard-Smith et al., 1998; Britsch et al., 2001). In the
absence of Sox10, early NC-derived structures, such as the cranial ganglia, are able to
form; however, severe morphological alterations in these structures become apparent by
E10.5 (Herbarth et al., 1998; Southard-Smith et al., 1998). The loss of certain NC-derived
structures in Sox10Dom/Dom and Sox10LacZ/LacZ embryos has been attributed to increased
apoptosis, because significantly larger numbers of dying migrating NC and dorsal root
ganglia cells are observed in Sox10Dom/Dom mice (Southard-Smith et al., 1998). The
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absence of enteric ganglia in the guts of Sox10Dom/Dom mice has also been attributed to
increased apoptosis because a large number of apoptotic cells can be detected in areas
containing NC cells prior to the time when they colonize the gut (Kapur, 1999). The
increased apoptosis observed in migratory NC cells in Dom homozygous mutants
suggests that Sox10 is essential for NC cell survival (Mollaaghababa et al., 2003).
In addition to being required for NC cell survival, Sox10 is also required for the
final specification of melanocytes and glia. Working in cooperation with the transcription
factor Paired Box 3 (Pax3), Sox10 has been shown to bind to and activate the expression
of the Microphthalmia- associated transcription factor (Mitf), which is required for the
terminal differentiation of melanoblasts and for the activation of genes required for
melanin synthesis (Bondurand et al., 2000, Potterf et al., 2000). In in vitro studies, Sox10
has also been shown to regulate the transcription of genes required for melanin synthesis,
including Dopachrome tautomerase (Dct), and Tyrosinase (Tyr) (reviewed in Harris et al.,
2010).
Although many transcriptional targets of Sox10 have been identified, the various
aspects of Sox10 regulation are only now beginning to be understood. The Sox10
promoter, which has not been well characterized, does not direct the expression of Sox10
to most of its typical expression sites (Deal et al., 2006). However, a total of 14 multiple
conserved sequences (MCS) that can drive Sox10 expression to various cell lineages have
been identified (Antonellis et al., 2006, Deal et al., 2007, Antonellis et al., 2008). A
subset of these sequences was first identified by mutation analysis of the transgeneinsertion Sox10Hry mutant, a mouse model of WS4. In this mutant a 16kb area located
47kb upstream of Sox10 is deleted (Antonellis et al., 2008). This deletion severely
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impairs but does not completely abrogate Sox10 expression, suggesting that this 16kb
region contains cis-regulatory elements necessary for Sox10 expression. Of these
elements, Sox10-MCS1c, Sox10-MCS4, Sox10-MCS5, Sox10-MCS7, and Sox10-MCS9
can drive reporter gene expression in cultured melanocytes. Furthermore, both Sox10MCS4 and Sox10-MCS7 are able to recapitulate Sox10 expression in vivo, in almost all
NC-derived structures. These enhancers contain binding sites for the SoxE family of
transcription factors, which bind as dimers and include Sox8, Sox9 and Sox10
(Antonellis et al., 2008). Recent studies have shown that both Sox9 and Sox10 are able to
bind to mouse Sox10 enhancers. Other transcription factors that have been shown to bind
to Sox10 enhancers include Pax3, Activating protein 2 (AP2) and Lymphoid enhancer
binding factor 1 (Lef1). Nevertheless, the ability of Sox9, Sox10, Pax3, AP2 and Lef1 to
transcriptionally activate Sox10 has not been evaluated (reviewed in Harris et al., 2010).
In the avian system, two Sox10 enhancers have been identified approximately 1kb
downstream of the Sox10 coding region. Together, these enhancers, termed Sox10E1 and
Sox10E2, are able to recapitulate Sox10 expression in the chick embryo. Sox10E1 is
active in migrating vagal and trunk NC cells, while Sox10E2 acts earlier in cranial NC
cells. The regulatory activity of Sox10E2 is dependent on binding by the transcription
factors Ets1, Sox9, and c-Myb; however, these factors do not appear to be required for
Sox10E1 activity. In vivo, Ets1, Sox9, and c-Myb were also found to be required for
endogenous Sox10 expression in delaminating and migrating NC cells in the cranial
neural tube region. In the chick embryo, Ets1 is not normally expressed in trunk NC cells;
however, ectopic Ets1 expression can drive reporter gene expression, via Sox10E2
activation, in trunk NC cells (Betancur et al., 2010). Although in the chick, Ets1 is not
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expressed in the trunk NC, studies in the mouse embryo have reported Ets1 expression
not only in cranial NC cells (Kola et al., 1993) but also in migrating trunk NC cells
(Vandenbunder et al., 1989).
Phenotypic analysis of double heterozygous mutants for the transcription factors
Ets1 and Sox10 revealed that a synergistic genetic interaction exists between these genes.
The presence of a synergistic genetic interaction between Ets1 and Sox10 may be the
result of an underlying functional interaction. One possibility regarding the nature of this
interaction, would be Ets1 acting as a regulator of Sox10 expression. Given the findings
in the chick embryo, where Ets1 regulates Sox10 expression in the cranial NC, we sought
to test whether a similar relationship exists between Ets1 and Sox10 in the mouse by
studying the ability of wild type and mutated Ets1 protein to activate a Sox10 regulatory
region. The Sox10-MCS4 enhancer was chosen as a possible target for Ets1, because this
enhancer is critical for Sox10 expression in melanocytes.
4.3. Materials and methods
4.3.1. Mapping of Ets1 binding sites in the Sox10-MCS4 and Sox10-MCS7enhancers
The coordinates of the Sox10-MCS4 and Sox10-MCS7 enhancers were obtained
from Antonellis et al., 2008. The coordinates given in this study are from the February
2006 University of California at Santa Cruz (UCSC) Genome Browser Mouse assembly.
In order to obtain the appropriate Sox10-MCS4 and Sox10-MCS7 sequences, the
coordinates were converted using BLAST analysis and the UCSC Mouse BLAT Genome
search, which allows alignment to previous genome assemblies. The coordinates for
Sox10-MCS4 and Sox10-MCS7 from the February 2006 UCSC Genome Browser Mouse
assembly
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chr15:79,020,080–79,020,899
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and

chr15:79,040,107–79,040,404,

	
  

respectively. These coordinates were found to correspond to chr15:79,023,25579,024,074 and chr15:79,043,282-79,043,579 of NCBI sequence NC_000081.5, for
Sox10-MCS4 and Sox10-MCS7, respectively.
Once the correct coordinates were identified, the 820bp sequence of Sox10-MCS4
and the 298bp sequence of Sox10-MCS7 were analyzed for potential Ets1 binding sites
using the MatInspector program (Genomatix, Inc), which locates transcription factor
binding sites within a sequence by using a library of matrix descriptions for these binding
sites.
4.3.2 Cell culture
The B16-F10 (B16 hereafter) mouse melanoma cell line was purchased from
ATCC (CRL-6322, ATCC). Cells were maintained in Dubelcco’s Modified Eagle’s
Medium (DMEM) (Cellgro), supplemented with 10% Fetal Bovine Serum (FBS), 100
U/ml penicillin, and 100 U/ml streptomycin (all from Thermo Scientific), 7Jf?D
CO2.
4.3.3 Plasmid constructs
The Ets1 overexpression vector (pCMV-HA-Ets1) and the pCMV-HA empty
vector (Clontech) were gifts from Dr. Satrajit Sinha (State University of New York
(SUNY) at Buffalo, Buffalo, NY). The pCMV-HA-Ets1 vector contains a Hyaluronic
acid (HA)-tagged version of the full length mouse Ets1 coding sequence (Nagarajan et
al., 2009). The Sox10-MCS4 luciferase vector (Sox10-MCS4 fragment in pLGF-E1b
vector) was a gift from Dr. William J. Pavan (National Institutes of Health (NIH),
Bethesda, MD). This vector contains the Sox10-MCS4 enhancer, which was shown to
drive expression to melanocytes, upstream of a minimal promoter (p1EB) which directs
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basal luciferase expression (Antonellis et al., 2008). The pRL-TK wild type Renilla
luciferase control vector (Promega) was a gift from Dr. Erasmo Perera (Florida
International University (FIU), Miami, FL). All plasmids were transformed into
Escherichia coli Dh5α competent cells (Life Technologies) and glycerol stocks were
prepared (Appendix I). Plasmids were purified from overnight culture using the QIAprep
Spin Miniprep Kit (Qiagen). Ethanol precipitation was carried out to purify and
concentrate plasmids to be used for transfections (Appendix V).
4.3.4 Sequencing the variable spotting mutation
DNA samples from 4 variable spotting mutant mice (2 homozygous and 2
heterozygous) were purchased from The Jackson Laboratory (Bar Harbor, Maine) by our
collaborator (Dr. William J. Pavan, NIH, Bethesda, MD) and sent to us for further
analysis. Sequencing of DNA from all 4 variable spotting mutant mice was carried out
using the forward primer 5’- AAGGTGTAGAGTAACTAGCATCGTCAG, or the
reverse primer 5’- AACTCCTAAGGCAGAGAAGAAAATAAG. Sequencing was
carried out at the Florida International University DNA Core Facility (Florida
International University, Miami, FL). Sequences were analyzed using the Applied
Biosystems Sequence Scanner v1.0 software (Applied Biosystems) and sequence
alignments against the Mus musculus genomic database were carried out using the
megablast algorithm (for highly similar sequences) via the Nucleotide BLAST server
(NCBI, NIH).
4.3.5 Site-directed mutagenesis
The mutant Ets1 overexpression vector (pCMV-HA-Ets1Mut) was prepared from
the PCMV-HA-Ets1 vector, using the Phusion Site-Directed Mutagenesis Kit (Thermo
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Scientific), following the manufacturer’s instructions. The High Performance Liquid
Chromatography (HPLC)-purified primers 5’-TCTGTATGAGTGAAGCAGCACTGTG
and 5’-CACAGTGCTGCTTCACTCATACAGA, which contain the desired G647A
mutation (corresponding to G305A in the open reading frame (ORF) of Ets1, Ref Seq
NM_011808.2) flanked by 11 non-mutated nucleotides were used to insert the mutation
into the Ets1 *-! L?7 +EBOC;H7I; >7?D -;79J?ED +-  9O9B;I E<  f <EH  I 
f<EH I f<EH I />;FH?C;HIM;H;:;I?=D;:JE7DD;7B879AJE879AJEJ>;
plasmid and were phosphorylated at the 5’ end in order to eliminate the need of a separate
phosphorylation step prior to ligation. A total of 500pg of plasmid were used for the PCR
reaction and the amount of PCR product was evaluated via gel electrophoresis with DNA
standards of various concentrations. The resulting PCR product was ligated for 5 minutes
at room temperature and transformed into Escherichia coli Dh5α competent cells (Life
Technologies) (Appendix I). Overnight cultures were prepared from selected colonies
and the plasmid was purified from these cultures using the QIAprep Spin Miniprep Kit
(Qiagen). The purified plasmid was sequenced to confirm the presence of the mutation
using

the

primers:

5’-CAGACACCTTGCAGACAGACTACT,

CACAGTGCTGCTTCACTCATACAGA,

and

5’-

5’-GGTGAGGCGGTCACAACTAT.

Ethanol precipitation was carried out to purify and concentrate the plasmid to be used for
transfections (Appendix V).
4.3.6 Plasmid DNA transfections and luciferase assay
Approximately 1.5 x 105 B16 cells were seeded in antibiotic-free cell culture
media, into each well of a 12 well plate (CytoOne), roughly 24 hours prior to
transfection. Once cells had reached 70-90% confluency they were co-transfected with

	
  

119

	
  

0.5µg/well Sox10-MCS4 luciferase reporter vector, 0.5µg/well pCMV-HA-Ets1, or
pCMV-HA-Ets1Mut or pCMV-HA empty vector, and 0.1µg/well pRL-TK Renilla
luciferase control vector. For each well, plasmid DNA was diluted in 50µl of Opti-MEM
I (Invitrogen). For each well, 4 µl of the lipid transfection reagent Lipofectamine 2000
(Invitrogen) were diluted in 50µl of Opti-MEM I. The diluted DNA and diluted
Lipofectamine reagent were incubated 5 minutes at room temperature. After 5 minutes,
the diluted DNA was combined with the diluted Lipofectamine and incubated 30 minutes
at room temperature. 100µl of lipid-DNA complexes were added to each well in a dropwise manner, evenly distributing drops throughout the well. Plates were gently rocked by
hand for 20 seconds. Cells were ?D9K87J;:7Jf *2 for 48 hours. After 48 hours,
the cells were gently washed with PBS (Thermo Scientific) and lysed with 1x Passive
Lysis Buffer (Promega), for 15 minutes at room temperature with light rocking. For each
well, 20µl of cell lysate were used to measure firefly and Renilla luciferase activities with
the Dual Luciferase Reporter Assay System (Promega). Firefly and Renilla luciferase
activities were measured using a TD-20/20 Luminometer (Turner Designs). For each
experiment the ratio of firefly to Renilla luciferase activity was calculated. Three
independent transfections were carried out, each one in triplicates.
4.3.7 Statistical analysis
The non-parametric Mann-Whitney U test was used to compare the mean
luciferase activity in cells transfected with the Ets1 overexpression vector to that of cells
transfected with the empty PCMV-HA vector (data from 3 independent experiments
carried out in triplicates). This test was also used to compare the mean relative luciferase
activity in cells transfected with the Ets1 overexpression vector to that of cells transfected
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with the Ets1 overexpression vector carrying the variable spotting mutation (data from 3
independent experiments carried out in triplicates).
4.4 Results
4.4.1 The Sox10-MCS4 and Sox10-MCS7 enhancers contain putative Ets1 binding sites.
Analysis of the 820bp sequence of the Sox10-MCS4 enhancer using the
MatInspector software (Genomatix, Inc.) revealed the presence of 4 potential Ets1
binding sites (Table 4.1). One potential Ets1 binding site was identified within the 298bp
Sox10-MSC7 sequence (ccgggagaGGAAcaaaaggtc, from 167 to 187 in the antisense
strand, relative to the 5’ end of the sense strand in Sox10-MCS7). The Sox10-MCS4
enhancer was chosen for further analysis because of the higher number of potential Ets1
binding sites present within this regulatory region.
4.4.2 Transactivation of the Sox10-MCS4 enhancer by Ets1
The ability of Ets1 to activate the Sox10-MCS4 enhancer was tested via luciferase
reporter assay. Compared to cells transfected with the empty PCMV-HA vector, cells
transfected with the Ets1 overexpression vector (PCMV-HA-Ets1) showed significantly
higher luciferase reporter activity (p<0.001) (Figure 4.1). The mean relative luciferase
activity in cells transfected with the Ets1 overexpression vector was 9.51, while in cells
transfected with the empty vector this value was 1.41. This increase in the relative
luciferase activity of the cells transfected with the Ets1 overexpression vector
corresponds to a 6.8 fold increase over the cells transfected with the empty vector.
4.4.3 Ets1 is the mutated gene in the spontaneous variable spotting mouse mutant
Spontaneous variable spotting mutant mice exhibit a similar phenotype to that of
the Ets1 mutant mice used in this study. Head blaze, white spotting of the tail and feet,
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and ventral spotting, which may be large, occur sporadically in homozygous variable
spotting (vs/vs) mice (Jackson Laboratories). On the other hand, the Ets1 null mutant
mice used in this study always have large belly spots and occasionally head blaze. As part
of an exome sequencing project at the National Institutes of Health (NIH), a possible
mutation within the ORF of Ets1 was identified. The existence of this mouse mutant was
brought to our attention by Dr. William J. Pavan (NIH, Bethesda, MD). Via direct
sequencing of 4 variable spotting mutants, we confirmed a nucleotide G-to-A transition
in exon 3 of the Ets1 gene (Figure 4.2), which results in a missense Glycine to Glutamate
mutation at amino acid 102 (G102E) of the Ets1 protein.
4.4.4 The variable spotting mutation results in decreased Sox10-MCS4 activation
In order to test whether the variable spotting mutation affects the ability of Ets1 to
activate the Sox10-MCS4 enhancer, the mutation was inserted into the Ets1 ORF via sitedirected mutagenesis. A significant decrease in relative luciferase activity was observed
in cells transfected with the Ets1 overexpression vector carrying the variable spotting
mutation compared to those transfected with the wild type Ets1 overexpression vector
(p<0.001) (Figure 4.3). This decrease corresponds to approximately a 50% reduction in
Sox10-MCS4 enhancer activation and indicates that this mutation reduces but does not
completely abrogate the ability of Ets1 to transactivate the Sox10-MCS4 enhancer.
4.5 Discussion
The proximal promoter region of Sox10 dos not direct Sox10 expression to cells
where Sox10 is typically expressed (Deal et al., 2006). A distant upstream region located
approximately 47kb upstream of Sox10 is able to recapitulate Sox10 expression in vivo to
most sites where Sox10 is expressed during development (Antonellis et al., 2008).
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Analysis of Sox10-MCS4, one of the enhancers located in this region and which drives
expression to melanocytes, revealed the presence of four potential binding sites for Ets1
suggesting the possibility that Ets1 could regulate Sox10 expression via this enhancer.
Through luciferase reporter assays we showed that Ets1 is able to drive reporter gene
expression through Sox10-MCS4. Additional experiments are needed to determine
whether Ets1 activates this enhancer by directly binding to it. Mutation or deletion of the
putative

Ets1

binding

sites

within

Sox10-MCS4,

along

with

Chromatin

Immunoprecipitation (ChIP) assays may provide some insight into whether the effect of
Ets1 is mediated by direct binding to the Sox10-MCS4 enhancer. Nevertheless, regardless
of whether or not Ets1 binds directly to Sox10-MCS4, its ability to drive expression
through this enhancer implies that, as in the avian system, Ets1 may regulate Sox10
expression.
The presence of a spontaneous mutation in Ets1 which results in a pigmentation
phenotype provided the opportunity to validate the finding that Ets1 can drive expression
through Sox10-MCS4. Although the G102E Ets1 mutant protein is able to activate the
Sox10-MCS4 enhancer, reporter gene expression is reduced by approximately 50%
compared to the wild type Ets1 protein (Figure 4.3). These results suggest that the
variable spotting mutation is a hypomorphic mutation, which reduces but does not
completely abrogate Ets1 protein function. The G102E mutation is present within the
Pointed (PNT) domain of the Ets1 protein. This domain enhances the transactivation
activity of Ets1 and contains a docking site for the mitogen-activated protein kinase
(MAPK) ERK2 (extracellular signal regulated kinase) (Seidel and Graves, 2002).
Docking of ERK2 at this site is critical for the phosphorylation of a threonine residue
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(T38) that is required for enhanced transcriptional activation by Ets1 via recruitment of
the transcription factor CREB-binding protein (CBP) (reviewed in Garrett-Sinha, 2013).
Mutating this ERK2 docking site was found to abrogate Ras/MAPK-mediated
enhancement of Ets1 transactivation activity to the same degree as mutating the
phosphoacceptor T38 residue (Seidel and Graves, 2002). Three residues within the PNT
domain of Ets1, Leucine 114 (L114), L116 and Phenylalanine 120 (F120) have been
shown to play a role in ERK2 binding (Seidel and Graves, 2002). Given the reduced Ets1
transactivation activity of the variable spotting mutant protein, it is possible that the
G102 residue may be important for docking of ERK2 and T38 phosphorylation;
nonetheless, the hypomorphic nature of the G102E mutation suggests this residue
although important, is likely not essential.
It is also possible that the effect of this mutation on Sox10-MCS4 activation is not
related to ERK2 docking and subsequent T38 phosphorylation. Phosphorylation of T38 is
important for Ets1 activation of Ras-responsive genes (Seidel and Graves, 2002). To date,
no evidence exists to support a direct role for the MAPK pathway in Sox10 activation in
the melanocyte lineage. Additionally the G102E mutation is located outside of the (114)
LXLXXXF(120) domain, which is crucial for ERK docking (Dittmer, 2003). Additional
experiments are needed to dissect the specific mechanism via which the variable spotting
mutation results in decreased Sox10-MCS4 activation.
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From
111
121
206
388

To
131
141
226
408

Anchor
121
131
216
398

Strand
+
+
+
-‐

Matrix	
  Sim
0.969
0.994
0.925
0.908

Sequence
cggccccaGGATgctccagga
atgctccaGGAAgtgctgtgc
ggatgcaaGGAAggggccctt
aaacaagaGGAAccagataaa

Table 4.1. Putative Ets1 binding sites in the Sox10-MCS4 enhancer sequence. Using the
MatInspector program, 4 potential Ets1 binding sites where identified within Sox10MCS4. The matrix similarity value refers to the conservation of the individual nucleotide
positions within in the sequence for the transcription factor in question. A matrix
similarity value greater than 0.80 usually indicates a good match to the matrix. The
positions of the potential Ets1 binding sites are indicated from the 5’ end of the sense
strand of the Sox10-MCS4 sequence. The core sequences are indicated in capital letters.
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Figure 4.1. Activation of the Sox10-MCS4 enhancer by Ets1. B16 mouse melanoma
cells were co-transfected with the Sox10-MCS4 luciferase reporter vector, the pRL-TK
Renilla luciferase control vector, and an expression vector encoding an HA-tagged
version of the full length mouse Ets1 coding sequence (PCMV-HA-Ets1) or the PCMVHA empty vector. Sox10-MCS4 enhancer activation, as measured by relative luciferase
activity, was significantly higher in cells transfected with the Ets1 overexpression vector
(PCMV-HA-Ets1), compared to cells transfected with the empty PCMV-HA vector
(Mann Whitney U, ***p<0.001). Firefly luciferase activity was normalized by Renilla
luciferase activity. Data represent the mean (bar height) and standard deviation (error
bars) of 3 independent experiments carried out in triplicates.
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Figure 4.2. Mutation analysis of variable spotting mice. Sequencing of (A) homozygous
and (B) heterozygous variable spotting mutant mice revealed a G-to-A transition (yellow
boxes) in exon 3 of the Ets1 gene at nucleotide position 647 (RefSeq NM_011808.2).
This mutation results in a Glycine to Glutamate change at amino acid 102 (G102E) of the
Ets1 protein.
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Figure 4.3. The variable spotting mutation inhibits Ets1-induced Sox10-MCS4 enhancer
activation. B16 mouse melanoma cells were co-transfected with the Sox10-MCS4
luciferase reporter vector, the pRL-TK Renilla luciferase control vector, and either an
expression vector encoding an HA-tagged version of the full length mouse Ets1 coding
sequence (PCMV-HA-Ets1), an expression vector encoding an HA-tagged version of the
full length mouse Ets1 coding sequence harboring the variable spotting mutation
(PCMV-HA-Ets1Mut), or the PCMV-HA empty vector. Relative luciferase activity was
significantly lower in cells transfected with the with the Ets1 overexpression vector
carrying the variable spotting mutation compared to the wild type Ets1 overexpression
vector (Mann Whitney U, ***p<0.001). The firefly luciferase activity was normalized by
Renilla luciferase activity. Data represent mean (bar height) and standard deviation (error
bars) of 3 independent experiments carried out in triplicates.
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CHAPTER V
Ets1 KNOCKDOWN INDUCES THE UPREGULATION OF THE TRANSCRIPTION
FACTOR Sox9 IN MOUSE MELANOMA CELLS
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5.1. Abstract
The development of melanocytes from the neural crest (NC) is dependent upon
the activation of several signaling pathways and transcription factors. These transcription
factors, which include, Mitf, Sox10, and Pax3, work together in the modulation of
melanocyte development. In addition to these transcription factors, signaling through the
G-protein coupled Endothelin receptor b (Ednrb) and the tyrosine kinase receptor c-Kit is
required for melanoblast survival, proliferation, migration, and differentiation. Much of
what is known about the factors that regulate normal and pathological processes in
melanocytes has been elucidated through the study of mouse pigmentation mutants.
Mutations or deletions in the transcription factor Ets1 result in ventral hypopigmentation
in the mouse. We previously showed that this hypopigmentation phenotype is, at least in
part, the result of decreased survival of NC cells and melanocyte precursors
(melanoblasts). We also characterized a synergistic genetic interaction between Ets1 and
Sox10, and the ability of Ets1 to transactivate a Sox10 enhancer known to drive Sox10
expression to melanocytes and melanoblasts. In order to characterize the molecular basis
for the hypopigmentation phenotype observed in Ets1 mutant mice, we analyzed the
effect of Ets1 overexpression and knockdown on the expression of various genes required
for melanocyte development. Gene expression analysis in mouse melanocyte and
melanoma cells did not reveal changes in the expression levels of Sox10, Pax3, Mitf, Kit,
and Ednrb. Nevertheless, knockdown of Ets1 in a mouse melanoma cell line resulted in a
6-fold increase in the expression levels of the transcription factor Sox9. Although Sox9
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has been implicated in melanocyte development, specifically in the activation of Sox10 in
the chick embryo and in the survival of trunk NC cells in the mouse, it is also required for
the final specification of NC cells as chondrocytes. Our data suggest that Ets1 may act as
a negative regulator of Sox9 and consequently a repressor of cartilage cell fate. These
results point to an additional role for Ets1 in the specification of NC cell fate.
5.2 Introduction
During development melanoblasts migrate dorsolaterally below the surface
ectoderm, eventually colonizing the epidermis and hair follicles where they proliferate
and differentiate into pigment-producing melanocytes (Le Douarin and Kalcheim, 1999).
Large numbers of melanocytes were also shown to derive from Schwann cell precursors
(SCPs), which arise from ventrally migrating NC cells (Adameyko et al., 2009). The
development of melanocytes from the NC is dependent on the activation of several
signaling pathways and transcription factors (Figure 5.1). These transcription factors,
which include, Mitf, Sox10 and Pax3, work together in the modulation of melanocyte
development. Additionally, the transcription factors Lef1, acting downstream of the
canonical Wnt/β-catenin signaling pathway, and β-catenin itself, which can translocate to
the nucleus and act as a transcription factor, have been shown to be important modulators
of melanocyte development (reviewed in Lin and Fisher, 2007; Hou and Pavan, 2008). In
addition to these transcription factors, signaling through the G-protein coupled
Endothelin receptor b (Ednrb) and the tyrosine kinase receptor c-Kit is required for
melanoblast survival, proliferation, migration, and differentiation (reviewed in Hou and
Pavan, 2008; Saldana-Caboverde and Kos, 2010).
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The transcription factor Mitf has been described as the master regulator of
melanocyte development. It has been implicated in melanocyte survival, proliferation and
differentiation through the study of several Mitf allelic mouse pigmentation mutants (Hou
and Pavan, 2008). Mitf is required for melanocyte survival by acting as a transcriptional
regulator of the anti-apoptotic protein Bcl2 (McGill et al., 2002) and of cyclin-dependent
kinase 2 (Cdk2), a cell cycle regulator essential for maintenance of melanoma cell
viability and cell cycle (Du et al., 2004). Another transcriptional target of Mitf, is the
hepatocyte growth factor (HGF) receptor c-Met, which has been shown to be involved in
melanocyte survival in vitro (McGill et al., 2006). Mitf regulates melanocyte proliferation
via transcriptional regulation of Cdk2 and the T-Box transcription factor 2 (TBX2) (Hou
and Pavan, 2008). It also promotes early melanocyte fate specification and melanocyte
differentiation through direct transcriptional regulation of the pigment enzymes
Tyrosinase (TYR), Tyrosinase related protein-1 (TRP1), and Dopachrome tautomerase
(Dct). Other genes that have been implicated in melanocyte differentiation and are
transcriptionally regulated by Mitf include absent in melanoma-1 (AIM-1), melanoma
antigen recognized by T-cells 1 (MART1), and silver homolog (SILV or Pmel17)
(reviewed in Levy et al., 2006).
The transcription factor Sox10, a member of the SoxE family of transcription
factors, is also required for melanocyte development. The importance of Sox10 for
melanocyte survival is evidenced by the hypopigmentation phenotype that results when it
is mutated or deleted. Its targeted deletion in the mouse results in almost a complete
absence of trunk melanoblasts (Hou et al., 2006). Sox10 regulates genes important for
melanocyte development via Mitf transcriptional activation. In cooperation with Pax3,
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Sox10 binds to and transcriptionally activates Mitf (Bondurand et al., 2000, Potterf et al.,
2000). It also activates the transcription of the melanogenic proteins Dct and TYR, which
are essential for melanocyte differentiation (reviewed in Harris et al., 2010). Another
SoxE-family transcription factor that has been recently implicated in melanocyte
development is Sox9. The transcription factor Sox9 is expressed in pre- and postmigratory NC cells and has been found to be important for the survival of trunk NC cells
(Cheung et al., 2005). Studies in the mouse, chick and Xenopus suggest that Sox9 acts
upstream of Sox10 (Silver et al., 2006). In the chick Sox9 was recently shown to directly
bind to and activate Sox10 regulatory regions, and to be required, along with Ets1, for
Sox10 expression in cranial NC cells (Betancur et al., 2010).
The transcription factor Pax3 is another important regulator of melanocyte
development; however, its specific roles in melanocyte development are not fully
understood. Pax3 has been shown to directly bind to and activate the Mitf promoter
(Watanabe et al., 1998), and to act synergistically with Sox10 to activate Mitf
transcription (Bondurand et al., 2000; Potterf et al., 2000). Recently, Pax3 was found to
indirectly activate the Kit promoter in various cell lines, including melanocytes (Guo et
al., 2010). Pax3 has also been shown to inhibit Sox10- and Mitf-dependent transcriptional
activation of Dct. By promoting the transcription of Mitf while inhibiting that of Dct,
Pax3 may be involved in the initial fate decision of melanoblasts as well as in preventing
the terminal differentiation of precursors in order to allow the sufficient expansion of
melanocyte precursors before they become terminally differentiated (Lang et al., 2005).
Signaling via Ednrb is required for melanoblast survival, proliferation, migration,
and differentiation. Binding of Endothelin 3 (Edn3) to Ednrb leads to the activation of the
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G proteins Gq/G11. Hypermorphic alleles of these G proteins lead to hyperpigmentation
in mice, however, their deletion does not result in hypopigmentation suggesting that other
G proteins may act downstream of Ednrb during melanocyte development. The activation
of G-proteins by Ednrb results in transcriptional and translational regulation of Mitf and
mediates many of the Ednrb-induced effects in melanoblast development; however, other
downstream targets of Ednrb, which may also be important for melanocyte development,
and particularly in melanoblast migration, are not currently known. Endothelin signaling
has been shown to interact with Kit signaling to promote melanoblast survival,
proliferation, and differentiation, with Ednrb being required in the final steps of
melanocyte differentiation rather than in the initial commitment to the melanocytic fate
(reviewed in Saldana-Caboverde and Kos, 2010). In the mouse, c-Kit and Kit ligand
(Kitl) mutations result in a phenotype characterized by a belly spot in heterozygous
animals, and by anemia, lack of coat pigmentation, and sterility in the few homozygotes
that survive. c-KIT and KITL mutations are responsible for human piebaldism, which is
characterized by, among other things, hair and skin hypopigmentation (reviewed in Hou
and Pavan, 2008). Signaling via c-Kit has been found to modulate Mitf and to be required
for the induction of Tyr expression (Hou et al., 2000).
The hypopigmentation phenotype of Ets1 mutant mice implies that this
transcription factor is important in melanocyte development. We previously showed that
this pigmentation phenotype appears to be the result, at least to some extent, of decreased
NC cell and melanoblast survival. In an attempt to characterize the molecular mechanism
via which Ets1 regulates melanocyte development, we examined the expression levels of
several melanoblast-specific genes in cells with higher and lower than normal levels of
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Ets1 protein. Understanding the molecular targets of Ets1 will provide more insight into
the specific function of this transcription factor in melanocyte development.
5.3. Materials and methods
5.3.1 Cell culture
The B16-F10 (B16 hereafter) mouse melanoma cell line was purchased from
ATCC (CRL-6322, ATCC). Cells were maintained in Dubelcco’s Modified Eagle’s
Medium (DMEM) (10-013-CV, Cellgro) supplemented with 10% Fetal Bovine Serum
(FBS), 100 U/ml penicillin, and 100 U/ml streptomycin (all from Thermo Scientific), at
f?D*2. The immortalized mouse melanocyte cell line melan-a (Sviderskaya et
al., 2002), was a kind gift from Dr. William J. Pavan (NIH, Bethesda, MD). Melan-a cells
were maintained in cell culture media consisting of RPMI 1640 (10-041-CV, Cellgro),
10% FBS, 100 U/ml penicillin, 100 U/ml streptomycin, 2mM L-glutamine (all from
Thermo Scientific), 200 nM 12-O-tetradecanoyl phorbol 13-acetate (TPA), and 200pM
Cholera Toxin (both from Sigma-Aldrich), 7Jf  *2.
5.3.2 Plasmid constructs
The Ets1 overexpression vector (pCMV-HA-Ets1) and the pCMV-HA empty
vector (Clontech) were gifts from Dr. Satrajit Sinha (SUNY at Buffalo, Buffalo, NY).
The pCMV-HA-Ets1 vector contains a Hyaluronic acid (HA)-tagged version of the full
length mouse Ets1 coding sequence (Nagarajan et al., 2009). Both plasmids were
transformed into Escherichia coli Dh5α competent cells (Life Technologies) and glycerol
stocks were prepared (Appendix I). Plasmids were purified from overnight cultures using
the QIAprep Spin Miniprep Kit (Qiagen). Ethanol precipitation was carried out to purify
and concentrate plasmids to be used for transfections (Appendix V).
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5.3.3 Plasmid DNA transfections
For plasmid DNA transfection, approximately, 3.5 x 105 melan-a or B16 cells
were seeded in antibiotic-free cell culture media, into each well of a 6 well plate
(CytoOne) roughly 24 hours before transfection. Once cells had reached 70-90%
confluency they were transfected with 2µg/well of plasmid DNA. For each well, 2µg of
DNA (PCMV-HA-Ets1 or PCMV_HA empty vector) were diluted in 125µl of OptiMEM I (Invitrogen). For each well, 10µl of the lipid transfection reagent Lipofectamine
2000 (Invitrogen) were diluted in 125µl of Opti-MEM I. The diluted DNA and diluted
Lipofectamine reagent were incubated 5 minutes at room temperature. After 5 minutes,
the diluted DNA and diluted Lipofectamine were combined and incubated 30 minutes at
room temperature. 250µl of these lipid-DNA complexes were added to each well in a
drop-wise manner, evenly distributing drops throughout the well. Plates were gently
HE9A;:8O>7D:<EH I;9ED:I ;BBIM;H;J>;D?D9K87J;:7Jf *2 (B16) or 10%
CO2 (melan-a) for 48 hours. After 48 hours, cells were harvested for total RNA and
protein to assay Ets1 expression by semi-quantitative real time PCR (See 5.3.5) and Ets1
protein by Western blot (See 5.3.6). For each cell line, three independent transfections
were carried out, each one in triplicates.
5.3.4 siRNA transfections
For siRNA transfections, approximately 1.5 x 105 melan-a or 2 x 105 B16 cells
were seeded in antibiotic-free cell culture media, into each well of a 6 well plate
(CytoOne) roughly 24 hours prior to transfecting. Once cells had reached 40–50%
confluency they were transfected with mouse Ets1 siRNAs or Non-targeting siRNA
controls. For one set of experiments, cells were transfected with 75pmol of the
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siGENOME SMARTpool Mouse Ets1 siRNA (Thermo Scientific) or 75pmol of the
siGENOME Non-Targeting siRNA Pool (Thermo Scientific). Each of these siRNA pools
was composed of 4 siRNAs. For each cell line, three independent transfections were
carried out, each one in triplicates.
In order to validate the results of the first set of experiments and to evaluate
possible off-target effects, cells were transfected with individual Ets1 and non-targeting
control siRNAs. Melan-a cells were transfected with 50pmol of each of 2 ONTARGETplus Mouse Ets1 siRNAs (Thermo Scientific, designated as siRNAs 1 and 2) or
100pmol of the siGENOME Non-targeting siRNA (Thermo Scientific). Three
independent transfections were carried out, each one in triplicates. B16 cells were
transfected with two sets of 2 Ets1 siRNAs from the ON-TARGETplus Mouse Ets1
siRNA set of 4 (Thermo Scientific). Cells were transfected with 50pmol of each of 2 ONTARGETplus Mouse Ets1 siRNAs (designated siRNAs 1 and 2 and siRNAs 3 and 4,
Thermo Scientific) or 100pmol of the siGENOME Non-targeting siRNA (Thermo
Scientific). For each set of Ets1 siRNAs, three independent transfections were carried
out, each one in triplicates.
All transfections were carried out using the Lipofectamine 2000 (Invitrogen) lipid
transfection reagent following the manufacturer’s instructions. For each well, a total of
75-100pmol of siRNA (Ets1 or non-targeting control, as described above) were diluted in
100µl of Opti-MEM I. For each well, 7.5µl of Lipofectamine 2000 were diluted in 100 µl
of Opti-MEM I. The diluted siRNA and diluted Lipofectamine were incubated for 5
minutes at room temperature. After 5 minutes, the diluted siRNA and diluted
Lipofectamine were combined and incubated for 30 minutes at room temperature. 200µl
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of these lipid-siRNA complexes were added to each well, in a drop-wise manner, evenly
distributing drops throughout the well. Plates were gently rocked by hand for
7FFHEN?C7J;BO   I;9ED:I  ;BBI M;H; J>;D ?D9K87J;: 7J f   *2 (B16) or 10%
CO2 (melan-a) for 48 hours. After 48 hours, cells were harvested for total RNA and
protein to assay Ets1 expression by semi-quantitative real time PCR (See 5.3.5) and Ets1
protein by Western blot (See 5.3.6).
5.3.5 RNA extraction, cDNA synthesis, and semi-quantitative real-time PCR
Approximately 48 hours after transfection, B16 and melan-a cells were washed
twice with ice cold filter-sterilized Phosphate Buffered Saline (PBS) (Thermo Scientific).
Total RNA from B16 or melan-a cells was isolated using the RNeasy Mini Kit (Qiagen).
RNA was treated with the RNase-free DNase Set (Qiagen) to remove genomic DNA
contamination. RNA quantification was carried out with the Nanodrop 3000 System
(Thermo Scientific). The RNA samples were then subjected to reverse transcription using
Maxima Reverse Transcriptase (Thermo Scientific) following the manufacturer’s
instructions. PCR using the primers 5'-CAAGCTTGCTGGTGAAAAGGA and 5'TGCGCTCATCTTAGGCTTTGT (Colombo et al., 2012), which flank an intronic region
of the housekeeping gene hypoxanthine–guanine phosphoribosyltransferase (HPRT), was
carried out to test cDNAs for the presence of genomic DNA contamination. PCR
products were visualized in a 2% agarose gel. A single band at 186bp confirmed the
absence of genomic DNA contamination, while the presence of an extra band at 1024bp
indicated the presence of genomic DNA. Mouse genomic DNA was used as a positive
control. All cDNAs synthesized were found to be free of genomic DNA contamination.
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The levels of expression of Ets1, Sox10, Mitf, Pax3, Ednrb, Kit, Sox9, and
Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) were examined via semiquantitative real-time PCR. Real-time PCR was performed using the Maxima® SYBR
Green/ROX qPCR Master Mix (Thermo Scientific) on a 7300 Real-Time System
(Applied Biosystems). The following primers were used to assay the levels of expression
of

each

gene:

Ets1:

5’-AGCGCTACGTATACCGCTTT,

and

5’-

ACTAGTCAGCATCCGGCTTT, Sox10: 5’-GGACTACAAGTACCAACCTCGG and
5’-GGACTGCAGCTCTGTCTTTGG

(Seong

et

al.,

2012),

Mitf:

5’-

TGAAACCTTGCTATGCTGGA and 5’-TACCTGGTGCCTCTGAGCTT (Colombo et
al.,

2012),

Pax3:

5’-TCCATCCGACCTGGTGCCAT

and

5’-

TTCTCCACGTCAGGCGTTG, Ednrb: 5’-TTTGCGCATTCTTGTCTAGG and 5’CTCTTGGGCATTCTTTCACA, Kit: 5’-TCCTCTGGGAGCTCTTCTCCTT and 5’GTTGGACAACCTGCTTGAATGTT, Sox9: 5’-CGGAGGAAGTCGGTGAAGA, and
5’-GTCGGTTTTGGGAGTGGTG and Gapdh: 5’-GTCTCCTGCGACTTCAGC, and 5’TCATTGTCATACCAGGAAATGAGC. The thermal profile of the PCR reaction was
f <EH   C?DKJ;I 7D:   9O9B;I E< f <EH  I;9ED:I 7D: f <EH  C?DKJ; 
Samples were analyzed in triplicates and the 2-ΔΔCT method was used to determine
relative levels of expression of the target genes, which were normalized to Gapdh
expression levels (Livak and Schmittgen, 2001). The reduction in Ets1 mRNA levels in
cells transfected with Ets1 siRNA relative to those transfected with non-targeting siRNA
was estimated from the fold change in Ets1 expression calculated via the 2-ΔΔCT method.
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5.3.6 Protein extraction and Western Blot
Overexpression and knockdown efficiency were also assayed via Western blot.
Approximately 48 hours after transfection, B16 and melan-a cells were washed twice
with ice cold filter-sterilized PBS (Thermo Scientific) and lysed using ice cold RIPA
Lysis Buffer (20mM Tris-HCl (pH7.5), 150mM NaCl, 1% Nonidet P40, 0.05% Sodium
Deoxycholate, 0.1% SDS, 2mM EDTA (pH8.0)) containing 1mM phenylmethylsulfonyl
fluoride (PMSF) (Sigma-Aldrich) and 1X Pierce Protease Inhibitor (Thermo Scientific) to
prevent protein degradation. Cell lysates were centrifuged at 16,000 RPM, 20 minutes at
f  3 )K+"  '. .7CFB; K<<;H $DL?JHE=;D 9EDJ7?D?D=  β-mercaptoethanol
(Sigma-Aldrich) was added to the supernatants to a final concentration of 1X. Samples
were boiled for 5 minutes and allowed to cool to room temperature prior to loading onto
Any kD™ Mini-PROTEAN® TGX™ Precast Gels (Bio-Rad) for SDS-PAGE protein
separation. Proteins were then transferred to 0.2µm PVDF membranes. After protein
transfer, the membranes were blocked with 5% Carnation non-fat instant dry milk in
TBST (Tris Buffered Saline + 0.2% Tween 20), 1 hour at room temperature, rocking at
75 RPM. The membranes were then incubated with a rabbit polyclonal anti-Ets1 antibody
(C-20) (sc-350, Santa Cruz Biotechnology) (1:400 in blocking solution), overnight at
f HE9A?D=7J-+( *DJ>;D;NJ:7O, the membranes were washed with TBST and
incubated with a goat anti-rabbit Horseradish Peroxidase (HRP)-conjugated antibody
(611-1324, Rockland Immunochemicals) (1:3,000 in blocking solution). Membranes
were incubated with Peroxide/Lumiglo Substrate (Cell Signaling), 15 seconds at room
temperature. Proteins were visualized by exposure to classic blue X-ray films
(MidScientific).
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Normalization was carried out by re-probing the membrane used for Ets1 Western
blot with a mouse monoclonal anti-β-actin antibody. After visualizing the results of the
Ets1 Western blot, membranes were rinsed extensively with 1X TBS. The membranes
were then stripped of bound antibody by incubating in stripping buffer (7M Guanidine
Hydrochloride (MP Biomedicals), 50mM Glycine (Fisher Scientific), 100mM KCl
(Fisher Scientific), 0.05mM EDTA (Fisher Scientific), 1.39% β-mercaptoethanol (SigmaAldrich)), 10 minutes at room temperature rocking at 80 RPM. Subsequently, membranes
were washed extensively with distilled water and blocked with 5% Carnation non-fat
instant dry milk in TBST, for 1 hour at room temperature, rocking at 75 RPM. The
membranes were then incubated with a mouse monoclonal anti-β-actin antibody (A5316,
Sigma-B:H?9> 

 ?D 8BE9A?D= IEBKJ?ED  EL;HD?=>J 7J f  HE9A?D= 7J  -+( 

The next day, the membranes were washed with TBST and incubated with a goat antimouse

Horseradish

Peroxidase

(HRP)-conjugated

antibody

(31430,

Thermo

Scientific/Pierce) (1:40,000 in blocking solution). Membranes were then incubated with
Peroxide/Lumiglo Substrate, 15 seconds at room temperature. Proteins were visualized
by exposure to classic blue X-ray films (MidScientific).
5.4 Results
5.4.1 Ets1 overexpression does not affect the expression of melanoblast-specific genes in
mouse melanocytes and mouse melanoma cells.
In order to characterize the molecular mechanism via which Ets1 regulates
melanocyte development, mouse melanocytes (melan-a) and melanoma cells (B16) were
transfected with an Ets1 overexpression vector (PCMV-HA-Ets1) or an empty vector
(PCMV-HA). Ets1 was confirmed to be overexpressed in the cells transfected with
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PCMV-HA-Ets1 via semi-quantitative real-time PCR and Western Blot, in both melan-a
and B16 cells (Figures 5.2 and 5.3, respectively). Transfection with PCMV-HA-Ets1
resulted in approximately a 100 fold increase in Ets1 expression in melan-a cells, and a
1,300 fold increase in Ets1 expression in B16 melanoma cells. For melan-a cells, the
expression levels of Kit, Ednrb, Pax3, Mitf, Sox10 and Sox9 were analyzed and no
substantial changes in expression were detected (Figure 5.2). Similarly, no considerable
changes in the expression levels of Kit, Pax3, Mitf, Sox10 and Sox9 were detected in B16
cells overexpressing Ets1. Ednrb expression was not assayed in B16 cells because
endogenous Ednrb expression in this cell line is very low, making it impossible to
accurately detect changes in expression levels via real-time PCR.
5.4.2 Knockdown of Ets1 leads to Sox9 upregulation in mouse melanoma cells.
Given the lack of substantial changes in the expression of melanoblast-specific
genes as a result of Ets1 overexpression, the effect of Ets1 knockdown on the expression
of these genes was assessed. The reduction in Ets1 mRNA levels in melan-a cells
transfected with Ets1 siRNAs relative to those transfected with non-targeting siRNAs
ranged from approximately 68% for cells transfected with 2 individual siRNAs to 80%
for cells transfected with the Ets1 siRNA pool (4 siRNAs). For B16 cells, the reduction
in Ets1 mRNA levels relative to the control ranged from approximately 65% for cells
transfected with 2 individual siRNAs to 72% for those transfected with the Ets1 siRNA
pool.
For both melan-a and B16 cells, an off-target effect on Kit expression was
detected in cells treated with the siGENOME Non-targeting siRNA pool (Thermo
Scientific); for this reason, Kit expression was not reported for these sets of experiments
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(Figures 5.4 B and 5.5 B). Nonetheless, no significant changes in Kit expression levels
were detected in melan-a and B16 cells transfected with sets of 2 individual Ets1 siRNAs
compared to those transfected with control siRNA (Figures 5.4 C and 5.5 C, D).
Similarly, for both cell lines, no substantial changes on the expression levels of Pax3,
Mitf, and Sox10 were detected (Figures 5.4 and 5.5). We observed a slight upregulation in
Ednrb expression (fold change = 2.006±0.087), in melan-a cells transfected with 2
individual Ets1 siRNAs (Figure 5.4 C). This upregulation was not observed in cells
transfected with the Ets1 siRNA pool (Figure 5.4 B). Ednrb expression was not assayed
for B16 cells because Ednrb expression in this cell line is very low, making it impossible
to accurately detect changes in expression levels via real-time PCR. A 6 fold increase in
Sox9 expression was observed in B16 cells transfected with Ets1 siRNA, regardless of the
siRNA or non-targeting control used (Figure 5.5 B, C & D). This change was not
observed in melan-a cells for which Sox9 expression was only evaluated in cells
transfected with individual Ets1 and control siRNAs (Figure 5.4 C).
5.5 Discussion
Deletion or mutation of the transcription factor Ets1 results in ventral
hypopigmentation in the mouse. The increased apoptosis observed in NC cells and
melanoblasts in Ets1 null embryos suggests that Ets1 is required for the survival of these
cells. We previously characterized a synergistic genetic interaction between Ets1 and
Sox10, a transcription factor required for the development of several NC cell derivatives,
including melanocytes. Additionally, we described the ability of Ets1 to activate the
Sox10-MCS4 enhancer, which drives Sox10 expression to melanoblasts and melanocytes,
and the impact of the spontaneous variable spotting mutation on the transactivation
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ability of Ets1. To further characterize the role of Ets1 in melanocyte development, we
sought to determine the molecular targets of Ets1 regulation via gene expression analysis
of melanocyte and melanoma cells with higher and lower than normal Ets1 expression
levels.
In mouse melanocytes and melanoma cells, the expression levels of the
transcription factors Pax3, Mitf, and Sox10 were not visibly affected by overexpression or
knockdown of Ets1. It is possible that neither Pax3 nor Mitf are direct targets of Ets1;
however, the lack of an effect in Sox10 expression was surprising given the ability of
Ets1 to activate the Sox10-MCS4 enhancer and the synergistic genetic interaction
between Ets1 and Sox10. One reasonable explanation for the absence of an effect on
Sox10 expression as a result of Ets1 knockdown is that in the mouse melanocyte and
melanoma cell lines used for this experiment other factors might be able to compensate
for Ets1 deficiency. In the case of Ets1 overexpression, the absence of a significant
change in the expression of Sox10 or other potential downstream targets could result if
endogenous Ets1 protein is sufficient to drive the expression of said targets, so that in
essence, the regulatory regions of these genes are already saturated by the endogenous
protein.
We also failed to detect substantial changes in the expression levels of Kit in
mouse melanocytes and melanoma cells as a result of Ets1 overexpression or knockdown.
A slight upregulation was observed in Ednrb (fold change = 2.006±0.087) in melan-a
cells transfected with 2 individual Ets1 siRNAs (Figure 5.4 C); however, this effect was
not observed in this cell line when transfected with an Ets1 siRNA pool (Figure 5.4 B). It
is possible that off-target effects caused by the Ets1 or non-targeting control siRNAs
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might be responsible for this discrepancy. This is a plausible explanation because an offtarget effect on Kit expression was detected and found to be caused by one of the siRNAs
in the control siRNA pool used for the first set of siRNA transfections. Additional
experiments are needed to determine whether the slight upregulation of Ednrb expression
observed in mouse melanocytes as a result of Ets1 knockdown is biologically relevant.
Knockdown of Ets1 led to a 6-fold increase in Sox9 expression in B16 melanoma
cells (Figure 5.5). This upregulation was not observed in melan-a cells (Figure 5.4). The
difference in Sox9 expression levels in B16 and melan-a cells emphasizes the impact that
the use of different cell lines can have on the expression levels of downstream target
genes in knockdown, as well as overexpression, studies. Ets1 overexpression did not
affect Sox9 expression in melanocytes (Figure 5.2) or melanoma cells (Figure 5.3), which
suggests that endogenous Ets1 protein might be sufficient to suppress Sox9 expression in
these cells.
The transcription factor Sox9 is a member of the SoxE family of transcription
factors, which includes Sox8, Sox9, and Sox10 (reviewed in Lee and Saint-Jeannet,
2011). Sox9 is expressed in pre-migratory NC cells and its expression precedes that of
migratory NC cell markers. Forced expression of Sox9 in the neural tube induces neural
crest-like properties at the expense of neuronal progenitors; however, other factors are
required to induce NC cell delamination (Cheung and Briscoe, 2003). In Xenopus
embryos, morpholino-induced Sox9 depletion results in the loss of NC cell progenitors
(Spokony et al., 2002). In the mouse embryo, Sox9 is first expressed around E8.5, in the
hindbrain region at the dorsal tip of the closing neural tube and in the dorsal folds of the
neural tube in the trunk. Sox9 remains expressed in migrating cranial NC cells (reviewed
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in Lee and Saint-Jeannet, 2011) but it is downregulated in trunk NC cells soon after they
become migratory (Cheung et al., 2005). Sox9 later becomes expressed in NC-derived
chondrocyte precursor cells, where it drives the expression of alpha-1 type-II Collagen
(Col2A1) (Bell et al., 1997). In the mouse, homozygous deletion of Sox9 is embryonic
lethal. Sox9 heterozygotes, on the other hand, die shortly after birth with severe skeletal
defects, including malformations of endochondral bones, a shortened jaw, and cleft palate
(Hong and Saint-Jeannet, 2005). In humans SOX9 mutations are responsible for
Campomelic Dysplasia, a disease characterized by skeletal and craniofacial
malformations as well as sex reversal resulting from abnormal testis development
(Wagner et al., 1994).
The transcription factor Sox9 has been implicated in early melanocyte
development because it is required for Sox10 expression (reviewed in Silver et al., 2006).
In the chick embryo, Sox9, together with Ets1, and c-Myb, are required for endogenous
Sox10 expression in the cranial NC (Betancur et al., 2010). Sox9 expression has also been
shown to be required for the formation of trunk NC cell derivatives. In mouse embryos
carrying a conditional Sox9 null allele, the numbers of neurons and glia in the trunk
region were severely reduced. In these mutants, Sox10 expression was maintained in premigratory NC cells, but reduced along the NC cell migration route. The large decrease in
the number of NC cell derivatives in Sox9 mutant mice was found to be the result of
increased apoptosis of pre-migratory and early migrating NC cells at E9.5 and E10.5. In
pre-migratory NC cells, Sox9 was also found to be required for the expression of Snail
(Cheung et al., 2005), a transcription factor that has been implicated in early pigment cell
development and differentiation (Silver et al., 2006). Although Sox9 seems to be required
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for melanocyte development early on, its prolonged expression has been shown to
negatively affect melanocyte development. Ectopic expression of Sox9 under the
melanocyte-specific Dopachrome tautomerase (Dct) promoter, which drives expression
to melanoblasts beginning at E10 and thereafter (Steel et al., 1992), results in
pigmentation defects in the mouse (Qin et al., 2004). The effect of prolonged Sox9
expression on pigmentation implies that failure to downregulate Sox9 in melanocyte
precursors can negatively affect melanocyte development (Qin et al., 2004). For this
reason, it has been suggested that the importance of Sox9 for melanocyte development is
centered on its ability to induce Sox10 expression (Harris et al., 2013).
Although Sox9 becomes downregulated early on during melanocyte development,
it has been found to be expressed in melanocytes (Cook et al., 2005; Passeron et al.,
2007), nevi, primary melanoma, and melanoma metastases (Passeron et al., 2007;
Passeron et al., 2009; Bakos et al., 2010; Rao et al., 2010). The relationship between Sox9
expression and melanoma progression is not well understood. A small but statistically
significant correlation between Sox9 expression, measured via immunohistochemistry,
and melanoma progression has been reported (Bakos et al., 2010). Conversely, a
moderate decrease in the levels of Sox9 expression with melanoma progression has also
been reported (Passeron et al., 2009). In addition, Sox9 overexpression in various
melanoma cell lines was found to inhibit the proliferation of these cells and their
tumorigenic potential in mice and in a human ex vivo model of melanoma, suggesting
that a negative relationship exists between Sox9 expression and melanoma progression
(Passeron et al., 2009).
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In the present study, knockdown of Ets1 led to a significant increase in Sox9
expression in mouse melanoma cells. At first glance, this result appears to contradict a
positive role for Ets1 in melanocyte development, since it suggests that Ets1 acts as a
negative regulator of Sox9, which is required for the development of trunk NC cell
derivatives. However, given the survival defect observed in NC cells and melanoblasts in
Ets1 null mutants, it is likely that Ets1 plays a dual role in melanocyte development,
initially, in the maintenance of NC cells and early melanocyte precursors, and later in cell
lineage specification by modulating the expression of other NC genes, including Sox9. A
role for Ets1 in cell lineage specification has been previously proposed. The upregulation
of Sox9 in the hearts of Ets1 mutant mice and the presence of ectopic NC cell-derived
cartilage nodules in these hearts suggests that Ets1 may act as a negative regulator of
Sox9, and thus cartilage fate, in NC cells (Gao et al., 2010). Additionally, because
prolonged Sox9 expression appears to negatively impact melanocyte development (Qin et
al., 2004), Ets1-induced Sox9 repression may be important for melanocyte differentiation.
It is possible that in trunk NC cells destined to become melanocytes, as in cardiac NC
cells, Ets1 serves as a repressor of chondrocyte fate. Future experiments comparing Sox9
expression and the numbers of chondrocyte precursors in the trunk region of Ets1 wild
type and mutant embryos will help to address whether the effects of Ets1 deficiency on
melanocyte development are also the result of improper NC or melanoblast
differentiation.
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Figure 5.1. The molecular basis for melanocyte development. The development of
melanocytes from the NC is dependent on the activation of several signaling pathways and
transcription factors. These transcription factors, which include, Mitf, Sox10 and Pax3, work
together in the modulation of melanocyte development. Additionally, the transcription factors
Lef1, acting downstream of the canonical Wnt/β-catenin signaling pathway, and β-catenin
itself, have been shown to be important modulators of melanocyte development. In addition
to these transcription factors, the G-protein coupled Endothelin receptor b (Ednrb) and the
tyrosine kinase receptor c-Kit are required for melanoblast survival, proliferation, migration,
and differentiation.
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Figure 5.2. Ets1 overexpression in melan-a cells does not substantially affect the
expression of melanoblast-specific genes. Melan-a cells were transfected with an Ets1
overexpression vector (PCMV-HA-Ets1) or an empty vector (PCMV-HA). Ets1 mRNA
and Ets1 protein overexpression were confirmed via semi-quantitative real-time PCR (B)
and Western blot (A), respectively. The expression of the genes Kit, Ednrb, Pax3, Mitf,
Sox10, and Sox9 did not differ substantially between cells transfected with the Ets1
overexpression vector and those transfected with empty vector. Data represent gene
expression levels in cells transfected with PCMV-HA-Ets1 relative to those transfected
with PCMV-HA. The mean (bar height) and standard deviation (error bars) are shown for
3 independent experiments carried out in triplicates.
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Figure 5.3. Ets1 overexpression in B16 cells does not considerably affect the expression
of melanoblast-specific genes. B16 cells were transfected with an Ets1 overexpression
vector (PCMV-HA-Ets1) or an empty vector (PCMV-HA). Ets1 mRNA and Ets1 protein
overexpression were confirmed via semi-quantitative real-time PCR (B) and Western blot
(A), respectively. The expression levels of Kit, Pax3, Mitf, Sox10, and Sox9 did not differ
substantially between cells transfected with the Ets1 overexpression vector and those
transfected with empty vector. Data represent gene expression levels in cells transfected
with PCMV-HA-Ets1 relative to those transfected with PCMV-HA. The mean (bar
height) and standard deviation (error bars) are shown for 3 independent experiments
carried out in triplicates.
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Figure 5.4. Ets1 knockdown in melan-a cells does not substantially affect the expression
of melanoblast-specific genes. Melan-a cells were transfected with an Ets1 siRNA pool
or a non-targeting control siRNA pool (A & B), or with 2 individual siRNAs from the
siRNA pool and a different individual control siRNA (C). Knockdown was confirmed via
Western blot (A) and semi-quantitative real-time PCR (B & C). The levels of Kit, Pax3,
Mitf, Sox10, and Sox9 did not differ considerably between cells transfected with the Ets1
siRNAs and those transfected with the non-targeting control siRNAs. Ednrb expression
appeared to be slightly upregulated in cells transfected with individual Ets1 siRNAs, but
this effect on Ednrb was not observed in cells transfected with the Ets1 siRNA pool. Data
represent gene expression levels in cells transfected with Ets1 siRNAs relative to those
transfected with control siRNAs. The mean (bar height) and standard deviation (error
bars) are shown for 3 independent experiments carried out in triplicates.
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Figure 5.5. Ets1 knockdown in B16 melanoma cells results in Sox9 upregulation. B16
cells were transfected with an Ets1 siRNA pool or a non-targeting control siRNA pool (A
& B), or with 2 individual siRNAs from the siRNA pool and a different individual
control siRNA (C & D). Knockdown was confirmed via Western blot (A) and semiquantitative real-time PCR (B, C, D). (B, C, D) The expression levels of Kit, Pax3, Mitf,
and Sox10 did not differ substantially between cells transfected with Ets1 siRNA and
those transfected with control siRNA. Sox9 was notably upregulated in B16 cells
transfected with Ets1 siRNAs compared to those transfected with control siRNAs. Data
represent gene expression levels in cells transfected with Ets1 siRNAs relative to those
transfected with control siRNAs. The mean (bar heights) and standard deviation (error
bars) are shown for 3 independent experiments carried out in triplicates.
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VI. CONCLUSIONS AND FUTURE DIRECTIONS
6.1 Conclusions
Melanocytes, the pigment producing cells, are responsible for hair and skin
pigmentation, which serves to protect organisms from damaging ultraviolet (UV)
radiation (Lin and Fisher, 2007). The skin is the most common site of cancer in humans.
Of all the types of skin cancers, melanoma, the cancer resulting from the malignant
transformation of melanocytes, is the least common but is responsible for the highest
number of skin cancer-related deaths in the United States (American Cancer Society,
2014). Melanocytes are derived from neural crest (NC) cells, a population of pluripotent
cells that arise from the dorsal aspect of the neural tube during vertebrate development
(Le Douarin and Kalcheim, 1999). Melanocyte development is guided by the activation
of transcription factors and by signaling molecules encountered by melanocyte precursors
(melanoblasts) during their migration. Pigmentation mutants of various species have
provided insight into the molecular pathways at work in melanocyte development and
pigment production. These mutants have also served as models of human pigmentation
disorders, including piebaldism, the four known types of Waardenburg Syndrome, and
albinism (reviewed in Baxter et al., 2004).
The deletion of the transcription factor Ets1 was recently found to result in
hypopigmentation in mice (Gao et al., 2010). The aim of this study was to establish the
temporal requirement and role of Ets1 during melanocyte development and to
characterize genetic and molecular interactions between Ets1 and other genes required for
melanocyte development. To this end, a combination of in vivo assays, genetic crosses,
and in vitro molecular assays were employed.
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In Chapter 2, the effect of Ets1 deletion on melanoblast and NC cell survival were
described. To establish the temporal requirement and mechanism of action of Ets1 during
melanocyte development, Dct-LacZ transgenic mice in which LacZ expression is driven
to melanoblasts under the control of the Dopachrome tautomerase (Dct) promoter, were
used to label melanoblasts via β-galactosidase staining in Ets1 null (Ets1-/-), heterozygous
(Ets1+/-) , and wild type (Ets1+/+) embryos. Ets1 null embryos were found to have fewer
melanoblasts, compared to heterozygous and wild type littermates, at all stages examined
(Embryonic day (E) 10.75-E15.5). Melanoblast proliferation was not affected at E10.75,
but a significant increase in melanoblast cell death was observed at this stage in Ets1 null
embryos compared to heterozygous littermates. At E10.25, NC cell survival was found
to be negatively affected in Ets1 null mutant embryos; however, the numbers of NC cells,
labeled via Sox10 immunofluorescence, did not differ significantly between Ets1 null and
Ets1 heterozygous embryos at this stage. Similarly, the amount and pattern of Sox10
expression was found to be unaffected in Ets1 null embryos at E9.5. These results suggest
that Ets1 is required between E10 and E11 in melanocyte development and that it
regulates the melanoblast and NC cell survival at this stage.
Given the early melanoblast and NC cell survival defect observed in Ets1 null
mutant mice, it seemed likely that Ets1 would play a role in the regulation of one or more
genes essential for the development of melanocytes and other NC cell derivatives. In
Chapter 3, a genetic interactions approach was chosen to determine whether a synergistic
genetic interaction exists between Ets1 and the transcription factor Sox10. Sox10 was
chosen for this study because experiments in the avian system have shown that Ets1
regulates Sox10 expression in cranial NC cells (Betancur et al., 2010). By comparing the
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frequency and area of hypopigmentation in single (Ets1+/- and Sox10LacZ/+) and double
heterozygous (Ets1-/-::Sox10LacZ/+) progeny from crosses between Ets1 heterozygous and
Sox10 heterozygous mice, Ets1 and Sox10 were found to interact synergistically during
melanocyte development.
In addition to its role in melanocyte development, the transcription factor Sox10 is
also required for proper gut innervation (Southard-Smith et al., 1998; Kapur, 1999). For
this reason, the effect of Ets1 deficiency on gut innervation was also examined. The nerve
free area in the distal colon of Ets1 null mice was found to be significantly greater than in
Ets1 heterozygous mice, indicating that Ets1 is also important for the development of
enteric ganglia, which are also derived from NC cells. Furthermore, Sox10 heterozygosity
was found to further exacerbate the decreased innervation observed in Ets1 null mice. In
fact, severe hypoganglionosis of the distal colon, which led to megacolon, was detected
in two Ets1-/-::Sox10LacZ/+ mice.
In order to further characterize the nature of the synergistic genetic interaction
between Ets1 and Sox10, the amount and pattern of Sox10 expression was compared in
Ets1 null, heterozygous, and wild type littermates. At E11.5 and E12.5 an apparent
decrease in Sox10 expression was observed in at least 50% of Ets1 null embryos
compared to Ets1 heterozygous and wild type littermates. These results suggest that Ets1
may regulate embryonic Sox10 expression; however, they could also be indicative of a
reduction in the number of Sox10 positive cells.
Synergistic genetic interactions may or may not indicate the presence of a
functional interaction between the genes in question. In order to gain a better
understanding of the underlying functional interaction that may exist between Ets1 and
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Sox10, the ability of Ets1 to activate the Sox10-MCS4 enhancer, an enhancer critical for
Sox10 expression in mouse melanocytes and melanoblasts (Antonellis et al., 2008) was
analyzed in Chapter 4 via in vitro luciferase reporter assay. In the mouse melanoma cell
line B16, Ets1 was able to activate this enhancer, suggesting a possible role for Ets1 in
the regulation of Sox10 expression. In this chapter, the spontaneous variable spotting
mutation, which causes hypopigmentation in mice and was suspected to be a mutation in
Ets1, was confirmed to be a G-to-A nucleotide transition in exon 3 of the Ets1 gene,
which predicts in a Glycine to Glutamate amino acid change at position 102 of the Ets1
protein (G102E missense mutation). Given that variable spotting mutants exhibit a
hypopigmentation phenotype, this mutation likely impairs Ets1 protein function,
particularly as it relates to potential roles in the regulation of genes critical for
melanocyte development. Consequently, this mutation provided a means to confirm the
effect of Ets1 in Sox10-MCS4 enhancer activity. The variable spotting mutation led to a
2-fold decrease in the activation of the Sox10-MCS4 enhancer, which suggests that this
mutation is hypomorphic, since it inhibits but does not completely abrogate Ets1 protein
function. The ability of Ets1 to activate the Sox10-MCS4 enhancer and the effect of the
variable spotting mutation on Sox10-MCS4 activation suggest that Ets1 may act as a
regulator of Sox10 expression during melanocyte development.
To assess the potential role of Ets1 in regulating Sox10 expression, the effect of
Ets1 overexpression and knockdown on Sox10 expression was investigated via semiquantitative real-time PCR in Chapter 5. The expression of other genes critical for
melanocyte development, including Pax3, Mitf, Kit, Sox9, and Ednrb was also examined.
Ets1 overexpression and knockdown were carried out in mouse melanocyte and
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melanoma cell lines because mouse melanoblast survival is severely impaired by
traditional transfection protocols. The expression levels of Sox10, Pax3, Mitf, Kit, and
Ednrb were not significantly affected by Ets1 overexpression or knockdown.
Nonetheless, in mouse melanoma cells, Ets1 knockdown led to approximately a 6-fold
increase in the expression levels of the transcription factor Sox9. The lack of a change in
the expression level of Sox10 in cells where Ets1 was knocked down, suggests that the
interaction between Ets1 and Sox10 may be indirect. Alternatively, it is possible that in
the cell lines used for this experiment other factors may be able to compensate for Ets1
deficiency. In the case of Ets1 overexpression, the absence of a significant change in the
expression of Sox10 or other potential downstream targets could result if the endogenous
Ets1 protein is sufficient to drive the expression of said targets.
The expression of the transcription factor Sox9 was significantly upregulated as a
result of Ets1 knockdown in mouse melanoma cells. Sox9 has been implicated in the
development of melanocytes and other NC cell derivatives (reviewed in Hong and SaintJeannet, 2005; Silver et al., 2006; Lee and Saint-Jeannet, 2011). Sox9, along with Ets1, is
required for Sox10 expression in cranial NC cells in the chick embryo (Betancur et al.,
2010). In the mouse, Sox9 has been shown to be required for the survival of trunk NC
cells (Cheung et al., 2005) and for the formation of NC-derived chondrocytes (Bell et al.,
1997). The apparent role of Ets1 as a negative regulator of Sox9 appears to be in
contradiction with the essential functions of Sox9 in early NC development; however,
ectopic and prolonged Sox9 expression has been shown to negatively affect melanocyte
development (Qin et al., 2004), possibly because Sox9 is involved in chondrocyte fate
specification. For this reason, Ets1-induced Sox9 repression may be important for
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melanocyte differentiation by preventing the activation of genes critical for chondrocyte
differentiation. It is possible that in trunk NC cells destined to become melanocytes, Ets1
serves as a repressor of chondrocyte fate.
Together, the results of this study suggest that Ets1 plays a dual role in
melanocyte development. The transcription factor Ets1 acts early during melanocyte
development by regulating the survival of NC cells and melanoblasts. The early role of
Ets1 in NC and melanoblast survival may be mediated through an interaction with the
transcription factor Sox10. The synergistic genetic interaction between Ets1 and Sox10,
and the ability of Ets1 to activate Sox10 regulatory regions required for embryonic Sox10
expression support this possibility. In addition to being required early for NC and
melanoblast survival, Ets1 may also be indirectly involved in melanocyte fate
specification by acting as a repressor of cartilage fate.
6.2. Future Directions
This study provided insights into the role of the transcription factor Ets1 in
melanocyte development and its interaction with the transcription factor Sox10 in this
process. Future research will focus on characterizing the molecular interaction between
Ets1 and Sox10 and Ets1 and Sox9, and on in vivo experiments aimed at understanding
whether the regulatory role of Ets1 on Sox9 expression impacts melanocyte development.
Although an apparent decrease in Sox10 expression was observed in Ets1 null
mutant embryos compared to heterozygous and wild type littermates, additional
experiments, involving the labeling and quantification of Sox10 positive cells, are needed
to determine whether Ets1 does in fact regulate embryonic Sox10 expression, or whether
this apparent decrease in Sox10 expression is the result of a decrease in the number of
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Sox10 positive cells. Sox10 expression was found to be unaffected by Ets1 knockdown
and overexpression in mouse melanocyte and melanoma cell lines; however, these cell
lines do not accurately represent the conditions present in melanoblasts. Given the
difficulties involved with the transfection of melanoblasts, experiments involving viral
infection as a means of overexpressing and knocking down Ets1 will be useful in
addressing a potential role for Ets1 in regulating Sox10 expression during melanocyte
development. Mouse NC cultures from Ets1 null, heterozygous and wild type embryos
may also be able to provide some insight regarding the timing during which Ets1 is
critical for melanocyte development and the regulation of other genes critical in this
process. Neural crest cultures can also be used as a tool to assay the effect of Ets1
deficiency on migration and fate specification.
Using in vitro luciferase reporter assay Ets1 was shown to activate the Sox10MCS4 enhancer. Bioinformatic analysis revealed the presence of 4 putative Ets1 binding
sites in this enhancer, which suggests that Ets1 may act by directly binding this Sox10
regulatory region. Mutation or deletion of the putative Ets1 binding sites within Sox10MCS4, along with Chromatin Immunoprecipitation (ChIP) assays may provide some
insight into whether the effect of Ets1 is mediated by direct binding to the Sox10-MCS4
enhancer. It will also be important to characterize the effects of the variable spotting
mutation on Ets1 protein function in order to understand how this mutation affects the
activation of downstream targets.
Gene expression analysis revealed a negative relationship between Ets1 and the
transcription factor Sox9 in mouse melanoma cells; however, it is unclear whether this
relationship exists in melanoblasts, and whether it is relevant in vivo. Future experiments
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should be aimed at characterizing Sox9 expression in Ets1 mutant embryos in vivo, and in
mouse melanoblasts and NC cells in vitro, using similar methods as aforementioned. If
Sox9 is found to be upregulated in Ets1 mutant mice, a detailed characterization of
chondrocyte precursor numbers and location could provide insight into a putative role for
Ets1 in NC lineage specification. The effect of Ets1 overexpression on Sox9 promoter
activation, in cells known to express Sox9, and direct binding of Ets1 to the Sox9
promoter, should also be assayed to determine whether Ets1 inhibits Sox9 expression
directly or indirectly.
In this study we also characterized the effect of Ets1 deficiency on the
development of enteric ganglia, which also derive from the NC. This study provided
evidence to support a role for Ets1 in gut innervation and a potential interaction with
Sox10 in this process. Additional cell survival and proliferation assays to compare the
numbers of dying and proliferating enteric ganglia precursor cells in Ets1-/-::Sox10+/+ and
Ets1-/-::Sox10LacZ/+ embryos are needed to determine whether Ets1 and Sox10 work
together to promote the survival and/or proliferation of these cells.
The results of this study in combination with the future work proposed will
provide a better understanding of the gene regulatory network directing melanocyte
development. A detailed characterization of this network is critical because alterations in
genes required for the development of melanocytes and other NC cell derivatives have
been recognized in human pathological conditions, including cancer. Many of the genes
required for melanocyte survival, proliferation, migration, and/or differentiation during
embryogenesis, have also been linked to melanoma development and progression. Some
transcription factors, such as Mitf, Pax3, Sox10 and Lef1, which are required for
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melanocyte development, have also been found to be either amplified or up-regulated in
melanoma tumors compared to normal melanocytes (Larue and Delmas, 2006; Levi et al.,
2006; Kubic et al., 2008; Plummer et al., 2008; Flamminger et al., 2009; Bakos et al.,
2010). Several studies have also reported increased Ets1 expression in melanoma lesions,
compared to benign melanocytic lesions and primary melanocytes (Keehn et al., 2003;
Rothhammer et al., 2004; Rothhamer et al., 2005). A better understanding of the
signaling molecules and transcription factors involved in melanocyte development will be
instrumental for the creation of more effective therapies against melanoma and other
pathological conditions of melanocytes.
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APPENDIX I
A. Transformation
For each plasmid used, transformation into Escherichia coli Dh5αTM-T1R chemically
competent cells (Life Technologies) was carried out as follows. A vial of E. coli Dh5α
competent cells (Life Technologies) containing 50µl of cell suspension was removed
from - f7D:J>7M;:ED?9; 2EHA?D=D;7H7<B7C;, 1µl of 100-200ng/µl plasmid DNA
was added to the vial of chemically competent cells. The tube was closed tightly and the
cells gently mixed by tapping the tube 2 times. Cells were incubated on ice for 30
C?DKJ;I  ;BBI M;H; J>;D >;7J I>E9A;: 7J f ?D 7 M7J;H 87J> <EH   I;9onds and
incubated on ice for 5 minutes. After 5 minutes, working near a flame, 250µl of room
temperature S.O.C medium (Life Technologies) was added to the vial of cells. Cells were
J>;D?D9K87J;:7Jf<EH>EKH HE9A?D=7J -+( 2EHA?D=D;7H7<B7Ce, cells were
spread on pre-warmed Luria Broth (LB) agar plates (1% Bacto-Tryptone (BD
Biosciences), 0.5% yeast extract (Fisher Scientific), 1% NaCl (Fisher Scientific), 1.5%
agarose (Fisher Scientific)), containing 100µg/ml Ampicillin (Fisher Scientific). The
following dilutions were plated: 20µl of cell suspension + 80µl of LB, 50µl of cell
suspension + 50µl of LB, or 100µl of undiluted cell suspension. Sterile, flamed Pasteur
pipets were used to spread cell suspensions on the LB agar plates. Plates were allowed to
dry at room temperature, near a flame for 15 minutes and then incubated overnight,
KFI?:;:EMD7Jf 
B. Pre-culture and Overnight Culture Preparation
Plates containing transformed 9;BBI M;H; H;CEL;: <HEC J>; f ?D9K87JEH 7<J;H
overnight incubation following transformation. Working near a flame, individual colonies
from each plate were carefully selected, using a different sterile pipet tip for each colony,
and placed in sterile 15ml conical tubes (Fisher Scientific) containing 3ml of LB media
with 100µg/ml Ampicillin (Fisher Scientific). /K8;IM;H;?D9K87J;:7Jf <EH>EKHI 
For colonies that produced growth, 100µl of pre-culture were added to a sterile 50ml
centrifuge tube containing 10ml of LB media with 100µg/ml Ampicillin. Cultures were
incubated overnight (no more than 16 hours).
C. Glycerol Stock Preparation
Plasmid purification was carried out using the Promega Wizard Plus SV Minipreps DNA
Purification System (Promega) or the QIAprep Spin Miniprep Kit (Qiagen), following the
manufacturer’s instructions. Approximately 8ml of overnight culture were used for
plasmid purification (2 minipreps of 4ml each). The remaining 2ml of culture were used
to prepare glycerol stocks (between 3 and 4 stocks per construct).
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Glycerol stocks were prepared from overnight cultures for cryopreservation. Working
near a flame 600µl of filtered, sterile 50% Glycerol (Fisher Scientific) were added to a
2ml cryovial (Corning). Subsequently 400µl of overnight culture were added to the vial,
which was then sealed tightly. Cells were mixed very gently by tapping the tube 3 times.
Cryovials were then placed on ice and transferred to - f<EHBED=J;HCIJEH7=;
Note: The cultures used for glycerol stocks were confirmed to contain the desired
plasmid prior to preparing the glycerol stock. For plasmids used for in situ hybridization
riboprobe synthesis, purified plasmids were visualized via gel electrophoresis (1%
agarose). Plasmids used for transfections into mammalian cells (luciferase and
overexpression assays) were analyzed via Polymerase Chain Reaction (PCR) or DNA
sequencing.

APPENDIX II
Embryo Powder
E15.5 embryos were dissected in cold PBS (pH7.4). Embryos were homogenized in PBS
by passing the embryos first through a 1ml pipette and then through a syringe with
18gauge 1 ½ inch needle. The homogenized embryos were transferred to a sterile 50ml
centrifuge tube (Corning). Four volumes of cold acetone were added to the homogenized
embryos. The embryos were incubated in ice for 30 minutes and centrifuged at 10,000g,
<EH   C?DKJ;I 7J f  />; IKF;HD7J7DJ M7I :?I97H:;: 7D: J>; F;BB;J M7I M7I>;: M?J>
9EB: 79;JED;  7D: 9;DJH?<K=;: ED9; 7=7?D 7J 
=  <EH   C?DKJ;I 7J f  />;
supernatant was discarded and the pellet was placed in a mortar and macerated into a fine
powder using a pestle. The embryo powder was placed on a sheet of filter paper and airdried overnight at room temperature. The embryo powder was transferred to sterile 2ml
centrifuge tubes and stoH;:7Jf
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APPENDIX III
A. Normal Q-Q plots of original and transformed hypopigmentation area data for
generation 1 (F1)

Figure A.1 Normal Q-Q plots of raw and transformed hypopigmentation area data for
generation 1. Normal Q-Q plots before (A) and after (B) applying the Box-Cox
transformation using a lambda value of 0.35. The transformed data have a distribution
that more closely resembles the normal distribution.

B. PAWS Output for One-Way ANOVA and contrasts of hypopigmentation areas of
Generation 1 (F1)
Descriptives
Area_mm2_Lambda0.35
95% Confidence Interval
for Mean

N

Std.

Lower

Upper

Deviation

Error

Bound

Bound

Minimum

Maximum

Ets1+/-

46

1.1719

1.49371

.22024

.7283

1.6155

.00

4.93

Sox10+/-

42

1.2282

1.49597

.23083

.7620

1.6943

.00

4.21

Ets1+/-::Sox10+/-

33

4.0468

1.34398

.23396

3.5702

4.5233

.00

6.50

121

1.9755

1.92505

.17500

1.6290

2.3220

.00

6.50

Total

	
  

Mean

Std.

Table A.1. Descriptive statistics for Box-Cox-transformed hypopigmentation area data
for generation 1.
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Test of Homogeneity of Variances
Area_mm2_Lambda0.35
Levene Statistic

df1

3.200

df2
2

Sig.
118

.044

	
  

Table A.2. Levene’s test of Homogeneity of Variances for the areas of hypopigmentation
of Ets1+/-, Sox10LacZ/+, and Ets1+/-::Sox10LacZ/+ mice in generation 1. The population
variances are significantly different (p=0.044, α=0.05).

ANOVA
Area_mm2_Lambda0.35
Sum of Squares

df

Mean Square

Between Groups

194.741

2

97.370

Within Groups

249.958

118

2.118

Total

444.699

120

F
45.967

Sig.
.000

	
  

Table A.3. One-Way ANOVA for the areas of hypopigmentation of Ets1+/-, Sox10LacZ/+,
and Ets1+/-::Sox10LacZ/+ mice in generation 1. The population means are significantly
different (p<0.001, α=0.05).

Contrast Coefficients
Contrast

Genotype
Ets1+/-

1

Sox10+/1

Ets1+/-::Sox10+/1

-2

	
  

Table A.4. Contrast Coefficients assigned to Ets1+/-, Sox10LacZ/+, and Ets1+/-::Sox10LacZ/+
mice in generation 1. These contrast coefficients were assigned to test whether the mean
area of hypopigmentation of Ets1+/-::Sox10LacZ/+ mice was significantly greater than the
sum of the mean areas of hypopigmentation of Ets1+/- and Sox10LacZ/+ mice.
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Contrast Tests
Contrast

Value of

Std.

Contrast

Error

t

df

Sig. (2-tailed)

Area_mm2_

Assume equal variances

1

-5.6935 .59435

-9.579

118

.000

Lambda0.35

Does not assume equal

1

-5.6935 .56633

-10.053

63.517

.000

variances

Table A.5. Contrast test comparing the sum of the mean areas of hypopigmentation in
Ets1+/- and Sox10LacZ/+ mice to the mean area of hypopigmentation of Ets1+/-::Sox10LacZ/+
mice in generation 1. The mean area of hypopigmentation of Ets1+/-::Sox10LacZ/+ mice is
significantly greater than the sum of the mean areas of hypopigmentation of Ets1+/- and
Sox10LacZ/+ mice (equal variances not assumed (Table A.2), p<0.001, α=0.05).

C. Normal Q-Q plots of original and transformed hypopigmentation area data for
generation 2 (F2)

Figure A.2 Normal Q-Q plots of raw and transformed hypopigmentation area data for
generation 2. Normal Q-Q plots before (A) and after (B) applying the Box-Cox
transformation using a lambda value of 0.3. The transformed data have a distribution that
more closely resembles the normal distribution.
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D. PAWS Output for One-Way ANOVA and contrasts of hypopigmentation areas of
	
  
Generation 2 (F2)
Descriptives
Area_mm2_Lambda0.3
95% Confidence Interval
for Mean

N

Mean

Std.

Std.

Lower

Upper

Deviation

Error

Bound

Bound

Minimum

Maximum

Ets1+/-

29

.8388

1.14211

.21208

.4044

1.2732

.00

3.62

Sox10+/-

19

1.2997

1.36898

.31407

.6399

1.9595

.00

3.45

Ets1+/-::Sox10+/-

28

3.5491

1.30402

.24644

3.0435

4.0548

.00

6.11

Total

76

1.9526

1.75732

.20158

1.5510

2.3541

.00

6.11

Table A.6. Descriptive statistics for Box-Cox-transformed hypopigmentation area data
for generation 2.

Test of Homogeneity of Variances
Area_mm2_Lambda0.3
Levene Statistic
1.121

df1

df2
2

Sig.
73

.332

Table A.7. Levene’s test of Homogeneity of Variances for the areas of hypopigmentation
of Ets1+/-, Sox10LacZ/+, and Ets1+/-::Sox10LacZ/+ mice in generation 2. The population
variances are not significantly different (p=0.332, α=0.05).

ANOVA
Area_mm2_Lambda0.3
Sum of Squares

df

Mean Square

Between Groups

115.443

2

57.722

Within Groups

116.170

73

1.591

Total

231.613

75

F
36.272

Sig.
.000

Table A.8. One-Way ANOVA for the areas of hypopigmentation of Ets1+/-, Sox10LacZ/+,
and Ets1+/-::Sox10LacZ/+ mice in generation 2. The population means are significantly
different (p<0.001, α=0.05).
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Contrast Coefficients
Contrast

Genotype
Ets1+/-

1

Sox10+/1

Ets1+/-::Sox10+/1

-2

Table A.9. Contrast Coefficients assigned to Ets1+/-, Sox10LacZ/+, and Ets1+/-::Sox10LacZ/+
mice in generation 2. These contrast coefficients were assigned to test whether the mean
area of hypopigmentation of Ets1+/-::Sox10LacZ/+ mice was significantly greater than the
sum of the mean areas of hypopigmentation of Ets1+/- and Sox10LacZ/+ mice.

Contrast Tests
Contrast

Value of

Std.

Contrast

Error

t

df

Sig. (2-tailed)

Area_mm2_ Assume equal variances

1

-4.9597

.60495

-8.199

73

.000

Lambda0.3

1

-4.9597

.62172

-7.977 53.392

.000

Does not assume equal
variances

Table A.10. Contrast test comparing the sum of the mean areas of hypopigmentation in
Ets1+/- and Sox10LacZ/+ mice to the mean area of hypopigmentation of Ets1+/-::Sox10LacZ/+
mice in generation 2. The mean area of hypopigmentation of Ets1+/-::Sox10LacZ/+ mice is
significantly greater than the sum of the mean areas of hypopigmentation of Ets1+/- and
Sox10LacZ/+ mice (equal variances assumed (Table A.7), p<0.001, α=0.05).
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E. Normal Q-Q plots of original and transformed hypopigmentation area data for
generation 3 (F3)

Figure A.3 Normal Q-Q plots of raw and transformed hypopigmentation area data for
generation 3. Normal Q-Q plots before (A) and after (B) applying the Box-Cox
transformation using a lambda value of 0.35. The transformed data have a distribution
that more closely resembles the normal distribution.

F. PAWS Output for One-Way ANOVA and contrasts of hypopigmentation areas of
Generation 3 (F3)
Descriptives
Area_mm2_Lambda0.35
95% Confidence
Interval for Mean

N

Mean

Std.

Std.

Lower

Upper

Deviation

Error

Bound

Bound

Minimum

Maximum

Ets1+/-

26

1.1366

1.45646

.28564

.5484

1.7249

.00

4.32

Sox10+/-

17

1.4384

1.78357

.43258

.5213

2.3554

.00

5.77

Ets1+/-::Sox1o+/-

34

4.8214

1.63322

.28009

4.2516

5.3913

1.34

8.19

Total

77

2.8303

2.39041

.27241

2.2877

3.3729

.00

8.19

Table A.11. Descriptive statistics for Box-Cox-transformed hypopigmentation area data
for
	
   generation 3.
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Test of Homogeneity of Variances
Area_mm2_Lambda0.35
Levene Statistic

df1

.492

df2
2

Sig.
74

.613

Table
A.12. Levene’s test of Homogeneity of Variances for the areas of
	
  
hypopigmentation of Ets1+/-, Sox10LacZ/+, and Ets1+/-::Sox10LacZ/+ mice in generation 3.
The population variances are not significantly different (p=0.613, α=0.05).

ANOVA
Area_mm2_Lambda0.35
Sum of Squares

df

Mean Square

Between Groups

242.313

2

121.156

Within Groups

191.954

74

2.594

Total

434.267

76

F
46.707

Sig.
.000

Table A.13. One-Way ANOVA for the areas of hypopigmentation of Ets1+/-, Sox10LacZ/+,
and Ets1+/-::Sox10LacZ/+ mice in generation 3. The population means are significantly
different (p<0.001, α=0.05).

Contrast Coefficients
Contrast

Genotype
Ets1+/-

1

Sox10+/1

Ets1+/-::Sox1o+/1

-2

Table A.14. Contrast Coefficients assigned to Ets1+/-, Sox10LacZ/+, and Ets1+/::Sox10LacZ/+ mice in generation 3. These contrast coefficients were assigned to test
whether the mean area of hypopigmentation of Ets1+/-::Sox10LacZ/+ mice was significantly
greater than the sum of the mean areas of hypopigmentation of Ets1+/- and Sox10LacZ/+
mice.
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Contrast Tests
Contrast

Value of

Std.

Contrast

Error

t

df

Sig. (2-tailed)

Area_mm2_ Assume equal variances

1

-7.0678

.74668

-9.466

74

.000

Lambda0.35 Does not assume equal

1

-7.0678

.76323

-9.260 62.390

.000

variances

	
  

Table A.15. Contrast test comparing the sum of the mean areas of hypopigmentation in
Ets1+/- and Sox10LacZ/+ mice to the mean area of hypopigmentation of Ets1+/-::Sox10LacZ/+
mice in generation 3. The mean area of hypopigmentation of Ets1+/-::Sox10LacZ/+ mice is
significantly greater than the sum of the mean areas of hypopigmentation of Ets1+/- and
Sox10LacZ/+ mice (equal variances not assumed (Table A.12), p<0.001, α=0.05).
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APPENDIX IV

Figure A.4. Acetylcholinesterase staining on the distal portion of colons from Ets1+/::Sox10+/+ mice. For each colon shown, the nerve free area in 8 randomly selected
0.25mm2 squares was measured using the ImageJ Program (NIH) (Magnifications A-E =
16x, F=12.5x).
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Figure A.5. Acetylcholinesterase staining on the distal portion of colons from Ets1+/::Sox10LacZ/+ mice. For each colon shown, the nerve free area in 8 randomly selected
0.25mm2 squares was measured using the ImageJ Program (NIH) (Magnifications A-E =
16x).
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Figure A.6. Acetylcholinesterase staining on the distal portion of colons from Ets1-/::Sox10+/+ mice. For each colon shown, the nerve free area in 8 randomly selected
0.25mm2 squares was measured using the ImageJ Program (NIH) (Magnifications A-H =
16x).
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Figure A.7. Acetylcholinesterase staining on the distal portion of colons from Ets1-/::Sox10LacZ/+ mice. For each colon shown, the nerve free area in 8 randomly selected
0.25mm2 squares was measured using the ImageJ Program (NIH) (Magnifications A-E =
16x).
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APPENDIX V
Ethanol Precipitation
Ethanol precipitation was carried out to purify and concentrate plasmids to be used for
transfections into mammalian cells. The process was carried out in a biosafety hood to
avoid contamination. To each plasmid, 2.5 volumes of 100% ethanol (Fisher Scientific)
and one tenth volume of 3M Na+ Acetate (Fisher Scientific) were added and the samples
mixed gently by inverting. Plasmids were incubated overnight at - f *DJ>;<EBBEM?D=
:7O  FB7IC?:I M;H; 9;DJH?<K=;: 7J 
 -+(    C?DKJ;I 7J f 7D: J>; IKF;HD7J7DJ
discarded. Plasmids were washed with 70% Ethanol (diluted in Nuclease-free water
(Thermo Scientific) 7D:9;DJH?<K=;:7J
-+( C?DKJ;I7Jf <J;H:?I97H:?D=
the supernatant plasmid pellets were allowed to dry for 10 minutes at room temperature.
Plasmids were then re-suspended in nuclease-free water and the concentration of each
plasmid was measured using a spectrophotometer. All plasmids were diluted to the
desired final concentrations using nuclease-free water.
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